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Abstract 
 
Previously, a protein O-mannosyl transferase (Pmt, SCO3154) and a polyprenol phosphate 
mannose synthase (Ppm1, SCO1423) were found to be required for the glycosylation of PstS, 
a phosphate binding protein, in the bacterium Streptomyces coelicolor. Bacteria in this genus 
are prolific producers of antibiotics and are often phenotypically resistant to multiple 
antibiotics. S. coelicolor pmt and ppm1 deficient mutants were hypersusceptible to cell-wall 
active antibiotics, suggesting that the protein modification could be required for cell wall and 
membrane homeostasis. The aim of this project was to investigate the S. coelicolor 
glycoproteome in order to better understand the physiological role of protein O-
glycosylation in this model actinobacterium. Glycoproteins were detected in, and enriched 
from the membrane and culture filtrate proteomes of the S. coelicolor parent strain, J1929 
and these were absent from the glycosylation deficient pmt (DT1025) and ppm1 (DT3017) 
mutants. Liquid chromatography coupled to mass spectrometry was used to characterise the 
membrane glycoproteome from the S. coelicolor parent strain, J1929 and 37 new 
glycoproteins were identified. Glycopeptides were modified on Ser/Thr residues with up to 
3 hexoses; consistent with previous observations that the glycoprotein PstS is modified with 
a trihexose. The S. coelicolor glycoprotein glycans were shown to consist of Hex₂ and Hex₃ 
oligosaccharides. A carbohydrate linkage analysis led to the observation of 2-substituted, 4-
substituted and terminal mannose residues, suggesting presence of (1->2) and (1->4) 
linkages in S. coelicolor glycoprotein glycans. The S. coelicolor glycoproteome comprises 
glycoproteins with various biological roles including solute binding, transport and cell wall 
biosynthesis. The genes encoding two S. coelicolor glycoproteins with putative roles in cell 
wall biosynthesis, an L, D transpeptidase (SCO4934) and a D-Ala-D-Ala, carboxypeptidase 
(SCO4847) were disrupted. Both mutants were hypersusceptible to β-lactam antibiotics, 
while the sco4847 mutant was hypersusceptible to lysozyme. These findings suggest that 
both proteins could be required for cell wall biosynthesis. As the phenotypes of the knockout 
mutants are reminiscent of the glycosylation deficient strains, we propose that   glycosylation 
might be required for enzyme function. 
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Chapter 1 – Introduction 
 
1.1 Protein glycosylation is present in all domains of life. 
 
Protein glycosylation, which is defined as the co- or posttranslational modification of a 
protein by the addition of a glycan, is one of the most complex and diverse protein 
modifications in nature (Spiro 1973). A variety of carbohydrates, as well as a range of 
anomeric configurations have been identified in glycoproteins in all domains of life (Spiro 
2002). Protein glycosylation is considered to be one of the most ubiquitous protein 
modifications in eukaryotes, with at least two thirds of all eukaryotic proteins estimated to 
be glycosylated (Dell et al. 2011). Most commonly, protein glycosylation occurs through the 
attachment of glycans to polypeptide chains through amide linkages to asparagine (Asn) 
residues (N-glycosylation), glycosidic linkages to serine(Ser)/threonine(Thr) residues (O-
glycosylation) or C-C linkages to tryptophan (Trp) residues (C-mannosylation). N-
glycosylation pathways have been characterised in all domains of life and despite some 
variations between species, involve the synthesis of the lipid linked oligosaccharide (LLO) and 
the en bloc transfer of the oligosaccharide onto acceptor polypeptides; a process mediated 
by an oligosaccharyltransferase (OST) (Dell et al. 2011). In contrast, protein O-glycosylation 
pathways tend to be processive, involving the sequential addition of monosaccharides to 
acceptor peptides. However, OST mediated O-glycosylation of bacterial pilins has been 
identified (discussed in 1.3.2). This introduction will focus on protein O-glycosylation 
pathways; mainly protein O-mannosylation and the role of the pathway in maintaining cell 
wall homeostasis. 
 
1.2 Protein O-glycosylation in eukaryotes. 
 
1.2.1 Mammalian protein O-glycosylation   
 
The most well studied examples of mammalian glycoproteins are mucins. Mucins are high 
molecular mass proteins that are characteristically heavily glycosylated in tandem repeats of 
Ser/Thr/Pro residues, found as cell surface exposed glycoproteins and in mucous secretions 
(Varki et al. 2009). Encoded by the MUC genes, mucins have roles in the lubrication of 
epithelial cells, serving as cell receptors, in fertilisation and in the immune response. In 
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humans, many diseases have been associated with abnormal mucin glycosylation. For 
example, the mucin polypeptide encoded by the MUC1 gene in humans is abnormally 
glycosylated in breast and other carcinomas (Brockhausen et al. 1995). Aberrant O-
glycosylation of cancer cells has been implicated in their attachment and invasion, as well as 
in their ability to survive in the blood stream (Brockhausen 1999).  
In contrast to the en bloc N-glycosylation of eukaryotic proteins in the endoplasmic reticulum 
(ER), O-glycosylation occurs mostly in the Golgi apparatus and is thought to involve the 
sequential addition of glycans to amino acids with a hydroxyl group (Ser, Thr, Tyr, Hyp 
[hydroxyproline] and Hyl [hydroxylysine]) (Spiro 2002; Varki et al. 2009). Mucins can be O-
glycosylated with a variety of monosaccharides including N-acetylgalactosamine (GalNAc), 
fucose (Fuc), mannose (Man), glucose (Glc), galactose (Gal), arabinose (Ara), xylose (Xyl), and 
N-acetylglucosamine (GlcNAc), in both α and β configurations. The first step in the 
glycosylation of mucin polypeptides is the covalent α-linkage of an O-GalNac moiety to the 
hydroxyl group of Ser/Thr, carried out by a polypeptide N-acetyl-galactosaminyltransferase 
(ppGalNAcT) (Varki et al. 2009). The sequential addition of other monosaccharides can result 
in the synthesis of a range of mucin structures (Figure 1.1). In contrast to the assembly of an 
oligosaccharide on a lipid linked carrier in N-glycosylation pathways, no lipid linked carrier is 
required in the synthesis of O-linked glycoproteins. Additionally, further processing of the O-
GalNac glycans by glycosidases in the Golgi, as is observed in the processing of N-linked 
glycans, does not occur. 
In addition to the O-glycosylation of secreted and membrane bound proteins in eukaryotes, 
the modification of nuclear and cytoplasmic proteins with simple O-GlcNac residues has been 
reported (Torres and Hart 1984; Wells et al. 2001; Hart 1997). Despite no consensus 
sequence having been identified, single O-GlcNac residues have been shown to modify 
Ser/Thr residues in cytoplasmic and nuclear proteins. O-GlcNAcylation is thought to have a 
role in the cellular signalling and regulation, T lymphocyte activation and the protection of 
proteins against cellular degradation (Kearse and Hart 1991; Han and Kudlow 1997; Swain et 
al. 2002). 
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Figure 1.1 Representative examples of O-GalNAc glycans from human respiratory mucins 
composed of different cores, which can be further extended and branched. Image adapted 
from Varki et al. (2009). 
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1.2.2 Protein O-mannosylation in yeast. 
 
Protein O-mannosylation was discovered in the cell-wall isolated proteins of S. cerevisiae and 
was long thought to be restricted to fungi (Sentandreu and Northcote 1968). While it is now 
clear that the modification is present in many eukaryotes and has also been identified in 
prokaryotes (discussed in section 1.3.3 and 1.5.2), many of the fundamental characteristics 
of the pathway have been elucidated in yeast (Loibl and Strahl 2013). Protein O-
mannosylation involves the sequential attachment of mannose (Man) to the hydroxyl of 
Ser/Thr residues in polypeptide chains, via a glycosidic linkage (Spiro 2002). O-mannosyl 
glycan synthesis is initiated in ER and is catalysed by a conserved family of 
glycosytransferases, PMTs (Haselbeck and Tanner 1983). The protein O-mannosylation 
pathway involves two main steps: the synthesis of the mannosyl donor and the transfer of 
mannose onto target polypeptide chains (Figure 1.2).  
The eukaryotic mannosyl donor, dolichol phosphate β-D-mannose (Dol-P-Man) is 
synthesised on the cytoplasmic face of the ER membrane where a glycosyltransferase GDP-
α-D-Man:Dol-P ß-D-mannosyltransferase (Dpm1) catalyses the transfer of mannose from 
GDP-α-D-mannose (GDP-Man) to Dol-P (Lommel and Strahl 2009). The baker’s yeast Dpm1 
(Dpm1p) was first identified by Haselbeck (1989) and its catalytic activity demonstrated after 
the heterologous expression of the enzyme in E. coli (Orlean et al. 1988). Dol-P-Man serves 
as the primary mannosyl donor for the protein O-mannosylation pathway in eukaryotes, 
however it is also required for the extension of the LLO in the ER in the protein N-
glycosylation pathway (Figure 1.2), as well as in GPI anchor biosynthesis (Kornfeld and 
Kornfeld 1985; Doering et al. 1990). Dol-P-Man was shown to be essential in yeast after dpm1 
knockout mutants were found to be lethal (Orlean 1990). This is not surprising considering 
the general requirement of the Dol-P-Man glycosyl donor for the synthesis of mannans in 
yeast. DPM1 homologues have been identified in other fungi, as well as in many other higher 
eukaryotes, including mice and humans (Zimmerman et al. 1996; Colussi et al. 1997; Tomita 
et al. 1998; Maeda and Kinoshita 2008). In humans, defects in DPM1 leading to changes in 
protein O-glycosylation patterns, are known to cause metabolic disorders that often result 
in mental and psychomotor retardation, termed congenital disorders of glycosylation 
(CDGs).  
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Figure 1.2 The protein O-mannosylation pathway in yeast shares dolichol phosphate-
mannose with the N-glycosylation pathway and GPI anchor biosynthesis. Images adapted 
from Loibl and Strahl (2013). 
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Following the synthesis of Dol-P-Man by Dpm1, the Dol-P-Man is flipped into the ER lumen, 
most likely via the action of a flippase (Lommel and Strahl 2009). A second 
glycosyltransferase, Dol-P-Man:protein O-mannosyltransferases (Pmt) then catalyses the 
transfer of Man from Dol-P-Man onto Ser/Thr residues of target proteins (Figure 1.2). Early 
work on protein O-mannosylation in yeast led to the suggestion that protein O-
mannosylation was coupled to translocation into the ER (Elorza et al. 1977). However, some 
studies have reported Pmt mediated O-mannosylation of proteins after translocation into 
the ER when they are misfolded, suggesting that the modification increases protein solubility 
and reduces the need for chaperones (Harty et al. 2001; Nakatsukasa et al. 2004).  
After the transfer of mannose onto target proteins in the ER, the glycoproteins can be further 
modified in the Golgi apparatus. In S. cerevisiae for example, extension of the glycan is 
carried out by mannosyltransferases of the KTR- and MNN1-family that can generate α(1,2) 
and  α(1,3) linkages (Lussier et al. 1999).  
Pmts belong to the GT-C family of glycosyltransferases, that are integral membrane proteins 
with between 7 and 13 transmembrane helices (Lairson et al. 2008; Lommel and Strahl 2009). 
S. cerevisiae has at least six PMT family members (Pmt1p-Pmt6p) (Strahl‐Bolsinger and 
Tanner 1991; Strahl-Bolsinger et al. 1993; Gentzsch and Tanner 1996). Strahl-Bolsinger and 
Scheinost (1999) proposed that S. cerevisiae Pmt1p consisted of seven transmembrane 
helices and that the N-terminus was localised in the cytoplasm, while the C-terminus was 
localised in the ER lumen (Figure 1.3). Further characterisation of Pmt1p demonstrated that 
the N-terminus interacts with Pmtp2 and that the central hydrophilic loop (loop 5) is required 
for mannosyltransferase activity of the enzyme (Girrbach et al. 2000). Additionally Girrbach 
et al. (2000) demonstrated that the amino acids Arg-64, Glu-78, Arg-138, and Leu-408 are 
required for Pmt1p activity (Figure 1.3).  
The disruption of PMT1 alone in S. cerevisiae demonstrated that there could be functional 
redundancy in Pmt activity and that PMT1 alone was not essential for growth (Strahl-
Bolsinger et al. 1993). However, knockout mutants in certain combinations of three PMTs in 
S. cerevisiae were lethal, suggesting that the modification is essential in yeast (Gentzsch and 
Tanner 1996). Additionally, using several combinations of double pmt mutants it was shown 
that protein O-mannosylation was required to maintain cell wall rigidity and integrity. 
Similarly, in S. pombe double mutants in PMT1 and PMT4, as well as a single knockout of 
PMT2 were lethal (Willer et al. 2005). Additionally, pmt1 and pmt4 single mutants displayed 
abnormal cell wall and septum formation, further suggesting that protein O-mannosylation  
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Figure 1.3 A schematic representation of S. cerevisiae Pmt1p, based on the work carried 
out by Girrbach et al. (2000). Pmt1p has seven transmembrane helices. Loop 5 was shown 
to be required for catalytic activity of the enzyme and three conserved motifs (MIR) were 
identified in as signatures of the PMT family proteins. The positions of the arginine (R), 
glutamic acid (D) and aspartic acid (E) residues required for activity enzyme activity are 
shown. 
 
 
 
 
  
Chapter 1 - Introduction 
28 
in yeast is required for stable cell wall formation. Since the identification of Pmts in yeast, 
PMT family proteins (termed POMTs) have been found in many higher eukaryotes (Lommel 
and Strahl 2009). The best studied O-mannosylated protein in higher eukaryotes is α-
dystroglycan (α-DG), a fundamental component of the dystrophin–glycoprotein complex 
(DGC) in skeletal muscle (Barresi and Campbell 2006). Several studies in flies have 
demonstrated that POMTs were required for correct muscle development, while a POMT1 
deficiency in mice was found to be lethal to embryonic development (Martín-Blanco and 
García-Bellido 1996; Ichimiya et al. 2004; Willer et al. 2004). In humans, the disruption of 
POMTs have been linked to changes in α-DG glycosylation, leading to congenital disorders of 
glycosylation (Muntoni and Voit 2004).  
 
1.3 Protein glycosylation in prokaryotes 
 
Prior to the mid-1970s, protein glycosylation was considered to occur exclusively in 
eukaryotes. The discovery of the first prokaryotic glycoprotein in the halophile 
Halobacterium salinarium (H. salinarium) by Mescher and Strominger (1976) challenged this 
idea. It is now clear that prokaryotes can modify proteins with both N- and O-linked glycans, 
and that these pathways have roles in pathogenesis, host invasion, maintaining cell wall 
integrity and survival in extreme environments (Nothaft and Szymanski 2010; Eichler 2013).  
 
1.3.1 Protein N-glycosylation in bacteria  
 
The first protein N-glycosylation pathway in bacteria was discovered in Campylobacter jejuni 
(C. jejuni) more than a decade ago and is arguably the most well characterised bacterial 
glycosylation system to date (Szymanski et al. 1999). Protein N-glycosylation takes place on 
the cytoplasmic face of the plasma membrane and is encoded by the pgl gene cluster 
(Szymanski et al. 1999; Linton et al. 2005). The pgl genes include five glycosyltransferases 
(pglH, pglJ, pglI, pglA, pglC), an oligosaccharyltransferase (pglB), a (UDP)-N-
acetylglucosamine: glucosamine 4-epimerase (gne), a LLO flippase (pglK) and genes involved 
in the synthesis of the rare amino sugar UDP-2,4-diacetamido bacillosamine (UDP-dinAcBac) 
(pglD, pglE, pglF) (Nothaft and Szymanski 2010). The pathway starts with the sequential 
assembly of a heptasaccharide on a lipid linked carrier, undecaprenyl pyrophosphate (Und-
PP) on the cytoplasmic face of the inner membrane (Linton et al. 2005). The lipid linked 
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heptasaccharide is translocated across the inner membrane into the periplasm, mediated by 
an ABC-type transporter with ATPase activity (PglK) (Alaimo et al. 2006). The heptasaccharide 
is transferred en bloc onto specific Asn residues on target proteins; a process mediated by 
PglB, a bacterial OST (Wacker et al. 2002). Bacteria have an N-glycosylation consensus 
sequence that is extended at the N-terminus, where a negatively charged amino acid 
(aspartic acid (D)/glutamic acid (E)) is present at the -2 position relative to the glycosylated 
Asn (N) residue (D/E-X-N-X-S/T, where X can be any amino acid except for proline) (Kowarik 
et al. 2006). Despite the full characterisation of the pathway, little is known about the role 
of the glycan. Glycosylation has been shown to be required for attachment to human 
epithelial cells, as well as for the colonisation in chickens (Jones et al. 2004; Karlyshev et al. 
2004). One study found that N-linked glycans in C. jejuni bind to human macrophage 
galactose like-lectins and suggested that N-glycosylation may serve to modulate the host 
immune response (Van Sorge et al. 2009). Recently however, work carried out by Alemka et 
al. (2013) demonstrated that N-glycosylation of cell surface proteins in C. jejuni may be 
required for protection against proteolytic cleavage by proteinases in the chicken gut. 
 
1.3.2 Pilin and flagellar O-glycosylation 
 
Flagellar O-glycosylation has been widely reported in Gram negative bacteria. The 
modification in Gram positive genera is so far limited to Clostridium and Listeria spp (Schirm 
et al. 2004; Twine et al. 2008). While no consensus sequence has been identified, the 
modification occurs on Ser/Thr residues (Logan 2006). The O-glycosylation of flagella in C. 
jejuni is probably the best described example, where the flagellin A (FlaA) and flagellin B 
(FlaB) subunits are modified with pseudaminic acid (Pse) and legionaminic (Leg) acid 
derivatives, at up to 19 different sites (Thibault et al. 2001; Zebian et al. 2016). The genes 
required for flagellar glycosylation in C. jejuni are known, and the pathway for Leg 
biosynthesis has been reconstituted in E. coli (Schoenhofen et al. 2009). Glycosylation of 
flagella in Campylobacter spp. is required for flagellar assembly and motility, and mutants 
defective in Pse biosynthesis have been shown to lack flagella and were consequently 
immobile (Goon et al. 2003). Similar observations have been made in the human pathogen 
Helicobacter pylori (H. pylori), that glycosylates flagella in a similar way to C. jejuni (Schirm et 
al. 2003). However, in H. pylori the glycans display less heterogeneity than in C. jejuni. 
Pilin glycosylation has been observed in some bacteria, and has been suggested to be 
involved in virulence. In Pseudomonas aeruginosa for example, the loss of pilin glycosylation 
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due to a deletion in the pilO gene led to reduced persistence in the lungs of mice (Smedley 
et al. 2005). Structural characterisation of the pilin glycans has demonstrated that they are 
composed of trisaccharides that are identical to the lipopolysaccharide O-antigen repeating 
unit in the strain (Castric et al. 2001). In contrast, the pilin glycans of Neisseria meningitidis 
(N. meningitidis) are modified with trisaccharides composed of Gal(β1-4)Gal(α1-3)2,4-
diacetamido-2,4,6-trideoxyhexose (Stimson et al. 1995).  
In contrast, the pilin glycans of Neisseria gonorrhoeae (N. gonorrhoeae) are thought to be 
disaccharides composed of an O-acetylated hexose residue linked to a 2,4-diacetamido-
2,4,6-trideoxyhexose (HexDATDH) (Hegge et al. 2004; Aas et al. 2007). Several studies have 
identified genes that encode proteins required for pilin glycosylation (pgl) in N. meningitides 
(Jennings et al. 1998; Power et al. 2000). These include an O-oligosaccharyltransferase (O-
OTase) PglL, which attaches the O-linked glycan to pili and was found to be part of a general 
O-glycosylation pathway in Neisseria spp. (Power et al. 2006; Ku et al. 2009). The general O-
glycosylation pathway in N. gonorrhoeae has been shown glycosylate at least 11 membrane 
proteins and lipoproteins including solute binding proteins of ABC transporters and protein 
chaperones (Vik et al. 2009). The proteins were shown to be modified on Ser/Thr residues 
with O-acetylated HexDATDH glycans, in amino acid sequence regions abundant in proline, 
alanine and serine. Similarly in N. meningitides, the general O-glycosylation pathway 
responsible for pilin glycosylation has also been shown to glycosylate the surface exposed 
glycoprotein, AniA (Ku et al. 2009). 
 
1.3.3 Protein O-mannosylation in mycobacteria 
 
While protein O-mannosylation has been described in several actinobacteria, including 
Corynebacterium spp. and Streptomyces spp. (described in section 1.5.2), it is particularly 
well studied in mycobacteria (Lommel and Strahl 2009). The earliest reports of mannosylated 
proteins in mycobacteria were described after the binding of culture filtrate proteins to the 
mannose binding lectin concanavalin A (Con A) (Espitia and Mancilla 1989; Fifis et al. 1991). 
The first direct evidence for glycosylated residues on a mycobacterial protein was presented 
by Dobos et al. (1995), who demonstrated that a 45/47 kDa culture filtrate protein from 
Mycobacterium tuberculosis (M. tuberculosis) was modified with hexoses. Further 
characterisation of the 45/47 kDa glycoprotein revealed that the modifying hexose was 
mannose and that the glycopeptides were modified on Thr residues with α-D-Man, 
mannobiose, or mannotriose (Dobos et al. 1996). Additionally, the glycosylation sites were 
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found to be localised near the N- and C- termini of the glycoprotein, in proline rich sequences. 
A carbohydrate linkage analysis revealed that the mannobiose and mannotriose glycans 
were composed of α1,2 linkages. In contrast, the characterisation of MPB83, a secreted 
glycoprotein from Mycobacterium bovis revealed that the glycoprotein was modified on 
threonine residues with mannose and α1,3-linked mannobiose (Michell et al. 2003). In 
Mycobacterium avium, the 32 kDa glycoprotein SmT was shown to be glycosylated with a 
dihexose glycan (Taylor et al. 2006). A recent study of the M. tuberculosis culture filtrate 
glycoproteome revealed that glycosylation could occur on both serine and threonine 
residues (Smith et al. 2014). Smith et al. (2014) revealed that glycosylation sites were often 
localised near the C-terminus of the glycoprotein, and that sequences surrounding the 
glycosylation sites had a higher propensity for hydrophobic amino acids (Pro, Ala).  
The protein O-glycosylation pathway in M. tuberculosis is distinctly similar to the protein O-
mannosylation pathway in S. cerevisiae (Figure 1.4.A). Mannose is thought to be transferred 
from GDP-Man onto polyprenol phosphate, a functional analogue of dolichol phosphate by 
a polyprenol phosphate mannose (Ppm) synthase. In M. tuberculosis, the catalytic activity of 
the Ppm synthase Mt-Ppm1 was shown in a cell free assay, where [¹⁴C]Man was transferred 
from GDP-Man onto various lipid monophosphate acceptors (Gurcha et al. 2002). Mt-Ppm1 
has a two domain architecture (D1 and D2), where D2 is responsible for the catalytic activity 
of the enzyme and D1 contained several transmembrane domains (Figure 1.4.B). The Mt-
Ppm1 homologues in other mycobacteria, such as Mycobacterium smegmatis (M. 
smegmatis) and Mycobacterium. leprae (M. leprae), exist as two separate proteins, Ppm1 
and Ppm2 (Gurcha et al. 2002). In M. smegmatis, Ms-Ppm2 was shown to be an integral 
membrane protein that interacts with, and enhances the catalytic activity of Ms-Ppm1 
(Baulard et al. 2003). These findings suggested that the two-domain architecture of Mt-Ppm1 
had a role in anchoring the protein to the membrane.  
Using a bioinformatics approach, a PMT homologue (Rv1002c) was identified in M. 
tuberculosis and shown to catalyse the first step of protein O-glycosylation of proteins that 
were translocated via the SEC pathway (VanderVen et al. 2005). An additional 
glycosyltransferase, a Ppm-dependent α1,2-mannosyltransferase (PimE) that was identified 
in M. smegmatis, is thought to be required for the elongation of the glycan chain (Morita et 
al. 2006; Liu et al. 2013a). Since α1,2-linked mannobiose and mannotriose glycans have been 
observed in M. tuberculosis glycoproteins, it is likely that a similar mechanism is present in 
other Mycobacterium spp. (Dobos et al. 1996).  
Chapter 1 - Introduction 
32 
  
 
 
 
 
 
 
Figure 1.4 Protein O-mannosylation in M. tuberculosis. A. The D2 domain of Mt-Ppm1 
catalyses the transfer of mannose from GDP-Man onto polyprenol phosphate (1). Mt-Pmt 
catalyses the first step of protein O-glycosylation by transferring mannose from polyprenol 
phosphate mannose onto target proteins, as they emerge from the SEC machinery (2). PimE 
further elongates the glycan chain by the addition of mannose with α1,2 linkages (3). B. A 
schematic representation of the ppm1 locus in M. tuberculosis, compared to M. leprae and 
M. smegmatis. Figure adapted from (Gurcha et al. 2002).  
Chapter 1 - Introduction 
33 
In pathogenic mycobacteria, protein O-glycosylation is thought to have a role in 
pathogenicity. The glycosylation of secreted glycoproteins has been shown to be required 
for antigenicity and the stimulation of the T lymphocyte response (Horn et al. 1999; Romain 
et al. 1999). The altered glycosylation pattern of the 45/47 kDa glycoprotein (Apa) after its 
heterologous expression in M. smegmatis resulted in a reduced capacity to stimulate a T 
lymphocyte response in vitro, while unglycosylated Apa was unable to stimulate this 
response altogether (Horn et al. 1999). The glycosylation of Apa has been shown to be 
required to enable its interaction with C-type lectins of the host immune system, further 
suggesting that the protein is important for immune recognition (Ragas et al. 2007). 
Additionally, a secreted glycoprotein from M. tuberculosis, SodC was recognized by human 
antibodies and was shown to contribute towards the persistence of the bacterium in 
macrophages (Piddington et al. 2001; Sartain et al. 2006; Sartain and Belisle 2009). M. leprae 
was shown to bind in a carbohydrate specific manner to r-langerin, suggesting its role in 
langerin ligand binding and host immune response stimulation (Kim et al. 2015). These 
studies suggest that the immunogenicity of secreted antigens in pathogenic mycobacteria is 
linked to their correct glycosylation, alluding to the idea that a disruption of glycosylation 
could significantly affect pathogenesis. Indeed, the inactivation of pmt (Rv1002c) in M. 
tuberculosis and the subsequent loss of protein O-glycosylation was shown to significantly 
impair growth and reduce its pathogenicity in immunocompromised mice (Liu et al. 2013a). 
M. smegmatis pmt mutants display no changes in growth however, were hypersensitive to 
SDS-treatment, suggesting that a loss of Pmt may result in changes in the cell wall. 
 
1.4 Bacterial cell walls and antibiotics 
 
1.4.1 Peptidoglycan biosynthesis in bacteria 
 
Peptidoglycan is the major polymer found in the cell walls of Gram positive and Gram 
negative bacteria. It has a crucial role in maintaining cell shape and counteracting turgor 
pressure (Typas et al. 2012). While variations exist, the basic peptidoglycan architecture in 
conserved in nearly all cell wall containing bacteria. In Gram positive bacteria, the cell wall is 
thick and multi-layered, where peptidoglycan is incorporated near the surface of the 
periplasmic membrane. Peptidoglycan biosynthesis starts in the cytoplasm with the 
biosynthesis of UDP-N-acetylmuramyl-pentapeptide (UDP-MurNAc-pentapeptide) and UDP-
N-acetyl glucosamine  (UDP-GlcNAc) (Figure 1.5)  (Barreteau et al. 2008).   
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Figure 1.5 A general overview of peptidoglycan biosynthesis in Gram positive bacteria. Red 
text indicates antibiotics that inhibit different aspects of cell wall biosynthesis. Images 
adapted from Typas et al. (2012).  
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The UDP-MurNAc pentapeptide is synthesised through a series of enzymatic reactions that 
sequentially add amino acids to UDP-MurNAc. The most common muropeptide is seen as L-
alanine-D-glutamic acid-meso diaminopimelic acid- (or L-lysine)-D-alanine-D-alanine. 
However variations in the peptide are widely reported in many bacterial species (Vollmer et 
al. 2008). At the cytoplasmic membrane, the MurNAc pentapeptide moiety is transferred 
from the nucleotide precursor onto a membrane lipid-linked acceptor, undecaprenyl 
phosphate, yielding undecaprenyl-pyrophosphoryl-MurNAc-pentapeptide (Bouhss et al. 
2008). In Gram positive bacteria, the GlcNAc moiety is added to the undecaprenyl-
pyrophosphoryl-MurNAc-pentapeptide and the lipid-linked stem pentapeptide is then 
flipped into the periplasm. Once facing the periplasm, the stem pentapeptide is incorporated 
into nascent peptidoglycan by penicillin binding proteins. 
Penicillin binding proteins (PBPs) are a class of cell wall biosynthetic enzymes in bacteria that 
are required to catalyse various reactions, such as the polymerisation of the glycan strand 
(transglycosylation) and peptidoglycan crosslinking (transpeptidation) (Sauvage et al. 2008). 
Some PBPs recognise the terminal D-alanyl- D-alanine (D-Ala-D-Ala) of stem pentapeptides 
as part of their catalytic mechanism. The structural resemblance between the D-Ala-D-Ala of 
peptide stems and the β-lactam antibiotic penicillin, means that PBPs can bind penicillin 
irreversibly by forming an acyl-enzyme that inhibits further activity of the PBP in cell wall 
biosynthesis (Tipper and Strominger 1965). There are two main types of PBPs in bacteria: 
high molecular mass (HMM) PBPs and low molecular mass (LMM) PBPs (Sauvage et al. 2008). 
HMM PBPs are often multifunctional enzymes with transpeptidase activity and the ability to 
elongate glycan chains that are uncross-linked (transglycosylation). LMM PBPs are generally 
monofunctional enzymes. Streptomycetes produce large numbers of PBPs, most likely due 
to their complex life cycle and challenging environment. S. coelicolor for example, is 
predicted to make at least 20 PBPs. However, the functional roles of very few of these have 
been characterised (Sauvage et al. 2008). 
 
1.4.2 Peptidoglycan crosslinking 
 
There are two main types of peptidoglycan crosslinking in bacteria, 4->3 crosslinking and 3-
>3 crosslinking. Most commonly, peptidoglycan crosslinking occurs between the carboxyl 
group of D-Ala at position 4 and the amine group of the amino acid at position 3 (4->3 
crosslinking), between two stem pentapeptides and is catalysed by D,D transpeptidases 
(Vollmer et al. 2008) (Figure 1.6). Alternatively, peptidoglycan crosslinking is catalysed 
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between the third position amino acids of two tetrapeptide stems (3->3 crosslinking). 
Peptidoglycan with 3->3 crosslinking was first identified in M. smegmatis. However the 
enzyme responsible for this catalytic activity, an L, D transpeptidase, was not identified until 
decades later in Enterococcus faecium (E. faecium) where 3->3 crosslinking is thought to have 
a role in antibiotic resistance (Wietzerbin et al. 1974; Mainardi et al. 2002). Peptidoglycan 
with 3->3 crosslinks has been identified in other Actinobacteria, including S. coelicolor 
(Hugonnet et al. 2014). In M. tuberculosis, the majority of peptidoglycan is thought to be 3-
>3 crosslinked and the chromosome encodes five L, D transpeptidases (Dubée et al. 2012b). 
Mutants defective in L, D transpeptidase activity were shown to have increased susceptibility 
to antibiotics, some of which target the cell wall, as well as displaying an increase in lysozyme 
sensitivity and altered colony morphology (Sanders et al. 2014; Schoonmaker et al. 2014). 
However, sensitivity to the antibiotics was mostly observed in the triple mutants, suggesting 
that there could be some overlap in function between L, D transpeptidases in mycobacteria. 
As in M. tuberculosis, there are five putative L, D transpeptidases annotated in the S. 
coelicolor genome (StrepDB). 
 
1.4.3 Antibiotics that target cell wall biosynthesis. 
 
Cell wall biosynthesis is an essential biological process in bacteria, and is the target of many 
antibiotics (Figure 1.5). The primary antibiotic targets in the cell wall are the enzymes that 
catalyse peptidoglycan biosynthesis. β-lactam antibiotics target multiple cell wall 
biosynthetic enzymes by mimicking the terminal D-Ala-D-Ala of stem pentapeptides 
(Sauvage et al. 2008). While peptidoglycan crosslinking (3->3) catalysed by L, D 
transpeptidases was initially thought to contribute to antibiotic resistance by bypassing 
classical PBP peptidoglycan crosslinking, L, D transpeptidases were recently shown to be 
inactivated by carbapenem antibiotics in E. faecium and M. tuberculosis (Dubée et al. 2012b; 
Dubée et al. 2012a). Glycopeptide antibiotics, such as vancomycin and teicoplanin act by a 
different mechanism to β-lactams, by targeting the peptidoglycan peptide stems. These 
antibiotics bind the terminal D-Ala-D-Ala of stem pentapeptides, preventing crosslinking of 
the peptidoglycan (Reynolds 1989). Some bacteria, such as the glycopeptide antibiotic 
producers Streptomyces, encode a vancomycin resistance pathway that results in the 
synthesis of pentapeptides ending in D-lactate, for which glycopeptide antibiotics have much 
lower affinity (Hong et al. 2004).   
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Figure 1.6 An overview of 4->3 and 3->3 peptidoglycan crosslinking in bacteria. 4->3 
crosslinking of stem pentapeptides is catalysed by D, D transpeptidases (DD TPase), while 3-
>3 crosslinking of tetrapeptide stems is catalysed by L, D Transpeptidases (L, D TPase). LL-
A2pm: 2,6 diaminopimelic acid. 
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Other cell-wall targets of antibiotics include the transglycosylation of peptide stems 
(ramoplanin), the dephosphorylation of the lipid carrier molecule involved in lipid carrier 
recycling (bacitracin) and the UDP-GlcNAc:dolichyl-phosphate GlcNAc-1-phosphate 
transferase that is involved to the addition of GlcNAc to the lipid-linked MurNAc- 
pentapeptide (tunicamycin) (Heifetz et al. 1979; Stone and Strominger 1971; Fang et al. 
2006). 
 
1.5 Streptomyces  
 
1.5.1 A general introduction to Streptomycetes 
 
Streptomycetes are a genus of high GC, Gram positive bacteria that belong to the phylum of 
Actinobacteria (Flärdh and Buttner 2009). Streptomycetes are mostly soil dwelling 
organisms, although they are known to occupy a wide range of niches (Hopwood 2007). They 
can metabolise a variety of carbon sources including sugars, organic acids, sugar alcohols and 
amino acids (Pridham and Gottlieb 1948) (Romano and Nickerson 1958). Streptomycetes 
have a complex lifecycle for a bacterium and are morphologically similar to filamentous 
fungi. The Streptomyces lifecycle begins under favourable conditions, when a spore 
germinates and germ tubes emerge to form filamentous hyphae (Figure 1.7) (Flärdh and 
Buttner 2009). Vegetative growth results in the formation of a network of hyphae called the 
substrate mycelium. The hyphae are often multinucleated since septation occurs only 
occasionally. When nutrients become depleted, aerial hyphae are generated and sporulation 
ensues. Due to their complex secondary metabolism, streptomycetes synthesise a multitude 
of natural products including immunosuppressants, insecticides, anti-tumour agents and 
around two thirds of clinically useful antibiotics (Hopwood 1999). Secondary metabolite 
production is initiated by nutrient depletion, and often coincides with morphological 
differentiation.   
S. coelicolor is a model organism of the Streptomyces genus and was the first streptomycete 
to have its genome sequenced (Bentley et al. 2002). S. coelicolor has a single ~ 8,667 kb linear 
chromosome that contains 7,825 predicted genes. More than 20 gene clusters are thought 
to contain genes necessary for secondary metabolite biosynthesis. Among these are the well 
characterised clusters for the pigmented antibiotics, actinorhodin (ACT) and 
undecylprodigiosins (REDs) (Liu et al. 2013b).   
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Figure 1.7 The life cycle of Streptomyces. Under favourable conditions, spore germination 
ensues and the growth of filamentous hyphae results in a network called the substrate 
mycelium. Nutrient limitation triggers differentiation, resulting in the formation of aerial 
hyphae and sporulation. Image adapted from Seipke et al. (2012). 
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ACT is a polyketide-derived benzoiso-chromanequinone that has a red/blue colour, 
depending on the environmental pH. REDs are pyrrole-based compounds that are 
synthesised by a pathway that overlaps with fatty acid biosynthesis. 
 
1.5.2 Protein O-mannosylation in Streptomyces 
 
The earliest reports of glycosylation in Streptomyces spp. were made after both native and 
heterologously expressed glycoproteins were characterised in Streptomyces lividans 
(Kluepfel et al. 1990; Ong et al. 1994). The first evidence of a protein O-glycosylation pathway 
was reported after an investigation into the nature of the phiC31 phage receptor in S. 
coelicolor (Cowlishaw and Smith 2001; Cowlishaw and Smith 2002). Cowlishaw and Smith 
(2001) isolated a collection of phiC31 phage resistant mutants that were deficient in the 
phage receptor. Several of the mutants were complemented by a homologue of fungal PMTs, 
a putative protein O-mannosyltransferase (pmt; sco3154) (Cowlishaw and Smith 2001). 
Additionally, glycoproteins were detected in the wild type strain J1929 by the presence of 
Con A reactivity and these were absent from the pmt strain. The phage receptor mutants 
that were not complemented by wildtype pmt were complemented by a gene with homology 
to DPM1 from S. cerevisiae, encoding a putative polyprenol phosphate mannose synthase 
(ppm1; sco1423) (Cowlishaw and Smith 2002). These studies suggested the presence of a 
protein O-glycosylation pathway in S. coelicolor that was similar to the protein O-
mannosylation pathway in fungi, and that the phiC31 phage receptor was a glycoprotein. The 
fact that homologues of pmt (sco3154) and ppm1 (sco1423) in several Streptomyces spp, 
have been annotated in the StrepDB, suggests that the pathway is highly conserved in 
streptomycetes. 
The only glycoprotein to be characterised in S. coelicolor is PstS, a periplasmic phosphate 
binding protein that was shown to be glycosylated with a trihexose in the wild type strain 
but not in the pmt strain (Wehmeier et al. 2009). Additionally, two out of three serine-rich 
synthetic peptides designed using the PstS amino acid sequence were shown to be 
glycosylated by an extract containing wild type J1929 S. coelicolor membranes. These 
findings suggest that protein O-glycosylation in S. coelicolor occurs on specific serine or 
threonine residues, and is not a random process. Using a cell free assay, Wehmeier et al. 
(2009) demonstrated that Ppm1 was required for the transfer of mannose from a nucleotide 
activated sugar (GDP-mannose) onto polyprenol phosphate in S. coelicolor membrane 
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fractions. This study presented the first evidence that O-glycosylation in S. coelicolor required 
a lipid-linked carrier and that the modifying carbohydrate could be mannose.  
Based on the pathway in mycobacteria, it was hypothesised that S. coelicolor Ppm1 was 
associated with a membrane protein that would serve as an anchor to the cytoplasmic face 
of the membrane (Varghese 2008). Anttonen (2010) presented evidence in support of this 
hypothesis by demonstrating that Ppm1 was present in both S. coelicolor cytosolic and 
membrane fractions. The S. coelicolor membrane protein SCO1014, that was identified as an 
orthologue of the transmembrane domain (D1) of Mt-Ppm1 in M. tuberculosis (Figure 1.4.B), 
was initially thought to be the membrane anchor. However, further studies found there to 
be no interaction between SCO1014 and Ppm1 in S. coelicolor (Anttonen 2010; Córdova-
Dávalos et al. 2014). Additionally, SCO1014 (Lnt1) mutants were sensitive to phiC31 phage 
infection and could glycosylate the M. tuberculosis glycoprotein Apa, suggesting that 
SCO1014 is not required for glycosylation in S. coelicolor (Córdova-Dávalos et al. 2014).  
The phage resistant S. coelicolor pmt and ppm1 mutants previously described by Cowlishaw 
and Smith (2001) also had a slow growth phenotype and were hypersusceptible to a range 
of antibiotics that target cell wall biosynthesis (Howlett et al. 2016). Although the antibiotic 
susceptibility phenotype in the pmt strains was less extreme than in the ppm1 strains, the 
pmt strains still displayed considerable sensitivity to β-lactam antibiotics and to vancomycin. 
This could suggest that glycosylation in S. coelicolor could be required for the correct 
functioning of periplasmic or membrane enzymes that are required for cell wall biosynthesis. 
Additionally, an RNAseq analysis of the ppm1 strain compared to the wild type strain J1929 
demonstrated that a loss of Ppm1 resulted in an upregulation of fatty acid biosynthetic genes 
presumably leading to overall changes in the membrane composition. Preliminary evidence 
showing changes in the membrane lipids of the S. coelicolor ppm1 mutant has been gathered 
using Raman spectroscopy (Howlett et al. 2016). Additionally, Howlett et al. (2016) identified 
GDP-mannose pyrophosphorylases (ManC – encoded by sco1388, sco3039 and sco4238) 
required for GDP-mannose biosynthesis in S. coelicolor. SCO3039 and SCO4238 together 
were found to have overlapping functions and strains with mutations in both genes were not 
obtained, suggesting lethality. However, mutants with depleted SCO3039 and SCO4238 
levels were isolated and were phenotypically similar to ppm1 mutants in antibiotic and 
phiC31 phage sensitivity. Additionally, it was shown that a mutation in manB (sco3028), 
encoding an enzyme with phosphomannomutase and phosphoglucomutase activity resulted 
in altered colony morphology, phiC31 phage resistance and an increase in antibiotic 
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sensitivity in S. coelicolor. These findings suggest that the activities of ManB and ManC are 
part of the protein O-glycosylation pathway in S. coelicolor.  
The current model for the protein O-glycosylation pathway in S. coelicolor is summarised in 
Figure 1.8. GDP-mannose biosynthesis requires the activities of ManA (phosphomannose 
isomerase, SCO3025), ManB (phosphomannomutase, SCO3028) and ManC (GDP-Mannose 
pyrophosphorylases, SCO3039, SCO4238). Ppm1 catalyses the transfer of mannose from 
GDP-mannose onto polyprenol phosphate (PP) on the cytoplasmic face of the membrane. 
Ppm1 is thought to be localised to the membrane by a membrane anchor; however this has 
yet to be identified. PP-mannose is flipped from the cytoplasmic face of the membrane onto 
the periplasmic face of the membrane by an unknown mechanism. Pmt is thought to catalyse 
the first step of O-glycosylation by the transfer of mannose from PP-mannose onto specific 
Ser/Thr residues in target proteins. Based on the dogma in M. tuberculosis (section 1.3.3) 
this is thought to occur on proteins as they emerge from the SEC secretory pathway, and 
protein folding is thought to happen after glycosylation.  
There are several unanswered questions regarding the mechanism and role of protein O-
glycosylation in S. coelicolor. Mainly, what is the physiological role of protein O-glycosylation 
in S. coelicolor? The pleiotropic phenotypes observed previously in glycosylation deficient 
pmt and ppm1 mutants suggests that glycosylation could be required for cell wall 
biosynthesis or membrane homeostasis (Howlett et al. 2016). A better understanding of the 
targets of O-glycosylation in S. coelicolor could help to underpin the role of this modification 
in maintaining cell wall homeostasis.  
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Figure 1.8 A model of protein O-glycosylation in S. coelicolor.
Chapter 2 – Materials and Methods 
44 
1.6 Aims 
 
The aim of this project was to investigate the S. coelicolor glycoproteome in order to better 
understand the physiological role of protein O-glycosylation in a model actinomycete. A 
further aim was to identify glycoproteins that could be of relevance to the antibiotic 
hypersensitivity phenotypes observed previously in the S. coelicolor pmt and ppm1 mutants 
(Howlett et al. 2016).  
Specifically, the objectives were: 
1. To characterise the S. coelicolor glycoproteome using biochemical and proteomics 
approaches. 
2. To characterise the glycans that modify S. coelicolor glycoproteins and investigate 
the linkages present. 
3. To investigate glycoproteins with a putative role in cell wall biosynthesis, by the 
characterisation of knockout mutants. 
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Chapter 2 – Materials and methods 
 
2.1 Materials 
 
2.1.1 Chemicals 
All chemicals were purchased from Sigma-Aldrich, Fisher Scientific, Thermo Fisher Scientific 
or VWR International unless otherwise stated. Difco nutrient broth (DNB) and Difco nutrient 
agar (Beckton Dickinson and Company) for the growth of S. coelicolor was purchased from 
Appleton Woods Ltd. Soya flour for the growth of S. coelicolor was purchased at Holland & 
Barratt. Casaminoacids, tryptone and yeast extract (Oxoid) were purchased from Thermo 
Fisher Scientific. All restriction enzymes, DNA polymerases and deoxynucleotides (dNTPs) 
were purchased from New England Biolabs (NEB). PCR primers were purchased from 
Integrated DNA Technologies. DNA sequencing was carried out by GATC BIOTECH.  
 
2.1.2 Software 
Snapgene viewer software (version 3.2) was used for the construction of plasmid maps and 
for the analysis of sequencing data. BLAST was used to carry out gene and protein sequence 
similarity and homology searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/ clustalo/) was used to perform multiple sequence 
alignments. Boxshade (version 3.21) was used to shade multiple sequence alignments 
(http://www.ch.embnet.org/software/ BOX_form.html). Weblogo software was used for the 
analysis of the S. coelicolor glycosylation motif (Crooks et al. 2004). Bruker Compass Data 
Analysis version 4.4 (Bruker), flexAnalysis version 3.0 (Bruker), MassHunter Software 
(Agilent) and Xcalibur software version 4 (Thermo Fisher Scientific) was used for the analysis 
of the mass spectrometry data. SigmaPlot version 13.0 (Systat software Inc) was used to 
produce the graphs reported in this study. Agarose gels were imaged using Quantity One 
(version 4.6.2; Basic) software. Transmembrane helices in proteins were predicted using the 
TMHMM Server v. 2.0 algorithm (http://www.cbs.dtu.dk/services/TMHMM/). Signal 
peptides were predicted using the SignalP 4.0 Server algorithm (Petersen et al. 2011). LipoP 
1.0 and PRED_LIPO software were used for the prediction of lipoproteins (Juncker et al. 2003; 
Bagos et al. 2008). TatP 1.0 Server was used for the prediction of twin arginine (TAT) signal 
peptides (Bendtsen et al. 2005). Conserved domains in proteins were detected using the 
Conserved Domain Database CD-search tool (Marchler-Bauer and Bryant 2004). 
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2.1.3 Media and Buffers 
 
Difco nutrient broth (DNB) 
8 g of Difco nutrient broth powder was dissolved in 1000 mL of distilled H₂O (ddH₂O) and 
autoclaved. 
 
Difco nutrient agar (DNA) 
4.6 g of Difco nutrient agar solid was 
dissolved in 200 mL of distilled H₂O in a 
250 mL DURAN bottle and autoclaved. 
 
Soft nutrient agar (SNA) (Kieser et al. 
2000). 
8 g of Difco nutrient broth powder and 5 g 
of Difco Bacto agar solid were suspended 
in 1000 mL of ddH₂O and autoclaved (115 
°, 15 min). 
 
Mannitol soya flour agar (MSA) (Kieser et 
al. 2000) 
Soya flour                     20 g    
Mannitol                     20 g 
Agar                             20 g 
Ultrapure H₂O     1000 mL  
Mannitol was dissolved in the Ultrapure 
H₂O and 200 mL was added to DURAN 
bottles (250 mL) each containing 4 g soya 
flour and 4 g agar. The media was 
autoclaved twice (115 °, 15 min). 
Luria Burtani (LB) broth and agar 
(Sandbrook et al. 1989) 
Tryptone                                  10 g 
Sodium chloride (NaCl)         10 g 
Yeast extract                             5 g 
ddH₂O                                1000 mL  
The tryptone, NaCl and yeast extract were 
dissolved in 1000 mL of ddH₂O and 
autoclaved (115 °, 15 min). For LB agar, 1.5 
g of agar per 100 mL of LB broth was 
added and autoclaved (115 °, 15 min). 
 
2 X YT Medium  (Sandbrook et al. 1989)
Bacto Tryptone            16 g 
Bacto Yeast Extract     10 g 
Sodium chloride             5 g 
Made up to 1000 mL with ddH₂O and 
autoclaved (115 °, 15 min). 
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2 X Germination medium (Kieser et al. 
2000) 
Difco yeast extract        1 g 
Difco casamino acids    1 g 
Made up to 100 mL with ddH₂O and 
autoclaved to sterilise. 200 µL of sterile 
5M CaCl₂ added. 
TES buffer 
TES     1.146 g  
Made up to 100 mL in ddH₂O and the pH 
was adjusted to 8.0. The buffer was 
autoclaved to sterilise (115 °, 15 min). 
 
Supplemented minimal medium, solid (SMMS) (Kieser et al. 2000) 
Difco casamino acids          2 g 
TES Buffer                       5.73 g 
Ultrapure H₂O       to 1000 mL 
The solution was made up and the pH was adjusted to 7.2. 200 mL was poured into a DURAN 
bottle (250 mL) containing 3 g of agar. The solution was autoclaved to sterilise and at the 
time of use, re-melted and the following was added: 
NaH₂PO₄ + K₂HPO₄ (50 mM each)           2 mL 
MgSO₄ (1 M stock)                                     1 mL          
Glucose (50 % w/v)                                 3.6 mL 
Trace elements*                                      0.2 mL 
*Trace elements solution was prepared by adding 0.1 g. l¯¹ of the following: ZnSO₄.7H₂O, 
FeSO₄.7H₂O, MncCl₂.4H₂O, CaCl₂.6H₂O and NaCl. The trace elements solution was stored at 
4 °C for up to 2 weeks. 
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For the preparation of chemically competent cells: 
TFB1 (Sandbrook et al. 1989) 
Rubidium chloride             100 mM  
Manganese chloride           50 mM  
Potassium acetate              30 mM 
Calcium chloride                 10 mM 
Glycerol                           15 % (v/v) 
The solution was made up to 100 mL with 
ddH₂O, the pH adjusted to 5.8 and filter 
sterilised.
 
TFB2 (Sandbrook et al. 1989) 
Acid MOPS                          10 mM  
Rubidium chloride             10 mM  
Calcium chloride                70 mM 
Glycerol                          15 % (v/v) 
The solution was made up to 100 mL with 
ddH₂O, the pH adjusted to 8.0 and 
autoclave sterilised (115 °, 15 min).
F134 Medium (Nieselt et al. 2010)  
F134 Main broth 
L-glutamic acid monosodium salt   55.2 g 
Ultrapure H₂O                                   865 mL  
 
SMM 0.1 M PO₄ buffer 
NaH₂PO₄                    7.88 g 
K₂H PO₄                      8.70 g 
Ultrapure H₂O   to 1000 mL 
 
SMM TE 
FeSO₄                  100 mg 
ZnSO₄                  100 mg 
MnCl₂                  100 mg 
CaCl₂                    100 mg 
NaCl                     100 mg 
Ultrapure H₂O to  950 mL 
HCl                            50 mL 
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TMS1 
FeSO₄ .7H₂O                5000 mg 
ZnSO₄.7H₂O                   440 mg 
CuSO₄.5H₂O                   390 mg 
MnSO₄                            150 mg 
Na₂MoO₄.2H₂O               10 mg 
CoCl₂.6H₂O                       20 mg 
Ultrapure H₂O          to 1000 mL 
 
To make F134 liquid medium 
F134 main broth                     865 mL 
MgSO₄ (1M stock)                       2 mL 
SMM TE                                         8 mL 
SMM 0.1 M PO₄ buffer             40 mL 
Antifoam                                    100 µL. 
Autoclave sterilised. At the time of use 80 
mL of glucose (50 % w/v stock, filter 
sterilised) and 5.6 mL of TMS1 (filter 
sterilised) was added.
To make F134 agar 
F134 main broth                     865 mL 
MgSO₄ (1M stock)                       2 mL 
SMM TE                                         8 mL 
SMM 0.1 M PO₄ buffer             40 mL 
Agar                                                15 g 
Autoclave sterilised. At the time of use 80 
mL of glucose (50 % w/v stock, filter 
sterilised) and 5.6 mL of TMS1 (filter 
sterilised) was added.
 
To make F134 soft agar 
F134 main broth                     865 mL 
MgSO₄ (1M stock)                       2 mL 
SMM TE                                         8 mL 
SMM 0.1 M PO₄ buffer             40 mL 
Agar                                                5 g 
Autoclave sterilised. At the time of use 80 
mL of glucose (50 % w/v stock, filter 
sterilised) and 5.6 mL of TMS1 (filter 
sterilised) was added.
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For S. coelicolor genomic DNA isolation 
CTAB/NaCl solution (10 % w/v CTAB, 0.7 M NaCl) (Kieser et al. 2000) 
4.1 g of NaCl was added to 80 mL of ddH₂O. 10 g of cetyltrimethylammonium bromide (CTAB) 
was slowly added whilst gently heating and mixing. The solution was made up to 100 mL with 
ddH₂O and autoclave sterilised. 
 
TE25S buffer (Kieser et al. 2000) 
Tris-HCl pH 8.0          25 mM  
EDTA                           25 mM  
Sucrose                         0.3 M 
Dissolved in ddH₂O and autoclave 
sterilised. 
TE buffer  
Tris-HCl, pH 8            10 mM  
EDTA, pH 8                  1 mM  
Dissolved in ddH₂O and filter sterilised. 
For Southern blotting 
20 X SSC 
Sodium chloride            3M 
Trisodium citrate      0.3 M 
Dissolved in ddH₂O and the pH was 
adjusted to 7.0. 
 
100 X Denhardt’s solution  
Bovine serum albumin (BSA)         1 g 
Ficoll 400                                           1 g 
Polyvinylpyrrolidone (PVP)            1 g 
Dissolved in 50 mL of ddH₂O. The solution 
was filter sterilised and stored at – 20 °C.
Pre-hybridisation solution 
20 X SSC                                        15 mL 
100 X Denhardt’s solution       2.5 mL 
10 % (w/v) SDS                          2.5 mL 
Deionized formamide              25 mL 
Made up to 50 mL with ddH₂O. 
For agarose gel electrophoresis 
10 X TBE buffer (Sandbrook et al. 1989) 
Tris base                  108.9 g 
Boris acid                  85.7 g 
EDTA (0.5 M, pH 8)  40 mL 
Made up to 1000 mL with ddH₂O. 
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For Western blotting 
10 X Transfer buffer 
Glycine        144 g 
Tris base     30.2 g 
Made up to 1000 mL with ddH₂O. 100 mL 
of the 10 X Transfer buffer stock was 
added to 100 mL of methanol and the 
solution was made up to 1000 mL for 1 X 
Transfer buffer solution. 
10 X TBS buffer 
Tris base             60.6 g 
NaCl                    87.6 g 
Dissolved in 800 mL of ddH₂O. The pH was 
adjusted to 7.5 and made up to 1000 mL 
with ddH₂O
Chemiluminescent detection 
Solution A (cover in foil to protect from 
the light) 
Tris-HCl (pH 8.5)        5 mL 
Distilled H₂O            45 mL 
Coumaric acid 90 mM stock (0.15 g into 10 
mL DMSO, stored at -20 °C) 110 µL 
Luminol 250 mM stock (0.44 g in 10 mL 
DMSO, stored at -20 °C) 250 µL 
Solution B 
Hydrogen peroxide 30 % v/v stock   100 µL 
Distilled H₂O                                          900 µL 
 
For use, 15 µL of solution B was added to 
5 mL of solution A in a Falcon tube covered 
with foil to protect from the light. 
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Table 2.1 List of bacterial strains 
Strain Description Source 
S. coelicolor J1929  pglY Bedford et al. (1995) 
S. coelicolor DT1025 pmt Cowlishaw and Smith (2001) 
S. coelicolor DT3017 ppm1 Cowlishaw and Smith (2002) 
S. coelicolor TK005 sco5204 This work 
S. coelicolor TK006 sco4847 This work 
S. coelicolor TK008 sco4934 This work 
S. coelicolor TK009 TK005: pTAK28   This work 
S. coelicolor TK010 TK008: pTAK32  This work 
S. coelicolor TK012 TK005: pTAK29    This work 
S. coelicolor TK013 TK006: pTAK30  This work 
S. coelicolor TK015 TK008: pIJ10257  This work 
S. coelicolor TK016 TK006: pIJ10257  This work 
S. coelicolor TK017 TK005: pIJ10257  This work 
S. coelicolor TK018 TK005: pMS82  This work 
S. coelicolor TK020 TK008: pTAK48.b This work 
S. coelicolor TK021 TK008: pTAK49.b This work 
S. coelicolor TK022 TK008: pTAK50.b This work 
S. coelicolor TK023 TK008: pTAk51.b This work 
S. coelicolor TK024 TK008: pTAK52.b This work 
S. coelicolor TK025 TK008: pTAK53.b This work 
Streptomyces phage ΦC31cΔ25 Sinclair and Bibb (1988) 
E. coli DH5α  
F– Φ80lacZΔM15 (Δ(lacZYA-
argF) U169 recA1 endA1 
hsdR17 (rK–, mK+) phoA 
supE44 λ– thi-1 gyrA96 relA Invitrogen 
E. coli ET12567 
[pUZ8002] (ETZ)  ET12567 - dam-13::Tn9, dcm-
6, hsdM, hsdS; pUZ8002 – tra, 
neo, RP4 
Paget et al. (1999) 
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Table 2.2 List of cosmids. The Tn5062 transposon contains an Apramycin resistance marker.  
Cosmid Description Tn5062 position 
2St3B6.1.G02 sco5177-sco5206, Tn5062 in sco5204 5661778 
2St3B6.1.G06 sco5177-sco5206, Tn5062 in sco5204 5662683 
2SCK31.2.F11 sco4909-sco4945, Tn5062 in sco4934 5369107 
5G8.1.A11 sco4820-sco4860, Tn5062 in sco4934 5279744 
 
 
 
Table 2.3 List of constructs 
Name Construct description Source 
pIJ10257 
attP-int-derived integration vector for the 
conjugal transfer of DNA from E. coli to 
Streptomyces spp. Contains Hygᴿ, oriT and 
ermE*p promoter. Hong et al. (2005) 
pGEM7  
Cloning vector; fi oriC, SP6 and T7 RNA 
polymerase promoters , multiple cloning site, 
Ampᴿ, lacZ for blue/white screening Promega 
pMS82  
attP-int-derived integration vector for the 
conjugal transfer of DNA from E. coli to 
Streptomyces spp. Contains Hygᴿ and oriT Gregory et al. (2003) 
pTAK28  sco5204 + 251 bp upstream in pMS82 This work 
pTAK29 sco5204 in pIJ10257  This work 
pTAK30 sco4847 in pIJ10257  This work 
pTAK32 sco4934 in pIJ10257 This work 
pTAK47  sco4934 in pGEM7  This work 
pTAK48 sco4934_T(40)A in pGEM7  This work 
pTAK49 sco4934_S(41)A in pGEM7 This work 
pTAK50 sco4934_T(40)A, S(41)A in pGEM7 This work 
pTAK51 sco4934_T(40)V in pGEM7 This work 
pTAK52 sco4934_S(41)V in pGEM7 This work 
pTAK53 sco4934_T(40)V, S(41)V in pGEM7 This work 
pTAK48.b  sco4934_T(40)A in pIJ10257  This work 
pTAK49.b  sco4934_S(41)A in pIJ10257 This work 
pTAK50.b  sco4934_T(40)A, S(41)A in pIJ10257 This work 
pTAK51.b  sco4934_T(40)V in pIJ10257 This work 
pTAK52.b  sco4934_S(41)V in pIJ10257 This work 
pTAK53.b  sco4934_T(40)V, S(41)V in pIJ10257 This work 
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Table 2.4 Selective antibiotics and concentrations used in this work 
Antibiotic Working Concentration (µg/mL) 
Hygromycin B (HmB) 75-100 
Ampicillin (Amp) 100 
Kanamycin (Kan) 50 
Chloramphenicol (Cml) 25 
Nalidixic Acid (Nx) 25 
Apramycin (Apr) 50 
 
 
 
Table 2.5 Antibiotics used in the disc diffusion assays 
Antibiotic Solvent 
Stock 
concentration 
(mg/mL) 
Ampicllin sterile ddH₂O 20 
Penicillin sterile ddH₂O 10 
Imipenem sterile ddH₂O 4 
Meropenem sterile ddH₂O 4 
Vancomycin sterile ddH₂O 4 
Bacitracin sterile ddH₂O 4 
Rifampicin DMSO 4 
Gentomycin sterile ddH₂O 4 
Teicoplanin sterile ddH₂O 4 
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2.2 Molecular procedures 
 
2.2.1 Growth of E. coli 
 
E. coli strains were cultivated on LB agar at 37 ⁰C overnight. E. coli strains were cultured for 
12 - 16 h at 37 ⁰C (180 rpm) in LB broth. Where appropriate, the growth medium was 
supplemented with antibiotics (Table 2.4) to maintain selection. E. coli strains were 
maintained in 20 % (v/v) glycerol at -80 ⁰C. 
 
2.2.2 Plasmid DNA Isolation, gel extraction and DNA sequencing. 
 
Plasmid and cosmid DNA was isolated from overnight E. coli cultures (2 – 5 mL) using the 
QIAprep Spin Miniprep Kit (QIAGEN) according to the manufacturer’s instructions. For the 
extraction of DNA from agarose gels, the band of interest was excised using a sterile scalpel 
and the DNA was extracted using the QIAquick Gel Extraction Kit (QIAGEN) per 
manufacturer’s instructions. Restriction enzymes were used per the manufacturer’s 
instructions. For DNA sequencing, samples were sent to GATC Biotech (https://www.gatc-
biotech.com/en/index.html). Sequencing primers are indicated in Table A.1.  
 
2.2.3 PCR conditions 
 
PCR to amplify DNA was carried out per the instructions provided by the manufacturer of the 
DNA polymerase. The DNA polymerases used in this work are Phusion, LongAmp® Taq, Taq 
and Q5 DNA polymerase; all purchased from NEB. PCR primers are listed in Table A.1. 
 
2.2.4 Preparation of chemically competent cells 
 
Competent E. coli cells were prepared by the rubidium chloride method (Sandbrook et al. 
1989). Overnight cultures were diluted 1/100 into 50 mL of fresh LB liquid medium and grown 
to an OD600nm of 0.4 – 0.5. Cells were placed on ice for 5 min. Cells were pelleted by 
centrifugation (10 min, 4000 rpm, 4 ⁰C). Pellets were re-suspended in TFB1 (4 ⁰C, 30 mL/100 
mL culture) and kept on ice for 90 min. The cells were pelleted again by centrifugation (10 
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min, 4000 rpm, 4 ⁰C). The pellet was re-suspended in TFB2 (4 ⁰C, 4 mL/100 mL culture). 
Competent cells were snap-frozen in liquid nitrogen, and stored at -80 ⁰C.  
 
2.2.5 Transformation of E. coli 
 
50-100 ng of plasmid DNA was incubated with 50 μL of competent cells on ice (20 min). The 
reactions were heat shocked (42 ⁰C, 45 s) and then incubated on ice for 5 min. Reactions 
were allowed to recover at 37 ⁰C for 1 h, after the addition of 500 µL of LB broth. The cells 
were plated onto LB agar plates, treated with appropriate selective antibiotics and incubated 
at 37 °C overnight. 
 
2.2.6 Agarose gel electrophoresis 
 
Agarose gel electrophoresis was carried out as previously described by Sandbrook et al. 
(1989). 0.8 – 1% agarose was dissolved into 1 X TBE buffer. Ethidium bromide (15 µg/mL) 
was added directly to the molten agarose. Electrophoresis was carried out at 65 – 100V in 1 
X TBE buffer. Gels were visualised under UV fluorescence and the images were recorded by 
a Biorad gel documentation system. Samples were run alongside suitable DNA markers 
(Figure 2.1). 
 
2.2.7 In-Fusion Cloning 
 
Infusion cloning was carried out per the manufacturer’s instructions. The assembly of the 
reaction required 50 – 100 ng of both vector DNA and PCR product, 2 µL of HD Infusion 
enzyme and ddH₂O to make the reaction up to 10 µL. Reactions were incubated for 15 min 
(50 ⁰C), after which 5 µL of the cloning product was transformed into E. coli competent cells. 
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Figure 2.1 DNA and protein molecular weight markers used in this work. A. Fast DNA ladder 
(NEB). Mass values are for 0.5 μg/lane. B. 1 Kb DNA ladder (NEB). Mass values are for 0.5 
μg/lane. C. 10 – 250 kDa unstained protein ladder (NEB). 
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2.3 Streptomyces work 
 
2.3.1 Streptomyces culture conditions 
 
Streptomyces culture conditions and genetic procedures used in this study have been 
previously described by Kieser et al. (2000) or (for F134 medium) by Nieselt et al. (2010). 
Streptomyces strains were grown on mannitol soya flour agar (MSA) for 7 days at 30 °C. If 
sporulation was not required, Streptomyces strains were grown on Difco nutrient agar at 30 
°C for 48 h.  For liquid cultures, S. coelicolor spores (~10¹⁰ mL ¯¹) were centrifuged (4000 rpm, 
4 ⁰C, 5 min) and resuspended in 5 mL TES Buffer. The spores were heat shocked at 50 ⁰C for 
10 min and then 5 mL of 2 x germination medium was added. The spore suspension was 
transferred to a sterile conical flask with glass beads and incubated for 6 - 12 h at 30 ⁰C with 
shaking (180 rpm). The growth medium was inoculated to an OD₄₅₀ of 0.03 – 0.05 and 
incubated at 30 ⁰C with shaking (180 rpm) for up to 60 h. 
 
2.3.2 Isolation of genomic DNA from S. coelicolor. 
 
S. coelicolor genomic DNA was isolated according to the CTAB method as described by Kieser 
et al. (2000). The mycelium from a 30 mL culture grown in Difco nutrient broth was pelleted 
by centrifugation (4000 rpm, 4 ⁰C, 5 min) and resuspended in 5 mL TE25S buffer (25 mM Tris-
HCl pH 8, 25 mM EDTA pH 8, 0.3 M sucrose). 100 μl of lysozyme solution (100 mg mL¯¹ in 
ddH₂O) was added and the suspension was incubated at 37 ⁰C for 60 min. 50 μl of proteinase 
K solution (20 mg mL¯¹ in ddH₂O) was added and the suspension was mixed by inversion. 300 
μl of 10 % (w/v) SDS solution was added, the suspension was mixed by inversion and 
incubated at 55 ⁰C for 60 min. 1 mL of 5 M NaCl solution was added and the suspension was 
mixed by inversion. 650 μl of CTAB/NaCl solution (10 % (w/v) CTAB in 0.7 M NaCl) was added, 
the suspension mixed by inversion and then incubated at 55 ⁰C for 10 min. The suspension 
was cooled to 37 ⁰C, 5 mL of chloroform/isoamyl alcohol (24:1) was added and the 
suspension was mixed by inversion for 30 min. Samples were centrifuged (12,000 rpm, 20 
⁰C, 15 min), the supernatant transferred to a separate tube and 0.6 volume isopropanol was 
added. Samples were mixed by inversion. After 3 min the samples were centrifuged (14,000 
rpm, 20⁰C, 5 min). The DNA pellet was rinsed in 5 mL of 70 % ethanol, air dried and dissolved 
in TE Buffer at 55 ⁰C for 5 min. 
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2.3.3 Preparation of S. coelicolor spores. 
 
Approximately 50 – 100 µL of S. coelicolor spores (~10¹⁰. mL ¯¹) were spread onto MSA plates 
and incubated for 5-6 days at 30 ⁰C until sporulation ensued. 4mL sterile 20 % (v/v) glycerol 
in ddH₂O was added to each plate and the spores were gently removed using a sterile cotton 
bud. The spore stocks were stored at -30 ⁰C. Spore stocks were titred by diluting spores in 
sterile ddH₂O and performing an appropriate dilution series. 5 µL aliquots of each dilution 
were plated onto Difco nutrient agar plates and the resulting colonies were counted after 
incubating the plates at 30 °C for 48 h. 
 
2.3.4. Growth assays on agar in sterile Microwell plates 
 
250 μl of sterile Difco nutrient broth or F134 medium + 1 % (w/v) agar was pipetted into the 
wells of a sterile Microwell plate. Approximately 10⁷ S. coelicolor spores were added to the 
surface of the agar and the plates were dried under a lamina flow cabinet for 15 min.  The 
plates were incubated at 30 ⁰C for up to 47 h and the absorbance at 492 nm was measured 
at regular intervals.  
 
2.3.5 Phage sensitivity tests 
 
Nutrient agar (Difco nutrient agar or F134 agar) plates supplemented with 0.5 % (w/v) 
glucose, 10 mM MgSO₄ and 8 mM Ca(NO₃)₂ were prepared in 55 mm x 16 mm petri dishes. 
A tenfold serial dilution of the φC31cΔ25 phage (from 10 ¯¹ to 10 ¯⁷) was prepared in nutrient 
broth. 100 μl of diluted φC31cΔ25 phage was added to the surface of the nutrient agar plate.  
Approximately 5 x 10⁶ S. coelicolor spores were suspended in 1 mL of soft agar (soft nutrient 
agar or F134 soft agar). The nutrient agar plate was overlaid with the soft top agar seeded 
with spores. The plates were incubated at 30 ⁰C for 16 – 20 h. 
 
2.3.6 Antibiotic production on SMMS 
 
25 mL of SMMS agar was poured into a sterile petri dish. S. coelicolor spores were adjusted 
to 10⁶ spores in a total volume 30 µL, diluted in MilliQ H₂O where necessary. The 30 µL spore 
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preparation was pipetted into the SMMS agar plate, and streaked out. The plates were 
incubated at 30 °C for 5 days. 
 
2.3.7 Antibiotic sensitivity disc diffusion assays 
 
20 mL Difco nutrient agar or F134 agar plates were prepared in 94 mm x 16 mm petri dishes. 
Approximately 107 S. coelicolor spores were suspended in 2.5 mL of soft nutrient agar or F134 
soft agar, respectively. The nutrient agar plates were overlaid with the soft agar containing 
the spores. Antibiotics were prepared on the day of the assay to the concentrations indicated 
in Table 2.5. A tenfold serial dilution of the initial antibiotic stock was prepared to obtain 
10¯¹, 10¯² and 10¯³ stocks in sterile water. 10 μl of each respective antibiotic concentration 
was added to 5 mm Whatman Grade 17 CHROMA filter paper discs (GE Healthcare Life 
Sciences). The filter paper discs were transferred onto the surface of the soft agar and the 
plates were incubated at 30 ⁰C for 48 – 60 h. Zones of inhibition (measured in mm) were 
recorded. 
 
2.3.8 Lysozyme sensitivity assays 
 
A stock solution of lysozyme (Thermo Fisher Scientific) was prepared to a final concentration 
of 100 mg/mL in ddH₂O. 125 µL of lysozyme solution was added to 50 mL of Difco nutrient 
agar to give a final lysozyme concentration of 0.25 mg/mL and the agar was poured into a 10 
x 10 cm petri dish. A 50 mL Difco nutrient agar plate without lysozyme was prepared for the 
negative control. S. coelicolor spores were adjusted to 10⁸ spores/mL in ddH₂O.  The adjusted 
spore stocks were diluted ten-fold in ddH₂O to prepare stocks from 10⁷ spores/mL to 10⁴ 
spores/mL. 5 µL of each spore stock was added to the agar plates and allowed to dry. The 
plates were incubated at 30 °C for 60 h. 
 
2.3.9 Conjugation from E. coli into Streptomyces 
 
The method of intergeneric conjugation used in this work was previously described by Gust 
et al. (2003). E. coli ET12567 [pUZ8002] competent cells were prepared after growth 
overnight in LB broth (37 ⁰C, 180 rpm) containing kanamycin (50 µg/mL) and 
chloramphenicol (25 µg/mL) to select for pUZ8002 and the dam mutation respectively. The 
Chapter 2 – Materials and Methods 
62 
 
E. coli ET12567 [pUZ8002] competent cells were transformed with ~ 100 ng of plasmid or 
cosmid DNA. The transformants were selected on LB agar plates containing the appropriate 
antibiotic for the incoming plasmid (Table 2.3), or apramycin (50 µg/mL) and carbenicillin 
(100 µg/mL) to select for the incoming Tn5062 transposon insertion cosmid. Colonies were 
inoculated in 10 mL of LB broth containing kanamycin (50 µg/mL), chloramphenicol (25 
µg/mL) and the appropriate antibiotic to select for the plasmid or cosmid, and grown 
overnight at 37 ⁰C with shaking (180 rpm). The overnight culture was diluted 1/100 into 10 
mL of fresh LB broth plus antibiotics and grown to an OD600nm of ~ 0.4 at 37 ⁰C for ~ 6 h. The 
cells were pelleted, washed twice with 10 mL of LB broth and re-suspended in 1 mL of fresh 
LB broth. Approximately 10⁸ cfu mL¯¹ S. coelicolor spores were heat shocked at 50 °C for 10 
min. 500 µL of the heat shocked spores were added to 500 µL of the E. coli cells in LB broth. 
The mixture was centrifuged briefly, the supernatant was removed and the pellet was 
resuspended in 100 µL LB broth. A dilution series from 10¯¹ to 10¯⁴ was prepared in sterile 
MilliQ H₂O, with each step in 100 μl. The 100 µL aliquots of each dilution were plated onto 
MSA + 10mM MgCl₂ and incubated at 30 °C for 16 – 20 h. The plates were overlayed with 1 
mL of sterile MilliQ H₂O containing 0.5 mg of Nalidixic acid and the appropriate antibiotic for 
the selection of the plasmid or cosmid. The plates were further incubated for 5 days at 30 °C 
until antibiotic resistant colonies were observed.  
For plasmid conjugation, the colonies were picked and crushed into 50 µL of sterile MilliQ 
H₂O. The crushed colonies were streaked for single colonies onto fresh MSA plates and 
incubated at 30 °C for 5 – 7 days until sporulation ensued. Single colonies were picked again, 
crushed into 50 µL of sterile MilliQ H₂O and the crushed colony was spread onto a fresh MSA 
plate. The plates were incubated at 30 °C for 5 – 7 days and the spores were harvested. 
Exconjugates were screened by PCR.  
For cosmid conjugation, colonies were picked and crushed into 50 µL of sterile MilliQ H₂O. 5 
µL of the crushed colony was plated onto Difco nutrient agar plates containing the 
transposon specific antibiotic apramycin, with and without kanamycin to identify colonies 
that had undergone double crossover events to lose the cosmid backbone. Kanamycin 
sensitive colonies were picked, crushed into 50 µL of sterile MilliQ and streaked for single 
colonies onto fresh MSA plates and incubated at 30 °C for 5 – 7 days until sporulation ensued. 
Single colonies were picked into 50 µL of sterile MilliQ, spread onto a fresh MSA plate and 
the plates were incubated at 30 °C for 5 – 7 days. Exconjugates were screened by PCR and 
southern blotting. 
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2.3.10 Generation of complementation plasmids 
 
pTAK29 and pTAK32 
The sco5204 and sco4934 coding sequences were amplified by PCR from S. coelicolor J1929 
genomic DNA using primers TK93 and TK94, and TK101 and TK102 respectively (Table A.1). 
The PCR products were separated by agarose gel electrophoresis and the bands 
corresponding to the sizes of sco5204 and sco4934 respectively, were excised and gel 
extracted. pIJ10257 vector DNA was restricted with Ndel, separated by agarose gel 
electrophoresis, excised and gel extracted. The sco5204 and sco4934 coding sequences 
respectively, were cloned into NdeI digested pIJ10257 using the In-fusion Cloning. The 
resulting plasmids, pTAK29 and pTAK32 respectively were confirmed by sequencing. 
pTAK28 
The sco5204 coding sequence + ~ 250 bp upstream was amplified by PCR from S. coelicolor 
J1929 genomic DNA using primers TK85 and TK86 (Table A.1). The PCR products were 
separated by agarose gel electrophoresis and the band corresponding to the size of sco5204 
+ ~ 250 bp was excised and gel extracted. pMS82 vector DNA was restricted with HindIII, 
separated by agarose gel electrophoresis, excised and gel extracted. The sco5204 coding 
sequence was cloned into HindIII digested pMS82 using the In-fusion Cloning. The resulting 
plasmid, pTAK28 was confirmed by sequencing. 
pTAK30 
Due to several repetitive sequences in sco4847, the gene could not be amplified by PCR 
directly from S. coelicolor J1929 genomic DNA. To simplify the template for PCR, the cosmid 
St5G8 (sco4820-sco4860) from the S. coelicolor genome library (kindly provided by Meirwyn 
Evans, University of Swansea) was used. The St5G8 cosmid DNA was restricted with BamHI. 
The digest was separated by agarose gel electrophoresis and a 2270 bp product containing 
the sco4847 coding sequence was excised and gel extracted. The purified DNA was used as 
a template for PCR with primers TK97 and TK98 (Table A.1), to amplify the sco4847 coding 
sequence. The PCR products were separated by agarose gel electrophoresis and the band 
corresponding to the size of sco4847 was excised and gel extracted. pIJ10257 vector DNA 
was restricted with Ndel, separated by agarose gel electrophoresis, excised and gel 
extracted. The sco4847 coding sequence was cloned into NdeI digested pIJ10257 using In-
fusion Cloning. The resulting plasmid, pTAK30 was confirmed by sequencing. 
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2.3.11 Generation of mutated sco4934 complementation plasmids 
 
Using pTAK32 as a template, the sco4934 coding sequence was amplified by PCR using 
primers TK160 and TK161 (Table A.1). The PCR products were separated by agarose gel 
electrophoresis and the band corresponding to the size of sco4934 was excised and gel 
extracted. pGEM7 vector DNA was restricted with SmaI, separated by agarose gel 
electrophoresis, excised and gel extracted. The sco4934 coding sequence was cloned into 
SmaI digested pGEM7 using In-fusion Cloning. The resulting plasmid, pTAK47 was confirmed 
by sequencing. Site directed mutagenesis, using the Q5 Site-directed Mutagenesis kit (NEB) 
per the manufacturer’s instructions, was used to introduce point mutations into the sco4934 
coding sequence by PCR. pTAK47 was used as the template for the PCR reactions and the 
mutagenic primers indicated in Table A.1. The mutations are (T(40)A, S(41)A, T(40)A and 
S(41)A, T(40)V, S(41)V, and T(40) and S(41)V respectively) summarised in Chapter 6, Table 
6.5. The resulting plasmids, pTAK48 – pTAK53 respectively were sequenced to confirm the 
correct mutations. Using each respective plasmid as a template, the mutant sco4934 coding 
sequences were amplified by PCR using primers TK101 and TK102. The PCR products were 
separated by agarose gel electrophoresis and the band corresponding to the size of sco4934 
was excised and gel extracted. pIJ10257 vector DNA was restricted with Ndel, separated by 
agarose gel electrophoresis, excised and gel extracted. The mutant sco4934 coding 
sequences were cloned into NdeI digested pIJ10257 using In-fusion Cloning. The resulting 
plasmids, pTAK48.b – pTAK53.b respectively were confirmed by sequencing. 
 
2.4 Southern blotting 
 
2.4.1 Alkaline transfer 
 
Approximately 1-2 µg of genomic DNA was digested overnight with the appropriate 
restriction enzyme and separated in a 1 % agarose gel at 50 mV for ~ 4 h. The DNA was 
depurinated by soaking the gel in 0.25 M HCl for 10 min on an orbital shaker and then rinsed 
in ddH₂O. The membrane (Zeta -probe GT membranes, BIORAD) was cut to the size of the 
gel and equilibrated in ddH₂O for 5 min. The transfer was set up by placing a gel tray upside 
down in a deep dish. Four sheets of blotting paper were cut to the length of the gel tray + 5 
cm at each end, and placed on the inverted gel tray. The blotting paper was saturated with 
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0.4 M NaOH and the bubbles were removed. The dish was filled with 0.4 M NaOH so that the 
ends of the blotting paper were immersed in NaOH. The blotting paper was further saturated 
with 0.4 M NaOH and the gel was placed carefully on top. A small amount of 0.4 M NaOH 
was poured on top of the gel. Plastic wrap was placed over the gel and a window was cut 
with a razor blade, allowing only the gel to be exposed. The equilibrated membrane was 
placed onto the gel surface whilst avoiding bubbles and then flooded with 0.4 M NaOH. Two 
pieces of blotting paper cut to the exact size of the gel, were soaked in ddH₂O and placed 
onto the gel/membrane stack; one at a time, whilst removing the bubbles. Precut paper 
towels (~ 8 cm high) were place on the gel/membrane stack. The stack was covered with a 
plastic plate, with a weight and left overnight for DNA to transfer to the membrane. After 
transfer, the paper towels were removed, the membrane was washed briefly in 2x SSC and 
the excess buffer was allowed to drip off. 
 
2.4.2 Preparation of the probe 
 
The probe was generated by PCR, using S. coelicolor J1929 genomic DNA as a template and 
the primers listed in Table A.1 The PCR product was separated in a 1 % agarose gel and the 
band corresponding to the size of the probe was excised and gel extracted. Probe DNA was 
labelled per the manufacturer’s instructions in the DIG-High Prime DNA Labelling and 
Detection Starter Kit II (Roche Life Sciences) (sco5204 mutants) or the Biotin DecaLabel DNA 
Labelling Kit (Thermo Fisher Scientific) (sco4934 mutants). 
 
2.4.2 Southern blot hybridisation and detection 
 
To confirm the generation of sco5204 mutants, the Southern blot hybridisation and 
detection procedure was carried out using the DIG-High Prime DNA Labelling and Detection 
Starter Kit II (Roche Life Sciences) per the manufacturer’s instructions. To confirm the 
generation of sco4934 mutants, salmon sperm DNA (0.5 mg/mL) was denatured at 100 °C for 
5 min and cooled on ice.  The denatured DNA (50 µg/mL) was added to pre-hybridisation 
solution (0.2 mL/cm² membrane) and incubated with the membrane for 2 h at 42 °C. The 
biotin labelled probe was denatured at 100 °C for 5 min cooled on ice. The denatured probe 
(100 ng/mL pre-hybridisation solution) was added to the pre-hybridisation solution (60 
µL/cm² membrane) and the solution was incubated overnight with the membrane at 42 °C 
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with shaking. The membrane was washed at room temperature for 2 x 10 min in 2x SSC, 0.1 
% SDS (50 mL) and then at 65 °C for 2 x 20 min in 0.1x SSC, 0.1 % SDS (50 mL), both with 
shaking. The excess liquid was removed from the membrane by briefly placing it on blotting 
paper. The southern blot detection procedure was carried out using the Biotin Chromogenic 
Detection Kit (Thermo Fisher Scientific) per the manufacturer’s instructions. 
 
2.5 Protein methods 
 
2.5.1 Ammonium sulfate precipitation of S. coelicolor culture filtrate proteins. 
 
S. coelicolor spores were germinated (as described in 2.3.1) and inoculated into 2 x 500 mL 
of F134 liquid medium in 2 l baffled flasks. The cultures were cultivated for 43 h at 30 ⁰C, 
with shaking at 180 rpm. The cultures were centrifuged at 4000 rpm for 10 min and the 
culture filtrate was separated from the pelleted cell mass. The culture filtrate was filtered 
through a 0.5 uM glass fibre Whatman filter (GE Healthcare Life Sciences) aided by a vacuum 
pump system at 4 ⁰C. Per 450 mL of culture filtrate, 167.94 g of ammonium sulfate was added 
(to prepare a 60 % saturated solution) and the mixture was stirred continuously for 1 h at 4 
⁰C. The mixture was centrifuged at 20 000 g at 4 ⁰C for 20 min. The pellet was solubilised in 
20 mM Tris-HCl buffer, pH 7.5. The culture filtrate protein was desalted using a HiPrep 26/10 
Desalting column (GE Healthcare Life Sciences) on the AKTA Pure chromatography system. 
The column was washed with ddH₂O and then equilibrated 20 mM Tris-HCl, pH 7.5 buffer 
with 0.4 M NaCl, two column volumes (CV) each at a flow rate of 10 mL/min. The culture 
filtrate protein was loaded onto the column and eluted then in 1.5 x CV of 20 mM Tris-HCl, 
pH 7.5 buffer with 0.4 M NaCl at a flow rate of 10 mL/min. 
 
2.5.2 Preparation of membrane proteins from S. coelicolor 
 
The mycelia from S. coelicolor cultures that were cultivated in F134 liquid medium were 
harvested by centrifugation (5 min, 3500 g, 4°C) and washed in 20 mM Tris-HCl buffer (pH 8, 
4°C). The mycelial pellets were re-suspended in twice the pellet volume of lysis buffer at 4°C 
[20 mM Tris-HCl pH 8, 4 mM MgCl₂, protease inhibitor tablet per volume (Roche) and 1 unit. 
mL¯¹ Benzonase (Sigma)]. The mycelia were lysed using a manual french press (Thermo Fisher 
Scientific) at 25 kPsi.  The cell debris was removed by centrifugation (30 min, 5525 g followed 
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by 30 min at 12 000–15 000 g, 4 °C). Membranes in the supernatant were pelleted by 
ultracentrifugation (1 h, 100 000 g, 4 °C) in a Beckman L7-65 Ultracentrifuge. The membrane 
pellets were solubilised overnight on ice in 1% (w/v) dodecyl-β-D maltoside (Sigma) dissolved 
in 20 mM Tris-HCl buffer (pH 8). Any insoluble matter was separated by centrifugation (5 
min, 5525 g, 4 °C). The solubilised membranes were stored in 50 % (v/v) glycerol at -80 °C. 
 
2.5.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
 
SDS-PAGE was carried out using the XCell SureLock™ Mini-Cell Electrophoresis System 
(Thermo Fisher Scientific). Protein samples were prepared by adding 1 part of 4 x RunBlue 
LDS Sample Buffer (Expedeon) to 3 parts of protein sample. β-mercaptoethanol was added 
to a final concentration of 5 % (v/v) and the samples were boiled at 80 °C for 10 min. The 
samples were loaded onto precast RunBlue SDS Protein Gels 4 - 12% (Expedeon) and 
separated using RunBlue SDS Run Buffer (Expedeon) at 160 V for approximately 1 h. The 10 
– 250 kDa protein ladder (NEB) (Figure 2.1) was run alongside the samples as a molecular 
mass standard. The gels were either prepared for western blotting (section 2.5.4) or stained 
in InstantBlue Protein Stain (Expedeon) for ~ 2 h. Gels were destained in ddH₂O for ~ 1 h. 
 
2.5.4 Glycoprotein detection using Con A  
 
Semi-dry western transfer, as described by Kurien and Scofield (2006), used in combination 
with chemiluminescent detection was performed following sample separation by SDS-PAGE. 
An Amersham Hybond P 0.2 PVDF membrane (GE Healthcare Life Sciences) cut to the size of 
the gel was prepared by soaking in methanol for 30 s and then rinsing in ddH₂O. The PVDF 
membrane and 3MM blotting papers were equilibrated in Transfer buffer for 15 min prior to 
blotting. Blotting was performed using the Trans-Blot® SD Semi-Dry Transfer Cell (15 V, 45 
min). The membranes were blocked for 30 min in 10 mL of TBS + 2 % (v/v) Tween 20. The 
membranes were washed for 2 x 5 min in TBS. The membranes were incubated for 2 h in 
12.5 mL of TBS + 0.05 % (v/v) Tween 20, 1 mM MgCl₂, 1 mM MnCl₂ and 1 mM CaCl₂ with 
Concanavalin A peroxidase conjugate (Con A-HRP) added to a final concentration of 5 µg/mL. 
For the inhibition of glycoprotein binding, membranes were incubated for 2 h in 12.5 mL of 
TBS + 0.05 % (v/v) Tween 20, 1 mM MgCl₂, 1 mM MnCl₂ and 1 mM CaCl₂ with Con A-HRP (5 
µg/mL) and 200 mM methyl α-D-glucopyranoside. The membranes were washed for 2 x 10 
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min in TBS + 0.05 % (v/v) Tween 20 and 1 x 5 min in TBS. Under dark room conditions the 
membranes were incubated in chemiluminescent detection solution for 1 min. After 
exposure to the blot, X-ray film (GE Healthcare Life Sciences) was incubated for 3 – 5 min in 
Developer solution (Kodak) and 3 min in Fixer solution (Kodak). The film was rinsed in water 
and allowed to dry. 
 
2.5.5 Glycoprotein enrichment using Con A affinity chromatography 
 
Con A affinity chromatography was carried out on the on the AKTA Pure chromatography 
system. All steps were carried out at a flow rate of 5 mL/min.  Approximately 10 mL of 
agarose bound Con A (Vector Laboratories) was packed into an empty XK 16/20 Column tube 
(GE Healthcare Life Sciences).). The column was washed with 20 mM Tris-HCl, pH 7.5 buffer 
with 0.4 M NaCl, 5 mM MgCl₂, 5 mM MnCl₂ and 5 mM CaCl₂ until the absorbance at 280 nm 
was zero. The column was then equilibrated in 5 x CV of binding buffer (20 mM Tris-HCl, pH 
7.5, 0.4 M NaCl and 0.1 % (w/v) n-dodecyl β-D-maltoside). The sample was loaded onto the 
column and the column was washed with 16 CV of binding buffer. Glycoproteins were eluted 
from the column in 4 x CV of Glycoprotein Eluting Solution for mannose- or glucose-binding 
lectins (Vector Laboratories, ES-1100) or 200 mM methyl α-D-glucopyranoside. Elution 
fractions were stored in 50 % (v/v) glycerol at -80 °C. 
 
2.6 Proteomics and Glycomics  
 
2.6.1 Protein identification 
 
The stained band was excised from an SDS-PAGE gel using a scalpel. The protein containing 
gel slice was cut into approximately 1 mm pieces and placed in a LoBind Eppendorf microfuge 
tube. The sample was sent to the Proteomics Laboratory of the York Bioscience Technology 
Facility to be identified by mass spectrometry. 
2.6.2 In-gel digestion of S. coelicolor glycoproteins. 
 
This method was provided by the Rachel Bates (Bioscience Technology Facility, University of 
York). S. coelicolor glycoproteins (quantities varying from 10 – 20 mg) were prepared in LDS 
sample buffer as described in section 2.5.3. The samples were separated in a NuPAGE™ 10 
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% Bis-Tris precast gel (1 mm x 10 well) (Thermo Fisher Scientific) for 7 min at 200 V constant. 
The gel was stained in InstantBlue Protein Stain for 2 h, and destained in ddH₂O for 1 h. 
Stained regions of the gel were cut into approximately 1 mm pieces for processing. Gel pieces 
were destained by washing for 2 x 20 min with 200 µL of 50 % (v/v) aqueous acetonitrile 
containing 25 mM ammonium bicarbonate ((NH₄)HCO₃), then once with 200 µL of 
acetonitrile for 5 min and dried in a vacuum concentrator for 20 min. The samples were 
reduced by adding 200 µL of 10 mM dithioerythritol (DTE) in 100 mM (NH₄)HCO₃ aq. and 
incubating 56 °C for 1 h. The supernatant was discarded and the gel pieces were allowed to 
return to room temperature. The samples were alkylated by adding 200 µL of 50 mM 
iodoacetamide in 100 mM (NH₄)HCO₃ aq. and incubating in the dark for 30 min at room 
temperature. The supernatant was discarded and the gel pieces were washed in 200 µL of 
100 mM (NH₄)HCO₃ aq. for 15 min. After the supernatant was discarded, the gel pieces were 
washed in 50 % (v/v) aqueous acetonitrile containing 25 mM (NH₄)HCO₃ for 15 min. The 
supernatant was discarded and the gel pieces were dehydrated in 200 µL of acetonitrile for 
5 min. The supernatant was removed and the gel pieces were dried in a vacuum concentrator 
for 20 min. For the removal of O-linked glycans, the gel pieces were subjected to a non-
reductive β-elimination as described in Section 2.6.3. Following dehydration with 
acetonitrile, 0.2 µg of sequencing-grade, modified porcine trypsin (Promega) in 25 mM 
ammonium bicarbonate (enough to cover gel pieces) was added to the gel pieces, and the 
digest was incubated at 37C overnight. The supernatant containing digested peptides was 
retained. The peptides from the residual gel were extracted by adding 200 µL of 50 % (v/v) 
aqueous acetonitrile for 15 min. The extracts were added to the retained supernatant and 
the extraction was repeated twice. The combined supernatant was dried in a vacuum 
concentrator (at a medium setting) and the peptides were reconstituted in 20 µL of 0.1 % 
trifluoroacetic acid (TFA) in ddH₂O.  
For the glycosylation site analysis of SCO4471, 10 µL of the tryptic peptides (in 0.1 % TFA) 
were further dried in a vacuum concentrator and reconstituted in 10 µL 50 mM ammonium 
bicarbonate. Endoproteinase Asp-N from Pseudomonas fragi mutant strain (Sigma-Aldrich) 
was dissolved in water to give a concentration of 0.1 mg/mL. A 2 µL aliquot of Asp-N solution 
was added to the peptide mixture and allowed to incubate at 37 °C overnight. The digested 
peptides were then acidified to 0.1 % TFA. 
 
2.6.3 In-gel non-reductive β-elimination release of O-linked glycans  
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This method was supplied by Rachel Bates (Bioscience Technology Facility, University of 
York). S. coelicolor glycoproteins (quantities varying from 10 – 20 mg) were prepared per the 
procedure for an in-gel trypic digest, to the point where the gel pieces were dried in a vaccum 
concentrator after reduction and alkylation (Section 2.6.2). For the removal of O-linked 
glycans as described by Taylor et al. (2006), 300 µL of 25 % (w/v) ammonium hydroxide was 
added to the dried gel pieces and they were incubated at 45 °C overnight. The supernatant 
(containing the glycans) was removed and retained, and the gel pieces were washed with 
200 µL of 100 mM (NH₄)HCO₃ aq. for 15 min. The supernatant was retained and the gel pieces 
were washed with 200µL of 25 mM (NH₄)HCO₃ in 50 % (v/v) aqueous acetonitrile for 15 min. 
The supernatant was retained, and the gel pieces were washed in 200 µL acetonitrile for 5 
min. The supernatant was retained and the gel pieces were dried in a vacuum concentrator 
for 20 min. The supernatants (containing the glycans) from each step were pooled and stored 
at – 80 °C. For the analysis of the deglycosylated protein, the in-gel digestion procedure 
(section 2.6.2) was continued. 
 
2.6.4 Permethylation of S. coelicolor glycoprotein glycans 
 
This method was supplied by Rachel Bates (Bioscience Technology Facility, University of 
York). Clean round bottom, screw-capped glass tubes were flamed using a Bunsen burner to 
remove any residual organic contamination. Maltose and cellobiose disaccharide standards 
were supplied in ddH₂O by the Proteomics Laboratory of the York Bioscience Technology 
Facility. S. coelicolor glycoprotein glycans isolated by non-reductive β-elimination (section 
2.6.3), and the maltose and cellobiose standards were dried in separate round bottom, 
screw-capped glass tubes in a vacuum concentrator at a medium heat setting. The dried 
glycans were dissolved in 0.5 – 1 mL of dimethyl sulfoxide (DMSO) and 2 microspatulas of 
ground NaOH were added. Using a glass pipette, ~ 5 drops of CH₃I were added, the tubes 
were recapped and swirled to mix, and then allowed to stand for 10 min at rt. ~ 10 drops of 
CH₃I were added, the tubes were recapped and swirled to mix, and then allowed to stand for 
10 min at rt. ~ 20 drops of CH₃I were added, the tubes were recapped and swirled to mix, 
and then allowed to stand for 1 h at rt. 1 mL of 100 mg/mL NaS₂O₃ in ddH₂O was added and 
then ~ 1 mL of CH₂Cl₂ was added. The tubes were mixed by shaking to form an emulsion and 
the caps were loosened to release gas build up. The upper (aqueous) phase was removed. 
The lower (CH₂Cl₂) phase was washed with ~ 0.5 mL of MilliQ H₂O three times. The CH₂Cl₂ 
was then dried under a stream of dry N₂. For analysis by MALDI-FT-ICR-MS or MALDI-TOF-
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MS, the glycans were resuspended in 20 µL of 50 % (v/v) aqueous acetonitrile. For the 
carbohydrate linkage analysis, the S. coelicolor glycoprotein glycans were further processed 
per section 2.6.5. 
 
2.6.5 Carbohydrate linkage analysis 
 
This method was supplied by Rachel Bates (Bioscience Technology Facility, University of 
York). S. coelicolor glycans were isolated by non-reductive β-elimination and permethylated. 
For hydrolysis, 500 µL of 2M TFA was added to the N₂ dried sample and the tube was 
incubated at 120 °C for 1 h. After cooling, the sample was dried in a vacuum concentrator at 
a medium heat setting. 100 µL of propan-2-ol was added and the sample was re-dried in a 
vacuum concentrator at a medium heat setting. The hydrolysis procedure was repeated 
once. For reduction, 100 µL of 1M NH₄OH was added to the sample and mixed. 500 µL of 20 
mg/mL NaBD₄ in DMSO was added, the tube was capped loosely and incubated at 40 °C for 
90 min. The reaction was quenched after the addition of 100 µL of glacial acetic acid and 
contents was mixed until fizzing stopped. For acetylation, 100 µL of anhydrous 1-
methylimidazole was added to the sample. 500 µL of Ac₂O was then added, the tube was 
capped and mixed, and allowed to stand for 10 min. To destroy unreacted Ac₂O, 1.5 mL of 
ddH₂O was added and the sample was cooled to rt. 1 mL of CH₂Cl₂ was added, the sample 
was vortexed and phases were allowed to separate for ~ 1 min. The upper phase was 
removed and the lower phase was washed with 500 µL of MilliQ H₂O; this was repeated a 
further 9 times. The CH₂Cl₂ was then dried under a stream of dry N₂. The sample was 
dissolved in 20 µL of CH₂Cl₂. 10 µL of dissolved sample was transferred to a screw-cap vial 
and analysed by GC-MS. Partially methylated alditol acetates of mannose and glucose 
(provided by the Proteomics Laboratory of the York Bioscience Technology Facility) were 
analysed as standards alongside the S. coelicolor glycans. 
 
2.6.6 Analysis of di/tri saccharides as permethylated di/tri saccharide alditols 
 
S. coelicolor glycans were isolated by non-reductive β-elimination. Maltose and 3α-
mannobiose (Sigma-Aldrich) standards were provided in ddH₂O by the Proteomics 
Laboratory of the York Bioscience Technology Facility and were prepared alongside the S. 
coelicolor glycans. The samples were dried in round bottom, screw-capped glass tubes in a 
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vacuum concentrator at a medium heat setting. For reduction, 250 µL of 10mg/mL NaBD₄ in 
0.5 M NH₄OH was added to the samples. The tubes were loosely capped and incubated at RT 
for 1 h. The reaction was quenched after the dropwise addition of glacial acetic acid until 
fizzing had stopped. The samples were dried in a vacuum concentrator at a medium heat 
setting. After the addition of 1 mL of 10 % (v/v) glacial acetic acid in methanol (MeOH), the 
samples were mixed and dried in a vacuum concentrator at a medium heat setting; this step 
was repeated three times. 1 mL of MeOH was added to the samples with mixing and they 
were dried in a vacuum concentrator at a medium heat setting; this step was also repeated 
three times. The samples were then methylated exactly as described in section 2.6.4 from 
the point where the glycans were dissolved in 0.5 – 1 mL DMSO, to the point of drying the 
CH₂Cl₂ under a stream of dry N₂. The samples were dissolved in 20 µL of CH₂Cl₂. 10 µL of 
dissolved sample was transferred to a screw-cap and analysed by GC-MS. 
 
2.6.7 GC-MS analysis 
 
This method was provided by Rachel Bates (Bioscience Technology Facility, University of 
York). GC-MS analysis was carried out on an Agilent Technologies 7890A GC system fitted 
with a DB-5 fused silica capillary column (30 m x 0.25 mm internal diameter). The carrier gas 
was helium. For the carbohydrate linkage analysis, the instrument settings were: 
temperature program: 50 °C (2 min), ramp to 130 °C at 40 °C/min, ramp to 230 °C at 4 °C/min; 
ionisation method: electron ionisation, +ve ion; electron energy: 70 eV; scanning: linear from 
m/z 50 – 800 over 2 s. For the analysis of partially methylated di/tri saccharide alditols the 
instrument settings were: temperature program: 100 °C (2 min), ramp to 325 °C at 20 °C/min 
(7 min); ionisation method: electron ionisation, +ve ion; electron energy: 70 eV; scanning: 
linear from m/z 50 – 800 over 2 s. 
 
2.6.8 LC-ESI-CID-MS/MS analysis 
 
This text was provided by Adam Dowle (Bioscience Technology Facility, University of York). 
Samples were loaded onto a nanoAcquity UPLC system (Waters) equipped with a 
nanoAcquity Symmetry C18, 5 µm trap (180 µm x 20 mm Waters) and a nanoAcquity HSS T3 
1.8 µm C18 capillary column (75 m x 250 mm, Waters). The trap wash solvent was 0.1 % 
(v/v) aqueous formic acid and the trapping flow rate was 10 µL/min. The trap was washed 
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for 5 min before switching flow to the capillary column.  The separation used a gradient 
elution of two solvents (solvent A: 0.1 % (v/v) formic acid; solvent B: acetonitrile containing 
0.1% (v/v) formic acid). The flow rate for the capillary column was 300 nL/min. Column 
temperature was 60 °C and the gradient profile was liner 2 – 30 % B over 125 mins then linear 
30-50 %B over 5 mins. All runs then proceeded to wash with 95 % solvent B for 2.5 min. The 
column was returned to initial conditions and re-equilibrated for 25 min before subsequent 
injections. The nanoLC system was interfaced with a maXis HD LC-MS/MS system (Bruker 
Daltonics) with a CaptiveSpray ionisation source (Bruker Daltonics). Positive ESI- MS & 
MS/MS spectra were acquired using AutoMSMS mode. Instrument control, data acquisition 
and processing were performed using Compass 1.7 software (microTOF control, Hystar and 
DataAnalysis, Bruker Daltonics). Instrument settings were: ion spray voltage: 1,450 V, dry 
gas: 3 L/min, dry gas temperature 150 °C, ion acquisition range: m/z 150-2,000, quadrupole 
low mass: 300 m/z, transfer time: 120 ms, collision RF: 1,400 Vpp, MS spectra rate: 5 Hz, 
cycle time: 3 s, and MS/MS spectra rate: 5 Hz at 2,500 cts to 20 Hz at 250,000 Hz. The collision 
energy and isolation width settings were automatically calculated using the AutoMSMS 
fragmentation table, absolute threshold 200 counts, preferred charge states: 2 – 4, singly 
charged ions excluded. A single MS/MS spectrum was acquired for each precursor and 
former target ions were excluded for 0.8 min unless the precursor intensity increased 
fourfold. Tandem mass spectral data were searched against a subset of the NCBInr database 
containing only Streptomyces coelicolor entries (8,578 sequences; 2,791,553 residues) using 
a locally-running copy of the Mascot program (Matrix Science Ltd., version 2.5), through the 
Bruker ProteinScape interface (version 2.1).  Search criteria specified: Enzyme, trypsin or 
trypsin and Asp-N; Peptide tolerance, 10 ppm; MS/MS tolerance, 0.1 Da; Instrument, ESI-
QUAD-TOF; Fixed modifications, carbamidomethyl (C); Variable modifications, oxidation (M) 
and deamidated (NQ).  Samples without glycan removal included the variable modifications 
Hex1 to Hex5 (ST).  Deglycosylated samples included the variable modifications:   Ser->Dha 
(S), Ser->Diamino-propanoate (S), Thr->DAb (T), Thr->Diamino-butyrate (T). Results were 
filtered to accept only peptides with an expect score of 0.05 or lower. 
 
2.6.9 LC-MS/MS analysis on the Orbitrap Fusion hybrid mass spectrometer 
 
This text was provided by Adam Dowle (Bioscience Technology Facility, University of York). 
Samples were loaded onto an UltiMate 3000 RSLCnano HPLC system (Thermo) equipped with 
a PepMap 100 Å C18, 5 µm trap column (300 µm x 5 mm Thermo) and an Acclaim PepMap 
Chapter 2 – Materials and Methods 
74 
 
RSLC, 2 µm, 100 Å, C18 RSLC nanocapillary column (75 m x 150 mm, Thermo). The trap wash 
solvent was 0.05% (v/v) aqueous trifluoroacetic acid and the trapping flow rate was 15 
µL/min. The trap was washed for 3 min before switching flow to the capillary column.  The 
separation used gradient elution of two solvents (solvent A: aqueous 1% (v/v) formic acid; 
solvent B: aqueous 80% (v/v) acetonitrile containing 1% (v/v) formic acid). The flow rate for 
the capillary column was 300 nL/min and the column temperature was 50°C. The linear multi-
step gradient profile was: 3-10% B over 8 mins, 10-35% B over 125 mins, 35-65% B over 50 
mins, 65-99% B over 7 mins and then proceeded to wash with 99% solvent B for 4 min. The 
column was returned to initial conditions and re-equilibrated for 15 min before subsequent 
injections. The nanoLC system was interfaced with an Orbitrap Fusion hybrid mass 
spectrometer (Thermo) with a Nanospray Flex ionisation source (Thermo). Positive ESI-MS 
and MS2 spectra were acquired using Xcalibur software (version 4.0, Thermo). Instrument 
source settings were: ion spray voltage, 2,200 V; sweep gas, 0 Arb; ion transfer tube 
temperature; 275°C. MS1 spectra were acquired in the Orbitrap with: 120,000 resolution, 
scan range: m/z 375-1,500; AGC target, 4e5; max fill time, 100 ms; data type, profile.  
Four distinct MS2 strategies were employed as detailed below: 
ETD_IT 
MS2 spectra were acquired in the linear ion trap specifying: quadrupole isolation, isolation 
window, m/z 1.6; activation type, ETD; reaction time, 50 ms; reagent target, 1e6; maximum 
ETD reagent inject time, 200 ms; scan range, normal; scan rate, rapid; first mass, m/z 110; 
AGC target, 5e3; max injection time, 100 ms; data type, centroid. Data dependent acquisition 
was performed in top speed mode using a 1 s cycle, selecting the most intense precursors 
with charge states 3-8.  Dynamic exclusion was performed for 50 s post precursor selection 
and a minimum threshold for fragmentation was set at 5e4. 
EDT_OT 
MS2 spectra were acquired in the Orbitrap specifying: quadrupole isolation, isolation 
window, m/z 1.6; activation type, ETD; reaction time, 50 ms; reagent target, 1e6; maximum 
ETD reagent inject time, 200 ms; scan range, normal; Orbitrap resolution, 30,000; first mass, 
m/z 110; AGC target, 5e3; max injection time, 100 ms; data type, centroid. Data dependent 
acquisition was performed in top speed mode using a 3 s cycle, selecting most the intense 
precursors.  Dynamic exclusion was performed for 50 s post precursor selection and a 
minimum threshold for fragmentation was set at 5e4. 
Chapter 2 – Materials and Methods 
75 
 
HCD_IC 
MS2 spectra were acquired in the linear ion trap specifying: quadrupole isolation, isolation 
window, m/z 1.6; activation type, HCD; collision energy, 32%; scan range, normal; scan rate, 
rapid; first mass, m/z 110; AGC target, 5e3; max injection time, 100 ms; data type, centroid. 
Data dependent acquisition was performed in top speed mode using a 3 s cycle, with most 
intense precursors selected.  Dynamic exclusion was performed for 50 s post precursor 
selection and a minimum threshold for fragmentation was set at 5e3. 
HCD/ETD_IC 
Precursors were sequentially selected and fragmented by both HCD and ETD. HCD spectra 
were acquired in the linear ion trap specifying quadrupole isolation, isolation window, m/z 
1.6; activation type, HCD; collision energy, 30%; scan range, normal; scan rate, rapid; first 
mass, m/z 110; AGC target, 1e4; max injection time, 60 ms; data type, centroid.  ETD spectra 
were acquired in the Orbitrap specifying: quadrupole isolation, isolation window, m/z 1.6; 
activation type, ETD; EThdD SA collision energy (15%), maximum ETD reagent inject time, 
120 ms; scan range, normal; Orbitrap resolution, 60,000; first mass, m/z 120; AGC target, 
5e4; max injection time, 200 ms; data type, centroid. Data dependent acquisition was 
performed in top N mode using a 20 precursor cycle for charge states 3-8.  Highest charge 
state then most intense were set as selection priorities. Dynamic exclusion was performed 
for 50 s post precursor selection and a minimum threshold for fragmentation was set at 5e3. 
Peak lists were generated in MGF format using Mascot Distiller (version 5, Matrix Science), 
stipulating a minimum signal to noise ratio of 2 and correlation (Rho) of 0.6. MGF files were 
searched against the Streptomyces coelicolor subset of the NCBInr database (8,578 
sequences; 2,791,553 residues) using a locally-running copy of the Mascot search program 
(Matrix Science Ltd., version 2.5.1).  Search criteria specified: Enzyme, trypsin; Fixed 
modifications, carbamidomethyl (C); Variable modifications, Hex (S,T), Hex2 (S,T), Hex3(S,T) 
and oxidation (M); Peptide tolerance, 10 ppm.  MS/MS tolerance was set to 0.5 Da for linear 
ion trap data and 0.05 Da for Orbitrap data. Instrument type was set at ESI-TRAP, ETD-TRAP 
or CID + ETD as appropriate. Results were filtered to accept only peptides with expect scores 
of 0.05 or lower. 
 
2.6.10 Assignment of O-glycosylation sites 
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All glycopeptide spectra with MASCOT expect scores of 0.05 or lower were manually 
validated. For glycopeptide spectra generated by CID and HCD fragmentation, glycosylation 
sites were only assigned in cases where only a single glycosylated residue was possible within 
the glycopeptide. For the site localisations of glycopeptides identified in the ETD_IT and 
ETD_OT acquisitions, an MD-score cut off of 10 was applied. In matches were the MD-score 
was greater than 10, the spectra were manually validated to confirm the site localisation.  
 
2.6.11 MALDI analysis 
 
This method was supplied by Rachel Bates (Bioscience Technology Facility). MALDI mass 
spectra were obtained on the Bruker solariX FT-ICR-MS or the Bruker ultraflex III MALDI-
TOF/TOF instrument. 2,5-Dihydroxybenzoic acid (Sigma) made up in 50 % (v/v) acetonitrile, 
0.1 % TFA was used as a matrix (20 mg/mL). The permethylated glycan solutions were diluted 
1:1, 1:2, 1:5 and 1:10 in the matrix solution and 1 µL of each dilution was spotted onto a 
ground steel MALDI target plate and air dried. The Bruker solariX FT-ICR-MS instrument was 
operated in positive mode with a smartbeamᵀᴹ laser operating at 355 nm. Each individual 
spectrum was acquired using 30 laser shots and an average spectra setting of 20. 
solariXcontrol software was used to obtain spectra. MS spectra were acquired over a mass 
range of m/z 154-3500.  Precusor ions were selected manually adjusting the collision energy 
manually to generate fragmentation. Positive-ion MALDI mass spectra were obtained using 
a Bruker ultraflex III in reflectron mode, equipped with an Nd:YAG smartbeamᵀᴹ laser.  MS 
spectra were acquired over a mass range of m/z 100-3000.  Spectra were externally 
calibrated against an adjacent spot containing 6 peptides (des-Arg1-Bradykinin, m/z 904.681; 
Angiotensin I, m/z 1296.685; Glu1-Fibrinopeptide B, m/z 1750.677; ACTH (1-17 clip), m/z 
2093.086; ACTH (18-39 CLIP), m/z 2465.198; ACTH (7-38 CLIP), m/z 3657.929.). 
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The most commonly employed technique for glycoprotein characterisation is high 
performance liquid chromatography (HPLC) coupled to mass spectrometry (MS) (Ongay et 
al. 2012). Although recent technological advances in mass spectrometry enable the analysis 
of complex biological samples, the analysis of glycoproteins in complex mixtures remains 
challenging. This is often because glycopeptides are less abundant and the signal intensities 
are often lower, than those of non-glycosylated peptides (Geyer and Geyer 2006). Therefore, 
glycoprotein enrichment and detection strategies are often required prior to their analysis 
using high-throughput proteomics. Lectins are a diverse group of proteins that interact with 
carbohydrate moieties attached to glycoconjugates and are most commonly exploited in 
glycoprotein enrichment strategies (Cummings 1994). The carbohydrate binding specificities 
of many lectins are well characterised and they are commercially available as conjugates to 
a range of matrices. The mannose binding lectin concanavalin A (Con A) has been used 
successfully to detect glycoproteins in mycobacteria, as well as a glycoprotein enrichment 
strategy (Espitia and Mancilla 1989; Garbe et al. 1993; Gonzalez-Zamorano et al. 2009; 
Wehmeier et al. 2009). 
S. coelicolor has a well characterised protein O-glycosylation pathway that is highly similar to 
the pathway in mycobacteria (discussed in Chapter 1) yet the glycoproteome is significantly 
less well-studied. Wehmeier et al. (2009) characterised a single glycoprotein in S. coelicolor, 
a periplasmic phosphate binding protein (SCO4142; PstS), after the enrichment of 
membranes using Con A sepharose. They suggested that other glycoproteins existed in S. 
coelicolor based on preliminary findings that alluded to the presence of ProQ Emerald 
staining of glycoproteins in the soluble and membrane associated protein fractions 
(Wehmeier unpublished). 
The aim of this chapter was to develop and validate reproducible methods of enriching and 
detecting glycoproteins in the S. coelicolor culture filtrate and membrane. These methods 
would form the first steps of a glycoproteomics workflow to enable an in-depth 
characterisation of the S. coelicolor glycoproteome (discussed in Chapter 4). 
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3.1 Phenotypes of glycosylation deficient S. coelicolor strains in F134 medium 
 
A glutamate based phosphate-limited medium (referred to as F134 medium) was selected 
for the cultivation of the S. coelicolor strains in this study. F134 medium was selected because 
phosphate depletion was previously shown to induce the expression of the S. coelicolor 
glycoprotein SCO4142 (PstS) (Nieselt et al. 2010; Thomas et al. 2012). SCO4142 could 
therefore serve as a positive control for the glycoprotein enrichment in this study.  
The glycosylation deficient DT1025 (pmt) and DT3017 (ppm1) S. coelicolor strains were 
previously shown to have a small colony phenotype, and increased antibiotic susceptibility 
compared to the S. coelicolor M145 derivative J1929, when grown on Difco nutrient agar 
(DNA) (Howlett et al. 2016). Additionally, both glycosylation deficient strains were identified 
as being resistant to infection by the phage φC31cΔ25 suggesting that the receptor is a 
glycoprotein (Cowlishaw and Smith 2001; Cowlishaw and Smith 2002). Prior to attempting 
glycoprotein enrichment from these strains, I tested the phenotypes associated with the pmt 
and ppm1 mutants on F134 medium.  
S. coelicolor strains J1929, DT1025 (pmt) and DT3017 (ppm1) were grown on both DNB + 1 
% (w/v) agar and F134 + 1 % (w/v) agar in microwell plates for 47 h. On DNB + 1 % (w/v) agar 
a modest reduction in growth rate was observed for DT3017 (ppm1) when compared to 
J1929 and DT1025 (pmt) (Figure 3.1.a). All three strains appeared to have entered stationary 
phase after 35 h. In contrast, all three strains grew more slowly on F134 medium and 
appeared to be still growing after 47 h (Figure 3.1.b). J1929 and DT1025 (pmt) grew similarly 
while DT3017 (ppm1) displayed a reduced growth phenotype after 30 h. To investigate the 
colony morphology J1929, DT1025 and DT3017 spores were plated onto DNA (Figure 3.2.a) 
and F134 agar plates (Figure 3.2.b) and grown for 2-3 days. Colonies appeared on DNA after 
2 days, while it took 3 days for colonies to reach the same size on F134 agar. DT3017 
displayed a distinct small colony phenotype when compared to J1929 and DT1025 on both 
DNA and F134 agar. Sensitivity of the three strains to the φC31cΔ25 phage was tested on 
DNA (Figure 3.3.a) and F134 agar (Figure 3.3.b). Large clear plaques were observed on J1929 
on both DNA and F134. Some plaques were obtained on the glycosylation deficient mutants 
on both DNA and F134 with a very low efficiency compared to J1929, and the plaque 
morphologies were small and turbid. These were seen previously on pmt and ppm1 mutants 
and have been linked to compensatory host range mutants of the φC31cΔ25 phage 
(Cowlishaw and Smith 2001). 
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Figure 3.1 The effect of medium on the growth of S. coelicolor J1929 and the glycosylation 
deficient mutant strains DT1025 (pmt) and DT3017 (ppm1). J1929 (black circle), DT1025 
(white circle) and DT3017 (black triangle) were cultivated on DNB + 1 % (w/v) agar (a) and 
F134 + 1 % (W/V) agar (b) respectively. The strains were cultivated in microwell plates over 
47 h and the absorbance at 492 nm was measured on a microplate reader. Error bars 
represent the standard error of the mean of three biological replicates. 
  
Chapter 3 – Enrichment and detection of glycoproteins  
81 
 
 
 
Figure 3.2 The effect of medium on the colony morphology of S. coelicolor J1929 and the 
glycosylation deficient mutants DT1025 (pmt) and DT3017 (ppm1). Spores were grown on 
DNA (a) for 2 days and F134 agar (b) for 3 days. Images representative of two biological and 
two technical replicates. 
 
 
 
Figure 3.3 Plaque formation by S. coelicolor J1929 and the glycosylation deficient mutants 
DT1025 (pmt) and DT3017 (ppm1) with the φC31cΔ25 phage on DNA (a) and F134 agar (b). 
φC31cΔ25 (~ 1 x 10³ pfu) was inoculated with J1929, whereas ~ 1 x 10 ⁸ pfu of φC31cΔ25 was 
inoculated with DT1025 and DT3017. Images representative of at least two biological 
replicates and two technical replicates. 
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The antibiotic sensitivity of S. coelicolor J1929, DT1025 (pmt) and DT3017 (ppm1) on F134 
agar compared to DNA was measured using disc diffusion assays (Figure 3.4; Table A.2 and 
Table A.3). Three biological replicates were tested at least once against four different 
concentrations of each antibiotic. On DNA both DT1025 (pmt) and DT3017 (ppm1) mutants 
had increased susceptibilities to ampicillin, imipenem, meropenem and vancomycin 
compared to the parent strain J1929. DT3017 (ppm1) mutants also displayed increased 
sensitivity to teicoplanin, rifampicin, bacitracin and penicillin. F134 suppresses the antibiotic 
sensitivity phenotype seen with DT1025 (pmt) and DT3017 (ppm1) grown on DNA, with the 
exception of vancomycin and penicillin susceptibilities. In summary, the overall growth and 
phage resistance phenotypes are maintained on F134 medium. However, the antibiotic 
susceptibilities are remarkably different on F134 compared to DNA, possibly reflecting the 
defined nature of F134. 
 
3.2 Detection and enrichment of glycoproteins in S. coelicolor J1929 that are absent from 
the glycosylation deficient strains  
 
S. coelicolor J1929, DT1025 (pmt) and DT3017 (ppm1) strains were cultivated in F134 medium 
for 25 h after a 12 h spore germination. The membrane proteins were isolated, analysed by 
SDS-PAGE, blotted onto polyvinylidene difluoride (PVDF) membrane and probed with Con A 
conjugated to horseradish peroxidase (Con A-HRP) (Figure 3.5). Strong bands of Con A 
reactivity were observed at ~ 100 kDa and ~ 55 kDa and fainter bands at ~ 90 kDa, ~ 50 kDa 
and ~ 45 kDa in J1929, which were absent from the glycosylation deficient DT1025 (pmt) and 
DT3017 (ppm1) (Figure 3.5.b). The Con A reactivity was lost in the present of methyl α-D 
glucopyranoside, a competitive inhibitor of mannose and glucose binding. The results 
suggest the presence of glycoproteins in the membrane of J1929, which are absent from the 
glycosylation deficient DT1025 (pmt) and DT3017 (ppm1). In order to identify glycoproteins 
in S. coelicolor lectin affinity chromatography was used enrich for glycoproteins from the 
membrane and culture filtrate of J1929. The glycosylation deficient DT1025 (pmt) served as 
a negative control for the glycoprotein enrichment. J1929 and DT1025 (pmt) were cultivated 
in F134 medium (2 x 500 mL cultures) for 43 h after a 6 h spore germination. The culture 
filtrate protein was isolated after ammonium sulfate precipitation and subjected to lectin 
affinity chromatography using agarose bound Con A (Figure 3.6).  
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Figure 3.4 Antibiotic susceptibility of glycosylation deficient S. coelicolor strains on DNA 
and F134 agar. Shown are the diameters of the growth inhibition zones (mm) from disc 
diffusuion assays. Bars represent the mean of three biological replicates with error bars 
indicating SEM. * indicates p < 0.05 that the observed difference between the mutant strains 
and J1929 has occurred by chance. Only a single antibiotic concentration shown; the full data 
set is in Table A.2 and Table A.3. 
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Figure 3.5 Detection of glycosylated proteins in the membrane of S. coelicolor J1929 using 
Con A-HRP. Protein loading was 17 µg for gels stained with protein stain (a) and 5 µg for 
western blots probed with Con A-HRP (b and c). a). Total membrane protein from J1929, 
DT1025 and DT3017 (lanes 2 – 4 respectively) was analysed by SDS-PAGE and stained with 
InstantBlue protein stain. The protein marker was the Broad range 10 – 250 kDa Mw marker 
(NEB) (lane 1). Bovine serum albumin was a negative control (lane 5) and Avidin was a 
positive control for the Con A-HRP reactivity. b) and c). Membrane protein was transferred 
to PVDF and probed with Con A -HRP, a 2 min (b) and 8 min (c) exposure to the membrane 
shown. Lanes indicate J1929 (lane 1 and 6), DT1025 (lane 2 and 7), DT3017 (lane 3 and 8), 
BSA (lanes 4 and 9) and avidin (lanes 5 and 10) in panel (b) and (c) respectively. This 
experiment was repeated at least 3 times with the same results. 
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Figure 3.6 Overlayed chromatograms indicating the Con A agarose enrichment of the 
culture filtrates from J1929 (b) and DT1025 (pmt) (a). The grey shading indicates where 
elution with methyl α-D-glucopyranoside elution buffer was carried out. ~ 5 mg of total 
culture filtrate was loaded onto the column. 
 
 
 
 
 
Figure 3.7 Analysis of J1929 and DT1025 (pmt) culture filtrate proteins after enrichment 
using Con A affinity chromatography and separated by SDS-PAGE, stained with Coomassie 
(a) and Con A-HRP (b). A single Coomassie stained protein was observed in the J1929 
retained fraction (red circle). Lanes indicate: 10 – 250 kDa broad range protein ladder (NEB) 
(lane 1, 8), J1929 total filtrate (lanes 2, 9), J1929 unbound filtrate (lanes 3, 10), J1929 retained 
fraction (lanes 4, 11), DT1025 total filtrate (lanes 5, 12), DT1025 unbound filtrate (lanes 6, 
13) and DT1025 retained fraction (lanes 7, 14). 
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After the elution of the glycoproteins from the column using methyl α-D-glucopyranoside, a 
small change in absorbance at 280 nm was observed in the J1929 sample. No change in 
absorbance at 280 nm was observed in the DT1025 sample. The retained fractions were 
subsequently pooled and concentrated. The total culture filtrate, unbound and retained 
fractions were fractionated by SDS-PAGE, blotted onto a PVDF membrane and probed with 
Con A-HRP (Figure 3.7). A single protein of ~ 45 kDa was observed by protein staining in the 
retained fraction of J1929 (Figure 3.7.a) which displayed significant Con A-HRP reactivity 
(Figure 3.7.b). Three additional bands at ~ 30 kDa, 40 kDa and 60 kDa were observed by Con 
A-HRP reactivity only in the J1929 retained fraction. There was no apparent enrichment of 
protein in the DT1025 sample. Some background Con A-HRP reactivity was observed in the 
DT1025 total and unbound fractions.  
The glycoprotein enrichment was also carried out on the total membrane protein isolated 
from J1929 and DT1025 (pmt) cultures. Approximately 2 mg of total membrane protein was 
subjected to Con A affinity chromatography (Figure 3.8). After the elution of the 
glycoproteins from the column using methyl α-D-glucopyranoside, peaks corresponding to a 
change in absorbance at 280 nm were observed in both J1929 and DT1025 samples. The total 
soluble protein, total membrane protein, unbound membrane protein and retained fractions 
were fractionated by SDS-PAGE, blotted onto a PVDF membrane and probed with Con A-HRP 
(Figure 3.9). As observed in the culture filtrate enrichment of J1929, a single protein of ~ 45 
kDa was observed by Coomassie staining in the J1929 membrane retained fraction.  No single 
protein appeared to be enriched in the DT1025 retained fraction, despite the change in 
absorbance at 280 nm observed on the chromatogram of the DT1025 enriched membrane. 
This could suggest that other glycoconjugates are present in the DT1025 membrane. Multiple 
Con A-HRP reactive bands were observed in the J1929 soluble and total membrane fractions. 
Several Con A-HRP reactive bands were observed in the elution fraction of the J1929 
membrane, including a highly reactive band observed at ~ 45 kDa. Taken together these data 
demonstrate the presence of a glycoproteome in the S. coelicolor membrane and culture 
filtrate, the synthesis of which requires Pmt. 
 
3.3 Identification and glycosylation site analysis of SCO4471 
 
The ~ 45 kDa proteins enriched from the J1929 culture filtrate and membrane were excised 
and identified by mass spectrometry (MALDI-TOF/TOF carried out by the Proteomics 
Department of the York Technology Facility). The protein identification summary of both   
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Figure 3.8 Overlayed chromatograms indicating the Con A agarose enrichment of the 
membrane proteins from J1929 (b) and DT1025 (pmt) (a). The elution volume is shaded in 
grey. ~ 2 mg of total membrane was loaded onto the column. 
 
 
 
 
 
 
Figure 3.9 Analysis of J1929 and DT1025 (pmt) membrane proteins by SDS-PAGE (lanes 1-
10) and Con A-HRP (lanes 11 - 18) after enrichment using Con A affinity chromatography. 
Lanes indicate: 10 – 250 kDa Broad range protein ladder (NEB) (lane 1, 10), J1929 total 
soluble (lanes 2, 11), J1929 total membrane (lanes 3, 12), J1929 unbound (lanes 4, 13), J1929 
elution (lanes 5, 14) DT1025 total soluble (lanes 6, 15) DT1024 total membrane (lanes 7, 16), 
DT1025 unbound (lanes 8, 17) and DT1025 elution (lanes 9, 18). 
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bands is shown in Table A.10. Both bands were identified as SCO4471, a putative lipoprotein 
with a predicted Mw of 47 kDa. The MALDI-TOF/TOF data generated from the protein 
identifications was searched via MASCOT for glycopeptides modified with Hex, Hex₂ and Hex₃ 
; however, none were identified. The protein sequence of SCO4471 was searched through 
the Conserved Domain Database (CDD) (http://www.ncbi.nlm.nih.gov/Structure/cdd/ 
wrpsb.cgi). The only hit was the CE4_SF superfamily (e-value: 5.06e-120) which describes the 
Catalytic NodB homology domain of the carbohydrate esterase 4 superfamily. This family 
includes chitin deacetylases and bacterial peptidoglycan N-acetyglucosamine deacetylases. 
The CDD search results suggested that SCO4471 could have a role in the cell wall, making it 
an interesting target for characterisation. SCO4471 orthologues were found in Streptomyces 
venezuelae (S. venezuelae), Streptomyces scabies (S. scabies), Streptomyces griseus (S. 
griseus), Streptomyces avermitilis (S. avermitilis) and Streptomyces lividans (S. lividans) 
(Figure 3.10). 
Previous work has shown that the NetOGlyc algorithm could successfully predict possible 
glycosylated peptides in M. tuberculosis (Herrmann et al. 2000). NetOGlyc 4.0 was used to 
scan S. coelicolor SCO4471 for amino acids predicted to be O-glycosylated. 15 Putative O-
glycosylation sites were predicted while six of the sites appeared to be on residues conserved 
in more than three S. coelicolor orthologues (Figure 3.10).  
To identify the predicted O-glycosylation sites, SCO4471 was deglycosylated using non-
reductive β-elimination. Non-reductive β-elimination of O-linked glycans from peptides using 
NH₄OH was previously shown to result in modified serine (S) or threonine (T) residues having 
a distinct mass (Rademaker et al. 1998). The modified masses can be used as indicators of a 
previously glycosylated residue. The release of O-linked glycan is a two-step process. First 
the glycan is released from the S/T residue to yield dehydroalanine (Dha)/dehyrobutyric acid 
(Dhb), observed as a mass decrease of 18 Da. Subsequently an amine group can be added to 
Dha/Dhb resulting in diamino-propanoate (S) or diamino-butyrate (T), observed as a mass 
decrease of 1 Da.  
No single enzyme could generate peptides amenable to ionisation covering all of the 
predicted glycosylation sites in SCO4471. Therefore, the deglycosylated SCO4471 was 
digested with trypsin and then half of the tryptic digest was further digested with Asp-N. The 
two digests were pooled and analysed by LC-ESI-MS/MS. This analysis was carried out by the 
Proteomics Department of the Bioscience Technology Facility. The MASCOT search results 
are summarised in Table A.11. 
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Figure 3.10 Clustal Omega alignment of SCO4471 and O-glycosylation sites predicted by 
NetOGlyc 4.0. S. coelicolor SCO4471 (sco4471) was aligned with orthologues from S. 
venezuelae (SVEN_3144), S. scabies (SCAB38671), S .griseus (SGR_4195), S. avermitilis 
(SAV_4797) and S. lividans (SLI_4749). Residues in red are predicted to be O-glycosylated by 
NetOGlyc. 4.0. Black and grey shading indicate 100 % amino acid identity and > 50 % amino 
acid similarity respectively. The lipid attachment site predicted by the LipoP 1.0 software is 
indicated by a yellow arrow. 
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Table 3.1 Peptides encompassing predicted glycosylation sites in SCO4471, observed by LC-MS after digestion with trypsin and Asp-N. Residues predicted 
to be O-glycosylated by NetOGlyc 4.0 are highlighted in red.  
 
Amino acid range Peptide monoisotopic mass Peptide sequence Modified S/T observed 
57 - 69 1262.6156 K.APAKPIGDGSTSY.T none 
57 - 72 1548.778 K.APAKPIGDGSTSYTGK.Q none 
59 - 72 1380.6915 P.AKPIGDGSTSYTGK.Q none 
61 - 72 1181.5569 K.PIGDGSTSYTGK.Q none 
148 - 161 1517.7374 R.GASDIGYLTDEHIK.A none 
150 - 161 1389.6783 A.SDIGYLTDEHIK.A none 
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Peptides encompassing five of the predicted O-glycosylation sites were observed by LC-MS, 
however these were unmodified (Table 3.1). These results could not demonstrate 
glycosylation of the predicted O-glycosylation sites in SCO4471. 
 
3.4 Large scale glycoprotein enrichment 
 
Con A affinity chromatography used in combination with western blotting using a Con A-HRP 
probe, appeared to be successful in the enrichment and detection of glycoproteins from the 
S. coelicolor J1929 membrane and culture filtrate proteomes in the small-scale trials (Section 
3.2). The Con A enrichment was subsequently scaled up to increase the amount of material 
for downstream glycoproteomics analyses. The membrane proteome was selected for the 
large scale Con A enrichment because it was easier and more cost effective to isolate large 
amounts membrane protein, than to isolate the equivalent amount of protein from the 
culture filtrate. There also appeared to be more different Con A reactive proteins enriched 
from the J1929 membrane (Figure 3.9, lane 14) than the culture filtrate (Figure 3.7, lane 11) 
suggesting that an enrichment of the membrane proteome could result in greater 
glycoproteome coverage. 
S. coelicolor J1929 was cultivated in F134 medium (4 x 500 mL cultures) for 43 h after a 6 h 
germination. The total membrane protein was isolated yielding 50 mg of protein. After the 
enrichment of the membranes using Con A affinity chromatography the total membrane 
protein, unbound membrane protein and retained fractions were separated by SDS-PAGE, 
blotted onto a PVDF membrane and probed with Con A-HRP (Figure 3.11). At least eight 
protein bands were clearly visible by protein staining in the elution fraction (Figure 3.11.a, 
lane 4) including a single band of ~ 45 kDa; mostly likely SCO4471. Of these, six bands 
appeared to be Con A-HRP reactive (Figure 3.11.b, lane 3) corresponding to the molecular 
masses of approximately 110 kDa, 65 kDa, 45 kDa, 40 kDa, 35 kDa and 30 kDa respectively. 
Con A reactivity was lost when the membranes were incubated in the presence of methyl α-
D glucopyranoside indicating that the Con A-HRP was binding specifically to mannosyl or 
glucosyl residues.  
The six proteins corresponding to the bands of Con A-HRP reactivity (Figure 3.11.a, labelled 
1 – 6) were excised and identified by mass spectrometry (MALDI-TOF/TOF carried out by the 
Proteomics Department of the York Bioscience Technology Facility). The MASCOT search 
results are summarised in Table 3.2. As expected the ~ 45 kDa protein (band 3) was the  
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Figure 3.11 Large scale enrichment of S. coelicolor J1929 membrane proteins using Con A 
affinity chromatography. The samples were analysed by SDS-PAGE (a) and western blotting 
using Con A-HRP as a probe (b and c). Con A-HRP reactivity was lost in the presence of a 
competitive inhibitor of mannose binding, methyl α-D glucopyranoside (c). The 10 – 250 kDa 
broad range protein ladder (NEB) was used as a Mw standard (panel a, lane 1). Arrows 1 – 6 
indicate protein bands excised and identified by mass spectrometry. 
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Table 3.2 MASCOT search results summary of the protein identifications of Con A enriched proteins excised in Figure 3.11 and analysed by mass 
spectrometry. Proteins were classified based on the bioinformatics database searches summarised in Table A.12. 
 
 
Band 
no. Gene Identifier Genome annotation 
Predicted 
Mw 
(kDa) Protein classification 
Number 
of 
peptides 
matched Score (coverage)  
1 SCO5204 Putative integral membrane protein 109.5 membrane protein 1 40 (1 %) 
2 SCO4856 Putative succinate dehydrogenase flavoprotein subunit 64.7 cytoplasmic protein 4 202 (10 %) 
3 SCO4471 Putative secreted protein 46 lipoprotein 3 153 (7 %) 
4 SCO4142 Periplasmic phosphate-binding protein  38.3 lipoprotein 1 68 (4 %) 
4 SCO6009 Solute-binding protein 39.3 lipoprotein 2 136 (8 %) 
5 SCO1796 Putative secreted protein 34.6 membrane protein 1 53 (5 %) 
6 SCO5776 Glutamate binding protein 29.5 lipoprotein 2 114 (11 %) 
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previously identified SCO4471. Band 4 was a mixture of two proteins, the previously 
characterised S. coelicolor glycoprotein SCO4142 (PstS) (Wehmeier et al. 2009) and SCO6009. 
The protein sequences were searched through various bioinformatics software to predict the 
presence of transmembrane domains, signal peptides and whether the proteins are 
lipoproteins (Table A.12). Four of the proteins identified are predicted to be lipoproteins 
(SCO6009, SCO5776, SCO4142 and SCO4471). All proteins identified are predicted to be 
localised in the membrane or the periplasm, with the exception of SCO4856. The Con A-HRP 
reactivity of band 2 (SCO4856) did not appear to increase in intensity in the Con A enriched 
fraction compared to the total membrane fraction (Figure 3.11.b). This might suggest that 
SCO4856 was not enriched by the Con A but is merely an abundant protein that bound non-
specifically to the column. 
 
3.5 Discussion 
 
S. coelicolor has a well characterised protein O-glycosylation pathway, but little is known 
about the constitution of the glycoproteome. To better understand the physiological 
processes affected by protein O-glycosylation in S. coelicolor we decided that an in-depth 
characterisation of the glycoproteome was required. The first step towards glycoproteome 
characterisation was the optimisation of methods for glycoprotein detection and 
enrichment. Previous work has shown that a disruption of protein O-glycosylation in S. 
coelicolor results in changes in growth, colony morphology, φC31cΔ25 phage sensitivity and 
sensitivity to antibiotics, when grown on DNA (Cowlishaw and Smith 2001; Cowlishaw and 
Smith 2002; Howlett et al. 2016). F134 medium was chosen for the cultivation of strains in 
this study as the timing for the expression of the S. coelicolor glycoprotein SCO4142 (PstS) 
was well known (Nieselt et al. 2010; Thomas et al. 2012) This protein could therefore serve 
as a positive control for the glycoprotein enrichment in this study. We also hoped to further 
the characterisation of SCO4142 using glycoproteomics approaches, since glycopeptides 
mapping this glycoprotein were not previously observed by Wehmeier et al. (2009).  
The phenotypes associated with defective glycosylation in S. coelicolor were studied on F134 
agar to investigate whether these effects were growth medium dependent. We 
hypothesised that similar phenotypes on both growth media could suggest that 
glycoproteins associated with these phenotypes on DNA, are also expressed on F134 agar. 
The overall growth rates of all strains tested were reduced on F134 agar compared to DNA. 
However, the slow growth phenotype of DT3017 (ppm1) previously observed on DNA was 
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still visible on F134 agar, albeit with altered overall growth kinetics. The small colony 
phenotype of DT3017 (ppm1) compared to J1929 and DT1025 (pmt) was evident on F134 
agar suggesting that this phenotype is not medium dependent. S. coelicolor J1929 was 
sensitive to infection by the phage φC31cΔ25 on both media, suggesting that the phage 
receptor glycoprotein is expressed when grown on DNA and F134 agar. Similarly, the 
glycosylation deficient strains were consistently resistant to infection by the phage 
φC31cΔ25 on both media, suggesting that the phage receptor is not glycosylated on DNA or 
F134 agar. The greatest phenotypic difference between the strains on F134 agar and DNA 
was observed in the differences in their antibiotic susceptibilities. The overall reduced 
sensitivity of the glycosylation deficient strains to ampicillin, imipenem, meropenem, 
bacitracin and vancomycin on F134 agar compared to DNA could be explained by the slow 
growth rate on F134 agar. β-lactam antibiotics (e.g. ampicillin, imipenem and meropenem) 
target proteins required for peptidoglycan crosslinking, while bacitracin inhibits steps in 
peptidoglycan biosynthesis (Stone and Strominger 1971; Waxman and Strominger 1983). 
Vancomycin acts by binding to the terminal D-alanyl-D-alanine dipeptide of peptidoglycan 
precursors and inhibiting their incorporation (Barna and Williams 1984). While a defective 
glycosylation system might alter the activity of cell-wall biosynthetic enzymes or limit cell-
wall precursors leading to greater antibiotic sensitivity under rapid growth conditions, under 
slow growth conditions such as those observed on F134 medium these effects could be 
reduced. It is however unclear why J1929 and DT1025 (pmt) displayed increased sensitivity 
to penicillin, teicoplanin and rifampicin on F134 agar compared to DNA. 
The analysis of the membrane using Con A-HRP after western blotting suggests that 
glycoproteins are present in S. coelicolor J1929, and are absent from the glycosylation 
deficient DT1025 (pmt) and DT3017 (ppm1). The concomitant loss of Con A-HRP reactivity in 
the presence of the competitive inhibitor of mannose binding, methyl α-D glucopyranoside 
suggests that Con A is binding to the glycan on glycoproteins in the membrane of J1929. This 
observation is further supported by the fact that glycoproteins were enriched from the S. 
coelicolor J1929 membrane and culture filtrate, but not from DT1025 (pmt) after Con A 
affinity chromatography. The peak eluted from the Con A column after the enrichment of 
DT1025 (pmt) membranes proteins (Figure 3.8), despite the apparent absence of Coomassie 
stained protein could be explained by the presence of other glycoconjugates in S. coelicolor 
membrane, such as teichoic acids. This is supported by the observation that it is also retained 
longer than the glycoprotein peak in the J1929 sample. 
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The Con A agarose (Vector Laboratories) used in this study was far more effective for 
glycoprotein enrichment than the Con A sepharose used previously by Wehmeier et al. 
(2009). The use of the latter resulted in a larger amount of non-specific binding, which was 
not observed with Con A agarose. In this work, the lack of non-specific binding to the Con A 
agarose was demonstrated in the Con A enrichments of the membrane and culture filtrate 
proteomes of DT1025 (pmt). The use of Con A agarose for glycoprotein enrichment was 
highly reproducible; all of the Con A-HRP reactive bands observed during the small-scale 
enrichments corresponded to the molecular masses of proteins observed by Coomassie 
staining and Con A-HRP reactivity after the large-scale enrichment.  
Five candidate glycoproteins were successfully enriched during this study. Included in these 
was the previously characterised S. coelicolor glycoprotein SCO4142 (PstS) (Wehmeier et al. 
2009). Four of the proteins are predicted to be lipoproteins, which are well known targets of 
O-glycosylation in M. tuberculosis (Dobos et al. 1995; Sutcliffe and Harrington 2004; Sartain 
and Belisle 2009). The homologue of SCO5776 in M. tuberculosis (Rv0411c) was previously 
identified by LC-ESI MS/MS after the enrichment of the culture filtrate by Con A affinity 
chromatography (Gonzalez-Zamorano et al. 2009). SCO4856, a putative succinate 
dehydrogenase flavoprotein subunit is part of a membrane-located complex facing the 
cytoplasm. This protein is homologous to the E. coli protein SdhA which has a role in the 
tricarboxylic acid (TCA) cycle (Yankovskaya et al. 2003). It is probable that the enrichment of 
this protein was non-specific due to its high abundance in the cell. However, the possibility 
that this protein is glycosylated cannot be excluded.  
The identification of SCO4471 is exciting because of its possible role in cell wall biosynthesis. 
The characterisation of the glycosylated amino acids in SCO4471 using non-reductive β-
elimination and mass spectrometry was unsuccessful, but glycosylation of SCO4471 cannot 
be ruled out. The O-glycosylation target site prediction algorithm NetOGlyc 4.0 identified 
seven putative glycosylated residues near the N-terminus, as well as three putative 
glycosylated residues near the C-terminus of SCO4471. It is possible that the C-terminal 
peptide (ETPASSGAPANAA) had difficulty ionising, because unlike most tryptic peptides the 
C-terminal amino acid is not basic. O-glycosylation sites in M. tuberculosis glycoproteins have 
been shown to occur more frequently at the C-terminal end of the protein (Smith et al. 2014). 
These results provide further evidence of a glycoproteome in S. coelicolor. The combination 
of glycoprotein enrichment using Con A and Con A-HRP as a glycoprotein detection strategy 
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provide promising first steps towards characterising the S. coelicolor glycoproteome. The 
next step was to validate the glycoproteins using glycoproteomics approaches.
   
 
 
 
 
 
 
 
 
 
Chapter 4 - A glycoproteomics characterisation of the 
membrane glycoproteome in Streptomyces coelicolor. 
 
 
 
 
 
 
 
 
 
 
Chapter 4 - Glycoproteomics 
99 
Chapter 4 – A glycoproteomics characterisation of the membrane 
glycoproteome in Streptomyces coelicolor. 
 
Glycoproteomics is the study of the modification of proteins with glycan moieties which can 
alter their activity and physico-chemical properties (Tissot et al. 2009). Mass spectrometry, 
because of its high sensitivity and selectivity, is arguably the most powerful and relevant 
analytical technology applied in glycoproteomics strategies. Glycoprotein characterisation by 
mass spectrometry most frequently involves the analysis of glycopeptides obtained after the 
proteolytic digestion of the glycoproteins (Wuhrer et al. 2007). Glycopeptide analysis can be 
complicated because of the combined information generated by the fragmentation of the 
peptide backbone, the glycan moieties and a combination of both. In order the gain 
information on the glycan, as well as being able to allocate the glycosylation site within a 
peptide it is often necessary to combine different mass spectrometry fragmentation 
techniques. 
Collision induced dissociation (CID) fragmentation is the most widely used fragmentation 
technique for proteome identification. CID fragmentation of peptides occur when they 
undergo collisions with a neutral target gas and the vibrational energy produced results in 
ion dissociation, occurring most frequently at the amide bonds along the peptide backbone 
(Wells and McLuckey 2005). This fragmentation results predominantly in y- and b-ion series, 
as well as ions that have undergone a neutral loss ammonia or water (Figure 4.1). CID 
fragmentation can be used to identify glycopeptides; however the localisation of 
glycosylation sites using CID spectra is often difficult due to the preferential cleavage of the 
glycan moiety (Huddleston et al. 1993).  This is because the glycan represents the lower 
energy fragmentation pathway and competes with the fragmentation of the peptide 
backbone. Higher energy collision dissociation (HCD) fragmentation is a higher energy form 
of the CID available on the Orbitrap mass spectrometer, that uses higher activation energy 
and a shorter activation time (Olsen et al. 2007). The fragmentation pattern is similar to that 
which is produced by CID fragmentation (i.e. y- and b-ions), but b-ions can be more 
frequently fragmented into a-ions and smaller species (Figure 4.1). The collision energies 
used by both HCD and CID on any instrument, are typically low energy (less than 100 eV) 
(Wells and McLuckey 2005; Olsen et al. 2007). 
Complementary techniques to CID and HCD fragmentation, that are often more successful 
in the localisation of glycosylation sites, are electron based methods such as electron capture 
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dissociation (ECD) and electron transfer dissociation (ETD) fragmentation. ETD 
fragmentation of a peptide occurs when an electron is transferred from a radical ion to a 
multiply charged peptide cation, resulting in fragmentation at the N-Cα bonds in the peptide 
backbone. This fragmentation favours cleavage of the peptide backbone, leaving the glycan 
structure intact and results in the generation of c- and z-type product ions (Huang and 
McLuckey 2010) (Figure 4.1).  
In Chapter 3 I presented further evidence of a glycoproteome in the S. coelicolor membrane 
and validated methods for glycoprotein enrichment and detection. The aim of this chapter 
was to use the methods developed in Chapter 3 as part of a glycoproteomics workflow to 
carry out an in-depth characterisation of the S. coelicolor membrane glycoproteome using 
mass spectrometry with CID, HCD and ETD fragmentation techniques. We hypothesised that 
some glycoproteins in S. coelicolor could be required for cell wall biosynthesis or maintaining 
membrane integrity, and could be of relevance to the antibiotic hypersensitivity phenotypes 
observed in the pmt and ppm1 strains (discussed in Chapter 1). 
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Figure 4.1 Peptide fragmentation as described by Roepstorff and Fohlman (1984). The 
fragment ions generated by peptide fragmentation observed in MS/MS spectra after using 
CID, HCD and ETD fragmentation techniques.  y- and b-type ions, as well as a- and x-type 
ions, are generated after CID and HCD fragmentation. c- and z-type ions are observed after 
ETD fragmentation.  
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4.1 Time course enrichment of the S. coelicolor membrane glycoproteome 
 
In order to maximise our characterisation of the membrane glycoproteome in S. coelicolor, I 
investigated whether the membrane glycoprotein profile changes during the different stages 
of S. coelicolor growth. This would ensure that we focussed on the growth stage where the 
most glycoproteins were produced. S. coelicolor J1929 spores were germinated for 6 h and 
then cultivated in defined phosphate limited (F134) liquid medium. The cultures were 
harvested after 20 h, 35 h, 43 h and 60 h of growth with shaking (4 x 500 mL cultures for each 
time-point). These time-points corresponded approximately to the transition from 
logarithmic growth into linear growth (20 h), mid-linear growth (35 h), the transition into 
stationary phase (43 h) and stationary phase (60 h) (Figure 4.2). After 60 h, the cultures were 
producing antibiotics, indicated by blue/red pigmentation. 
The total membrane protein was isolated from the cultures harvested at each time point, 
yielding 52 mg (20 h), 140 mg (35 h), 106 mg (43 h) and 80 mg (60 h) of protein. After the 
enrichment of the solubilised membrane proteins using Con A affinity chromatography the 
total, unbound and elution fractions were separated by SDS-PAGE, blotted onto a PVDF 
membrane and probed with Con A-HRP (Figure 4.3). 
Over the four time points, changes in the abundance and numbers of proteins enriched by 
Con A affinity chromatography were observed by Coomassie staining. This could suggest that 
the expression of some glycoproteins in S. coelicolor is growth stage dependent. The Con A-
HRP reactivity profiles of the elution fractions, which appeared to change over the time 
course, are consistent with this observation. Only a single Con A-HRP reactive band of ~ 30 
kDa was observed in the 20 h elution fraction, while numerous Con A-HRP reactive bands 
were observed in the 35 h and 43 h elution fractions. After 60 h, many of the Con A-HRP 
reactive bands observed after 35 h and 43 h were absent. For example, a Con A-HRP reactive 
protein with a Mw of ~ 110 kDa was enriched from the 35 h and 43 h membranes, but was 
absent from the enrichment of the 20 h and 60 h membranes. This might suggest that the 
protein has a role in the linear growth stage in S. coelicolor. Similarly, a Con A-HRP reactive 
protein of ~ 40 kDa appeared to be most highly enriched after 60 h. This protein could be 
PstS (SCO4142) which was previously shown to increase in expression as S. coelicolor M145 
cultures approached stationary phase, when grown in F134 medium (Thomas et al. 2012). 
Some Con A-HRP reactive bands were observed in the unbound fractions and their relative 
abundances did not appear to change over the time course. It is possible that due to the 
proteins’ tertiary structures, the glycans on these glycoproteins were not exposed to enable 
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efficient binding to the Con A agarose column. However, after denaturation and separation 
of the proteins by SDS-PAGE, the glycans could be exposed to enable binding by the Con A-
HRP.  
Taken together this data suggests that the membrane glycoproteome does change in S. 
coelicolor cultures as they grow. Therefore, to increase the coverage of the glycoproteome 
in the proteomics analyses, all four samples were selected for analysis. 
 
4.2 A glycoproteomics characterisation of the S. coelicolor membrane glycoproteome. 
 
4.2.1   Analysis of glycoproteins using mass spectrometry with CID fragmentation. 
 
In order to demonstrate the presence of glycoproteins in the Con A enriched S. coelicolor 
membrane protein fractions that were isolated in the time course experiment, the proteins 
were subjected to in-gel tryptic digestion and analysed by mass spectrometry with CID 
fragmentation (LC-ESI-CID-MS/MS carried out on the Bruker maXis HD system by the 
Proteomics Laboratory of the York Bioscience Technology Facility). Since the previously 
characterised S. coelicolor glycoprotein PstS was shown to be modified with a trihexose 
(Wehmeier et al. 2009) and numerous glycoproteins with short mannose modifications have 
been previously described in the closely related M. tuberculosis (Dobos et al. 1996; Michell 
et al. 2003; Sartain and Belisle 2009), I focussed on short hexose modifications in my 
analyses.  
Peak lists were submitted to two independent Mascot searches. One search allowed for the 
variable modification of Hex, Hex₂ and Hex₃ addition at S and T residues.  The other search 
considered the variable Hex₄ and Hex₅ modification of the same residues.   The searches 
were split because Mascot limits the number of variable modifications to six meaning that 
when oxidation (M) and deamidation (N/Q) are added a maximum of four Hex modifications 
can be included. Although it was anticipated that the modification of peptides would be 
limited to a maximum of three Hex per residue, the Hex₄ and Hex₅ modifications were 
incorporated to help aid identification of multiply glycosylated peptides where loss of the 
glycan is observed upon CID fragmentation. 
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Figure 4.2 Growth curve of S. coelicolor J1929 in liquid F134 medium. S. coelicolor J1929 
spores were germinated for 6 h and the cultures were grown for 56 h in F134 medium. 
Measurements of cell dry weight (CDW) were taken to monitor growth at regular intervals. 
The time points selected to harvest the cultures for glycoprotein isolation are indicated by 
red arrows. Error bars represent the standard error of the mean of three biological replicates. 
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Figure 4.3 A time course glycoprotein enrichment of S. coelicolor J1929 membrane proteins using Con A affinity chromatography. The membrane fractions 
were analysed by SDS-PAGE (lanes 1 - 14) and western blotting using Con A-HRP as a probe (lanes 15 – 26).  The protein mw marker (lane 1 and 11) was the 
Broad range protein ladder (NEB). 
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For example, if a peptide has two glycosylated amino acids each as Hex₂ then the precursor 
mass is isobaric with a single Hex₄ addition.  The Mascot algorithm does not account for the 
loss of glycosylation in the product ion spectrum, meaning that there are situations where 
incorrect assignment of a single Hex₄ modification can generate a higher score than the 
correct assignment of Hex₂ at two positions.  All glycopeptide identifications were manually 
validated to ensure correct site identification. 
As summarised in Table 4.1, 24 S. coelicolor glycopeptides were identified. The full list of 
individual glycopeptides identified is shown in Table A.13. Annotated spectra of the 
glycopeptides where site allocations were made are shown in Figures A.2 - A.3. The best 
matching spectrum corresponding to each identification is included in Appendix A.7 (Digital 
appendix). Approximately 40 % of the glycopeptides identified were observed at multiple 
time points. Additionally, 60 % of the assignments were supported by more than one 
spectrum.  
The most frequently observed glycopeptide was TEQSASAGGAEESAPAGK (aa 42 – 59) 
belonging to SCO4739, a putative lipoprotein. This glycopeptide was observed after 20 h, 35 
h and 60 h of growth. There was heterogeneity in the number of hexoses modifying this 
glycopeptide, which was observed with up to nine hexoses. The spectra generated by CID 
fragmentation were mostly dominated by product ions formed because of the preferential 
cleavage of glycosidic bonds associated with a glycopeptide. In these cases, the glycopeptide 
was identified after the mass difference between the peptide backbone identified from the 
MS/MS spectra, and the precursor ion mass was equivalent to a hexose (162 Da) or multiples 
thereof. Since the unambiguous assignment of glycosylation sites relies on the observation 
of peptide product ions containing at least one hexose residue, in many cases it was not 
possible to map the glycosylation sites in the glycopeptides identified using CID 
fragmentation.  
For example, Figure 4.4 shows the spectrum of the glycopeptide TEQSASAGGAEESAPAGK (aa 
42 – 59) modified with 3 hexose residues. This glycopeptide is detected as the doubly 
charged precursor ion m/z 1067.459, corresponding to a mass of 2132.918 Da. The predicted 
mass of the unmodified peptide TEQSASAGGAEESAPAGK is 1646.738 Da, which is a 
difference of 3 hexose residues (486.180 Da) from the mass of the glycosylated precursor. A 
product ion corresponding to the mass of the precursor that has undergone a neutral loss of 
Hex₃ was observed ([M+H – Hex₃]⁺ at m/z 1647.7495). The spectrum is dominated by the y-
ion series without the glycan, which give the sequence of the peptide. 
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Table 4.1 High confidence glycopeptides identified over the four different time points, using mass spectrometry with CID fragmentation. The full list of 
glycopeptides identified is included in Table A.13. The best matching spectra for each glycopeptide is included in Appendix A.7. 
SCO 
Number Time point (h) Peptide 
Mascot expect value 
of the best matching 
spectrum # Hex¹ # MS/MS² 
Site assignment 
in peptide 
SCO0472 35 GGGSTPSATPAASVQDPLVATFDGGLYILDGK 2.10E-04 9 2 - 
SCO0996 20 ATAPSAEGFPVTIDNCGVK 3.00E-05 3 1 - 
SCO1714 35 TVTEPAADR 1.90E-02 3 1 - 
SCO3357 43 DEGPAHADAVGGAGSASPAPAAK 1.30E-02 6 1 - 
SCO3540 35, 43 ATPAELSPYYEQK 5.50E-05 2 2 - 
SCO4141 60 TPQPPATEDTRPGR 4.00E-02 1 1 - 
SCO4739 20 TEQSASAGGAEESAPAGK 1.10E-08 3 1 - 
SCO4739 20 TEQSASAGGAEESAPAGK 4.10E-06 4 1 - 
SCO4739 20 TEQSASAGGAEESAPAGK 2.50E-03 5 1 - 
SCO4739 20 TEQSASAGGAEESAPAGK 2.50E-04 6 1 - 
SCO4739 20 TEQSASAGGAEESAPAGK 1.20E-02 7 2 - 
SCO4739 20, 35, 60 TEQSASAGGAEESAPAGK 1.10E-03 8 7 - 
SCO4739 20, 35 TEQSASAGGAEESAPAGK 3.40E-04 9 2 - 
SCO4847 20, 35 SATAASPSAEASGEAGGTGK 3.00E-04 9 2 - 
SCO4905 60 ATEVPTDYGPAPSR 9.10E-03 3 1 - 
SCO4905 20 ATPGLPAQVFLLCGSSLVAVDR 1.90E-04 2 1 - 
SCO4905 20 ATPGLPAQVFLLCGSSLVAVDR 1.60E-08 3 1 - 
SCO4934 35, 60 TSQAEVDEAAAK 1.90E-04 2 2 - 
SCO4934 20, 35, 43, 60 TSQAEVDEAAAK 2.40E-04 3 4 - 
SCO5115 60 AVDGLSFDLER 8.90E-03 1 1 S6 
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SCO 
Number Time point (h) Peptide 
Mascot expect value 
of the best matching 
spectrum # Hex¹ # MS/MS² 
Site assignment 
in peptide 
SCO5204 43 QVQSQFNSEQDIAESIR 1.20E-02 1 1 - 
SCO5736 20 EGDTGSPEVQVALLSR 5.00E-04 1 1 - 
SCO5818 60 SPHAARLAALVTK 4.10E-02 5 1 S1, T12 
SCO6558 43 IPDITLER 1.20E-02 1 2 T5 
 
¹ Indicates the number of hexose residues on the peptide 
² Indicates the number of high confidence MS/MS spectra confirming the identification. 
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The b8 + Hex₃ and b9(*) + Hex₃ ions suggest that the Hex₃ is in the TEQSASAGG part of the 
glycopeptide, in which three potential glycosylation sites reside (Thr42, Thr45, Ser47). 
However, it is unclear from this spectrum which residue/s are modified and how many 
hexoses reside on each residue. The b16 + Hex₂ ion is indicative of a product ion resulting 
from the neutral loss of a single Hex, since the Hex₃ on the peptide must reside in the 
TEQSASAGGAEESAPA part of the glycopeptide.  
In cases where only a single glycosylated residue was possible within the glycopeptide (i.e. a 
single S/T) the glycosylation site was assigned by default. As demonstrated in Figure 4.5, the 
SCO5115 glycopeptide AVDGLSFDLER (aa 38 – 48) modified with a single Hex has only one 
possible modified residue (Ser43). The doubly charged precursor m/z 692.336 corresponds 
to a glycopeptide mass of 1382.672 Da, which is one hexose (162.052 Da) higher than the 
mass of the unmodified peptide (1220.603 Da). In this case the assignment is supported by 
the presence of y6 + Hex, y7 + Hex, y8 + Hex, y9 + Hex and b9 + Hex product ions; b9 + Hex was 
observed in low abundance. There were three higher intensity product ions in the spectrum 
that could not be assigned to the glycopeptide (m/z 781.381; m/z 710.348; m/z 595.325). 
This could indicate a chimeric spectrum, which arises when peptides with similar m/z ratios 
co-elute and are simultaneously fragmented (Houel et al. 2010). Despite this observation, 
most of the high intensity product ions were assigned to AVDGLSFDLER + Hex and therefore 
confidence in the assignment is maintained. 
 
4.2.2 Analysis of glycoproteins using mass spectrometry with HCD and ETD fragmentation. 
 
The mass spectrometry analysis using CID fragmentation was successful in the identification 
of numerous S. coelicolor glycopeptides. However, localisation of the glycosylation sites was 
not possible in many of the glycopeptides, as expected. To increase the number of 
glycosylation site localisations made, complementary experiments were carried out using 
both ETD and HCD fragmentation techniques. For this analysis, only membranes isolated 
after 43 h of growth were prepared and analysed. This time point was selected as a 
compromise between actively growing cultures and sufficient biomass generation. S. 
coelicolor J1929 was cultivated for 43 h in F134 liquid medium, after the spores were 
germinated for 6 h (3 x 300 mL cultures pooled). Glycoproteins were enriched from the total 
membrane protein using lectin affinity chromatography.  
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Figure 4.4 CID spectrum of the tryptic peptide TEQSASAGGAEESAPAGK (aa 42 – 59) + Hex₃ of the predicted lipoprotein SCO4739 observed at 20 h. 
Precursor m/z 1067.459; charge = 2+; retention time = 25.7 min; e-value = 1.10E-08. The underlined section indicates that the Hex₃ is located within the 
TEQSASAGG part of the glycopeptide. Possible glycosylated residues are indicated with a blue asterix. Product ions that contain hexose residues are indicted 
+ Hex(n), where n = number of hexose residues. The precursor ion is indicated by a .  Product ions exhibiting a neutral loss of H₂O and NH₃ are indicated 
by (0) and (*) respectively. 
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Figure 4.5 CID spectrum of the SCO5115 tryptic peptide AVDGLSFDLER (aa 38 – 48) indicates monohexosylation on Ser43 observed at 60 h. Precursor m/z 
= 692.336; charge = 2+; retention time = 103.6 min; e-value = 8.90E-03. Product ions that contain the hexose are indicated by + Hex(n), where n = number 
of hexose residues. The precursor ion is indicated by a . 
Chapter 4 - Glycoproteomics 
112 
Analysis of the elution fraction by SDS-PAGE confirmed the presence of enriched proteins in 
the elution fraction that approximated to the molecular masses of proteins enriched 
previously in the time course glycoprotein enrichment. The elution fraction was subjected to 
in-gel tryptic digestion after SDS-PAGE and analysed by mass spectrometry, using both HCD 
and ETD fragmentation techniques (carried out on the Thermo Orbitrap Fusion Tribrid mass 
spectrometer by Adam Dowle in the Proteomics Laboratory, in the York Bioscience 
Technology Facility).  
As in the analysis of the data acquired using the maXis HD with CID fragmentation, we 
focussed on short hexose modifications (Hex, Hex₂ and Hex₃). Multiple data acquisition 
techniques are available on the Orbitrap Fusion mass spectrometer. The S. coelicolor 
glycopeptides in this experiment were analysed using both HCD and ETD fragmentation, and 
using both the ion trap (low resolution, high speed - mass accuracy < 0.5 Da) 
and Orbitrap (high resolution, lower speed - mass accuracy < 3 ppm) mass analysers.  Four 
different data acquisitions were performed to include these options: 
 
1) MS in Orbitrap, HCD measured in ion trap (HCD_IT) 
2) MS in Orbitrap, ETD measured ion trap (ETD_IT) 
3) MS in Orbitrap, ETD measured in Orbitrap (ETD_OT) 
4) MS in Orbitrap, HCD measured in ion trap and ETD measured in Orbitrap (HCD_IT; 
ETD_OT) 
 
The combined efforts of the four data acquisitions resulted in the identification of 44 S. 
coelicolor glycopeptides (Table 4.2). These included seven glycopeptides belonging to the 
previously characterised S. coelicolor glycoprotein, PstS (SCO4142). The full list of individual 
glycopeptides identified by all techniques is shown in Table A.14. Annotated spectra of the 
glycopeptides where site allocations were made are shown in Figures A.4 – A.15. The best 
matching spectra (i.e. the match with the lowest e-value) corresponding to each 
identification is included in Appendix A.7 (Digital appendix).  
Approximately 30 % of the glycopeptide assignments were supported by multiple spectra. 
More than half of the glycopeptides identified (~60 %) were observed after HCD 
fragmentation only. Glycosylation sites were automatically assigned in peptides where only 
one possible site was present within the glycopeptide. 
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Table 4.2 High confidence glycopeptides identified using HCD_IT, ETD_OT and ETD_IT mass spectrometry. The full list of glycopeptides identified is included 
in Table A.14. The best matching spectra for each glycopeptide is included in Appendix A.7. 
 
SCO 
Number Method Peptide 
Mascot expect 
score of the best 
matching spectrum # Hex¹ 
# 
MS/MS² 
Delta Mascot 
Score³ 
Site assignment in 
peptide 
SCO0996 HCD_IT ATAPSAEGFPVTIDNCGVK 8.20E-04 2 1 - - 
SCO0996 HCD_IT ATAPSAEGFPVTIDNCGVK 2.10E-02 3 1 - - 
SCO2035 HCD_IT DDGSESAGPVVAPSGAQGK 6.60E-03 2 1 - - 
SCO2096 HCD_IT KLDACPNESAVAVPVTGDDGPK 5.90E-03 3 1 - - 
SCO2156 HCD_IT EGTFLGKCAELCGVDHSR 1.50E-03 1 1 - - 
SCO2838 ETD_IT AAGAGITQQPK 2.00E-03 2 1 Only possible site T7 
SCO2963 ETD_IT GRGSSDADR 6.50E-03 1 1 0 - 
SCO3044 HCD_IT GDAGQPSDEPAADSEIGVLVQNATR 3.20E-05 3 2 - - 
SCO3046 HCD_IT, ETD_OT VAKPTPNAAGQTPLNILVIGSDAR 3.10E-06 2 2 32 T5 
SCO3184 ETD_IT, ETD_OT ATVETAAPDRGDGYGVALR 1.10E-05 1 3 4.1 - 
SCO3184 HCD_IT KATVETAAPDRGDGYGVALR 1.40E-03 1 2 - - 
SCO3353 
HCT_IT, ETD_IT, 
ETD_OT KPSAPECGTPPAGSAK 1.60E-05 2 3 35.2 T9 
SCO3353 
HCT_IT, ETD_IT, 
ETD_OT KPSAPECGTPPAGSAK 7.10E-04 3 3 15.5 T9 
SCO3357 ETD_IT ASPSKAPDRVDAVR 2.90E-02 6 1 0 - 
SCO3357 ETD_OT DEGPAHADAVGGAGSASPAPAAK 7.60E-04 6 1 Manual assignment S15, S17 
SCO3357 HCD_IT QVYDKGDPVSSPSGENVITYR 2.30E-03 3 1 - - 
SCO3540 HCD_IT AAGATEAATATLTPLPK 2.20E-05 3 2 - - 
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SCO 
Number Method Peptide 
Mascot expect score 
of the best matching 
spectrum # Hex¹ 
# 
MS/MS² 
Delta Mascot 
Score³ 
Site assignment in 
peptide 
SCO3540 HCD_IT AAGATEAATATLTPLPK 2.00E-04 2 1 - - 
SCO3540 HCD_IT ATPAELSPYYEQK 3.90E-04 2 1 - - 
SCO3848 HCD_IT QGTDVDKESTVNLVVSTGAPK 4.70E-04 1 1 - - 
SCO3848 HCD_IT QGTDVDKESTVNLVVSTGAPK 5.30E-04 2 2 - - 
SCO3891 HCD_IT EQQTAIADTFSEGR 9.10E-04 2 1 - - 
SCO4013 HCD_IT TDAVSPYPLPQSTNK 2.30E-02 1 1 - - 
SCO4130 HCD_IT 
TSATAPSGTRPVQSGFAHDAQGA 
QSAAANYAVALGSDGMFDK 6.50E-05 2 3 - - 
SCO4141 
HCD_IT, ETD_OT, 
ETD_IT TPQPPATEDTRPGR 2.10E-04 1 4 13 T1 
SCO4142 HCD_IT 
ADTLPATKSFLNYMASEDGQG 
LLADAGYAPMPTEIITK 7.80E-04 1 1 -   
SCO4142 HCD_IT CDDAKGQLQASGSSAQK 4.80E-02 1 1 -   
SCO4142 ETD_OT DGIKTVDVK 8.10E-03 1 1 Only possible site T5 
SCO4142 HCD_IT 
GGQSAQGSSGLAGQVKQTP 
GAISYFELSYAK 3.60E-05 1 1 -   
SCO4142 ETD_IT QTPGAISYFELSYAKDGIK 2.80E-03 1 1 24.8 S12 
SCO4142 ETD_IT, HCD_IT TAAAEPVKATVENATAAIGAAK 1.90E-03 1 2 0.8 - 
SCO4142 HCD_IT 
VCKDGQAIDLPMVGGPIAVG 
FNVTGVDSLVLDAPTMAK 1.40E-02 1 1 - - 
SCO4256 ETD_OT GGGGGGGGESKKPKPPVR 1.80E-02 3 1 Only possible site S10 
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SCO 
Number Method Peptide 
Mascot expect score 
of the best matching 
spectrum 
# 
Hex¹ 
# 
MS/MS² 
Delta Mascot 
Score³ 
Site assignment in 
peptide 
SCO4307 ETD_IT LIYAGAGTAGR 6.00E-03 1 1 Only possible site T8 
SCO4548 HCD_IT TTSSSSSTAPSAPSAPR 4.20E-04 1 1 - - 
SCO4885 HCD_IT SDQAPEPGFADSPYITVTFR 8.10E-07 1 1 - - 
SCO4905 HCD_IT ATPGLPAQVFLLCGSSLVAVDR 7.20E-05 2 1 - - 
SCO4905 HCD_IT ATPGLPAQVFLLCGSSLVAVDR 2.40E-02 3 1 - - 
SCO4968 ETD_OT VDFKEPAEQDASAGPEAKPQR 9.10E-06 1 2 Only possible site S12 
SCO5646 HCD_IT AILTKDNPQGDVFFGVDNTLLSR 5.90E-03 1 1 - - 
SCO5751 ETD_OT KPADPKPEPSDSAIAAAPADKVTVK 4.40E-04 6 2 31.8 S10, S12 
SCO5776 HCD_IT SEKVDFAGPYLLAHQDVLIR 1.30E-03 1 1 Only possible site S1 
SCO7218 ETD_OT ASSGGHYPVTVENCGEK 6.60E-04 3 2 7.8 - 
SCO7218 ETD_IT ASSGGHYPVTVENCGEKLTFEK 4.70E-03 3 1 6.1 - 
 
¹ Number of hexose residues on the peptide 
² Number of high confidence MS/MS spectra confirming the match 
³ The difference between the Mascot ion scores for the two best alternative modification sites in the same peptide, assigned by the database search. The 
MD-score for HCD was not considered to be reliable and therefore is not reported. 
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For the localisation of sites in glycopeptide spectra generated by HCD fragmentation, a 
similar approach to the analysis of data acquired by CID fragmentation was taken. HCD yields 
a similar fragmentation pattern to that which is produced as a result of CID fragmentation 
on the maXis HD, namely the generation of b- and y-type product ions (Olsen et al. 2007) 
Spectra generated by HCD fragmentation were generally dominated by product ions formed 
as a result of the preferential cleavage of glycosidic bonds associated with a glycopeptide. 
Glycopeptide identifications were therefore manually validated to assure correct site 
identification. However, in most cases it was not possible to allocate the glycosylation sites 
in glycopeptides that were observed by HCD fragmentation only. Five glycopeptides 
previously identified after CID fragmentation on the maXis HD (Table 4.1) were observed 
after HCD fragmentation on the Orbitrap (Table 4.2). 
For example, the glycopeptide ATPGLPAQVFLLCGSSLVAVDR belonging to SCO4905 (aa 53 – 
74) modified with two hexose residues was observed by both HCD and CID fragmentation 
(Figure 4.6 A and B respectively). The triply charged precursor ions m/z 865.778 and m/z 
865.783 (HCD (A) and CID (B) spectra respectively) are consistent with a glycopeptide mass 
of 2594.3 Da. The predicted mass of unmodified ATPGLPAQVFLLCGSSLVAVDR with cysteine 
carbamidomethylation is 2270.1879 Da, which is a difference of 2 hexose residues (324.105 
Da) from the mass of the glycosylated peptide. Both spectra are dominated by the y-ion 
series, although none were observed with the glycan attached. In the HCD spectra, more b-
series ions are observed (b10, b11, b12) in comparison to the CID spectra (b4, b10), yet again 
none were observed with a hexose attached. Due to the absence of product ions with the 
hexose attached, the glycosylation site could not be assigned.  
 
4.2.3 The identification of glycosylation sites 
 
Savitski et al. (2011) previously validated the use of the Mascot Delta-Score (MD-score) as a 
method of localising phosphorylation sites within 180 synthetic phosphopeptides, in which 
the modification sites were known. The MD-score measures the difference between the 
Mascot ion scores for the two best alternative modification sites in the same peptide, 
assigned by the database search. They suggested using a false localisation rate (FLR) 
threshold of 1 %, which equated to an MD-score cut-off of 10. Due to the lack of similar 
validation studies carried out on synthetic glycopeptides with known glycosylation site 
localisations to date, the study by Savitski et al. (2011) was used as a guide for the analysis 
of site localisation in the spectra generated by ETD fragmentation in this study.  
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Figure 4.6 A. HCD spectrum of the SCO4905 glycopeptide ATPGLPAQVFLLCGSSLVAVDR (aa 53 – 74) modified with two hexoses. Precursor m/z 865.778; 
charge = 3+; retention time = 133.2 min; scan = 4335; e-value = 7.20E-05. Product ions bearing hexose were not observed. The precursor ion is indicated by 
a . 
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Figure 4.6 B. CID spectrum of the glycopeptide ATPGLPAQVFLLCGSSLVAVDR (aa 53 – 74) modified with two hexoses observed at 20 h. Precursor m/z 
865.783; charge = 3+; retention time = 122.5 min; e-value = 1.90E-04. Product ions bearing hexose were not observed. The precursor ion is indicated by a
. (++) Indicates the doubly charged product ion series. 
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For the site localisations of glycopeptides identified in the ETD_IT and ETD_OT acquisitions, 
an MD-score cut-off of 10 was applied. In matches were the MD-score was greater than 10, 
the spectra were manually validated to confirm the site localisation assignment.   
For example, Figure 4. 7 shows the ETD spectrum of the triply charged m/z 750.7115 of the 
SCO4142 (PstS) glycopeptide QTPGAISYFELSYAKDGIK (aa 240 – 258) which is modified with 
a single hexose. The MD-score for this glycopeptide is 24.8. The z9 + Hex, z10 + Hex, z11 + Hex, 
z12 + Hex and z13 + Hex product ions, as well as c15 + Hex and c16 + Hex ion show that Ser251 
is modified with a single hexose. Thus, ETD enabled the confident characterisation of the 
glycosylation site within this glycopeptide.  
Despite the previous characterisation of PstS (SCO4142) as a glycoprotein by Wehmeier et 
al. (2009), this is the first direct evidence of S. coelicolor PstS glycopeptides. Wehmeier et al. 
(2009) previously demonstrated that two synthetic peptides belonging to PstS (SCO4142), 
PS2 – GQLQASGSSAQKNA and PS3 - PMPTEIITKVRETISGLS were glycosylated in a cell-free 
peptide glycosylation assay, but not PS1 – GSDDTGGNSGSDSSSAAANSNI. The data in this 
study is consistent with their findings as glycopeptides were identified that map within the 
regions covered by PS2 and PS3, but not PS1 (Figure 4.8). Glycopeptide coverage of PS3 was 
only partial. However, two potentially glycosylated threonine residues reside in the region 
covered by the glycopeptide. Neither of the glycosylation sites identified in this work resided 
within PS2 or PS3. 
The mass spectrometry analysis using ETD fragmentation greatly increased the number of 
glycosylation site allocations in the S. coelicolor glycopeptides, when compared to the HCD 
and CID fragmentation techniques. However, HCD fragmentation performed better than ETD 
in the number of glycopeptide identifications made. ETD fragmentation is more efficient for 
higher multiply charged precursor ions (3+, 4+, 5+, etc.) and it is probable that some of the 
precursor ions with lower charged states that were observed after HCD fragmentation, were 
not selected for ETD fragmentation (Brodbelt 2015). 
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Figure 4.7 ETD spectrum of the SCO4142 glycopeptide QTPGAISYFELSYAKDGIK (aa 240 – 258) modified with a hexose on Ser251. Precursor m/z 750.7115; 
charge = 3+; retention time = 91.5 min; scan = 24203; e-value = 2.80E-03. The precursor ion is indicated by a . (++) indicates the doubly charged ion series. 
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Figure 4.8 The amino acid sequence of PstS (SCO4142) indicating protein coverage by 
glycopeptides (underlined) in this study. Glycosylated residues identified in this study are 
highlighted in red. The blue boxes highlight the synthetic peptides (PS1, PS2 and PS3) that 
were used in the cell-free glycosylation assay by Wehmeier et al. (2009). 
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4.2.4   The identification of 37 new glycoproteins in S. coelicolor 
 
As a result of the combined approaches of using mass spectrometry with CID, HCD and ETD 
fragmentation techniques, 37 new S. coelicolor glycoproteins were identified, as well as the 
previously characterised S. coelicolor glycoprotein PstS (SCO4142). Database searches were 
carried out in order to classify the proteins as lipoproteins (Table 4.3), membrane proteins 
(Table 4.4) and secreted proteins (Table 4.5). Proteins that did not contain any predicted 
transmembrane domains or secretory signals were also grouped together (Table 4.6). 
Predicted transmembrane domains were identified using TMHMM server 2.0 (Krogh et al. 
2001). Predicted lipoproteins were identified using the LipoP 1.0 server (Juncker et al. 2003). 
Signal peptides were predicted using SignalP 4.1 Server and the TatP 1.0 server (Bendtsen et 
al. 2005; Petersen et al. 2011). Proteins were functionally annotated using the combined 
efforts of the Streptomyces genome database (StrepDB; strepdb.streptomyces.org.uk/) and 
the Conserved Domain Database (CDD) (http://www.ncbi.nlm.nih.gov/Structure 
/cdd/wrpsb.cgi) (Marchler-Bauer et al. 2014). In some cases, the literature was contradictory 
to the results observed after the database searches. For example, SCO7218 is annotated as 
a putative iron transport lipoprotein in the StrepDB. However, the LipoP 1.0 server did not 
predict a lipoprotein signal peptide (SpII) in this protein. SCO7218 is upstream of an ABC 
transporter (SCO7216/SCO7217) which is consistent with the known genome architecture of 
solute binding lipoproteins in S. coelicolor (Thompson et al. 2010). In these cases, the 
literature searches were considered to be more reliable in assigning a category to the 
proteins. 
Three of the glycoproteins identified in this study (SCO5204, SCO5776, SCO4142) were 
identified previously as enriched proteins after the large scale Con A enrichment of the S. 
coelicolor membrane described in Chapter 3 (Table 3.2). More than a third of the newly 
identified glycoproteins are predicted lipoproteins and other secreted proteins. Among these 
are a number of substrate binding proteins predicted to interact with ABC transporters, for 
example SCO0472, SCO5776, SCO7218, SCO4885 and SCO4142 (PstS).  
Nearly 50 % of the glycoproteins identified in this study are predicted membrane proteins, 
while a few had no predicted transmembrane domains or secretory signals at all. For 
example, the predicted ribosomal protein S15 is a homologue of the E. coli ribosomal protein 
RpsO (also known as SecC) that is a known component of the 30S ribosomal subunit 
(Zimmermann et al. 1972). Additionally, several the predicted lipoproteins and secreted 
proteins identified in this study are predicted to contain TAT pathway secretory signals.  
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Taken together, these results directly demonstrate the presence of a glycoproteome in the 
S. coelicolor membrane that includes membrane, secreted, lipoproteins and possibly some 
intracellular proteins. 
 
4.3 Glycosylation site positional analysis 
 
Several the glycoproteins identified in this work were predicted to contain numerous 
transmembrane helices (Table 4.4). To demonstrate that the glycosylation sites were not 
situated within transmembrane helices, the positions of the glycosylated peptides were 
mapped relative to the predicted transmembrane domains of each respective membrane 
glycoprotein (Figure 4.9). None of the glycosylated peptides mapped within a predicted 
transmembrane helix. A small number of glycopeptides mapped within regions predicted to 
be cytoplasmic facing (SCO2963, SCO4141, SCO4256, SCO4968 and SCO4548), however most 
were predicted on periplasmic facing parts of the glycoproteins. These results suggest that 
glycosylation may be possible on the cytoplasmic face of the membrane in S. coelicolor.  
O-glycosylation sites in M. tuberculosis have been observed at a higher frequency nearer the 
N- or C-terminal parts of the glycoprotein (Dobos et al. 1996; Sartain and Belisle 2009; Smith 
et al. 2014). To investigate whether this was true for S. coelicolor glycoproteins, the positions 
of the O-glycosylation sites identified in this study were analysed relative to the total number 
of amino acids in the protein (Figure 4.10). Glycosylation sites were not found to be more 
frequently located nearer to the N- or C-terminal ends of the glycoproteins. 
The amino acid sequence composition of the glycosylation motif was determined by 
submitting the sequences that contained the confidently allocated glycosylation sites to 
Weblogo (Crooks et al. 2004). The Weblogo software generates graphical representations of 
patterns observed within a multiple sequence alignment. The sequence logo resulting from 
the analysis of eighteen individual S. coelicolor glycosylation sites is shown in Figure 4.11, 
where the height of each amino acid indicates its relative frequency at that position. 
Glycosylation was observed more frequently on serine than threonine residues. There was a 
higher propensity for alanine, proline and glycine near the glycosylation site. This is 
consistent with what has been observed previously in M. tuberculosis glycopeptides (Smith 
et al. 2014). However, it is unclear from this data whether peptides rich in these amino acids 
are more likely to produce product ions resulting in confident site localisations. 
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Table 4.3   Predicted lipoproteins identified as S. coelicolor glycoproteins in this study  
 
SCO Number 
Genome 
annotation Top hit in Conserved Domain Database Accession E-Value¹ #TMHMM ² SignalP 4.1 ³ TatP 1.0 ⁴ LipoP 1.0 ⁵ 
SCO0472 
putative 
secreted protein none - - - Y - 0.548 Y - 0.381 SpII - 22.2623 
SCO0996 
putative 
lipoprotein 
TroA_a: predicted to function as initial 
receptors in ABC transport of metal ions 
in eubacteria cd01148 4.09E-133 - Y - 0.526 N SpI - 11.5964 
SCO1714 
putative 
secreted protein none - - 1 Y - 0.498 N SpII - 12.878 
SCO2838 
putative 
secreted 
endoglucanase. Glycosyl hydrolases family 6 pfam01341  7.32E-99 - Y - 0.639 Y - 0.377 SpII - 32.6736 
SCO3357 
hypothetical 
protein none - - - N Y - 0.492 SpII - 17.3077 
SCO4142 
phosphate-
binding protein 
precursor 
PBP2_PstS: substrate binding domain of 
ABC-type phosphate transporter cd13565  4.57E-80 - Y - 0.595 N SpII - 26.7983 
SCO4739 
putative 
lipoprotein none - - - Y - 0.579 N SpII - 20.7928 
SCO4885 
putative 
lipoprotein 
PBP1_BmpA_PnrA_like: the PnrA 
lipoprotein (also known as Tp0319 or 
TmpC) represents a novel family of 
bacterial purine nucleoside receptor 
encoded within an ATP-binding cassette 
(ABC) transport system (pnrABCDE).  cd06354  2.40E-107 - N N SpII - 23.8395 
SCO4905 
putative 
lipoprotein none - - - Y - 0.574 N SpII - 13.7291 
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SCO Number 
Genome 
annotation Top hit in Conserved Domain Database Accession E-Value¹ #TMHMM ² SignalP 4.1 ³ TatP 1.0 ⁴ LipoP 1.0 ⁵ 
SCO4934 
putative 
lipoprotein 
LDT_IgD_like_2 : IgD-like repeat domain 
of mycobacterial L,D-transpeptidases cd13432  2.81E-39 - Y - 0.571 Y - 0.483 SpII - 24.1553 
SCO5646 
putative solute 
binding lipoprotein 
PBP2_TbpA: substrate binding domain 
of thiamin transporter, a member of the 
type 2 periplasmic binding fold 
superfamily. cd13545  
2.50E-
115 - N Y - 0.468 SpII - 13.5061 
SCO7218 
putative iron 
transport 
lipoprotein 
TroA_a: predicted to function as initial 
receptors in ABC transport of metal ions 
in eubacteria cd01148 
3.57E-
137 - Y - 0.632 N SpI - 14.1761 
 
 
¹ E-value of the top hit in the CDD database 
² The number of transmembrane helices predicted by the TMHMM 2.0 server (http://www.cbs.dtu.dk/services/TMHMM/). 
³ SignalP 4.1 software predicts the presence of a signal peptide (http://www.cbs.dtu.dk/services/SignalP/). D-score is a score used to discriminate signal 
peptides from non-signal peptides. Scores > 0.450 indicate a signal peptide. 
⁴ TatP 1.0 predicts the presence of twin arginine (TAT) signal peptides. D-sore > 0.36 predicts the presence of a TAT pathway signal. 
⁵ LipoP 1.0 software produces predictions of lipoproteins (http://www.cbs.dtu.dk/services/LipoP/). SpI denotes SEC signal peptide; SpII denotes lipoprotein 
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Table 4.4   Predicted membrane proteins identified as S. coelicolor glycoproteins in this study  
SCO Number Genome annotation 
Top hit in Conserved Domain 
Database Accession E-Value¹ #TMHMM ² SignalP 4.1 ³ TatP 1.0 ⁴ LipoP 1.0 ⁵ 
SCO2096 putative membrane protein 
Transglutaminase-like 
superfamily: family includes 
animal transglutaminases and 
other bacterial proteins of 
unknown function pfam01841 7.25E-26 6 Y - 0.529 N 
SpII - 
8.2333 
SCO2035 putative membrane protein 
Thioredoxin_like Superfamily: 
protein disulfide 
oxidoreductases and other 
proteins with a Thioredoxin fold cl00388  2.10E-17 1 N N N 
SCO2156 
putative cytochrome c 
oxidase subunit II 
CyoA: Heme/copper-type 
cytochrome/quinol oxidase, 
subunit 2 COG1622  4.29e-53  3 N N N 
SCO2963 putative membrane protein 
PHA03249 Superfamily: DNA 
packaging tegument protein 
UL25 cl19799  9.21E-05 1 N N N 
SCO3044 
conserved hypothetical 
protein 
LytR_cpsA_psr : cell envelope-
related transcriptional 
attenuator domain pfam03816  2.04E-53 1 N N N 
SCO3046 
conserved hypothetical 
protein 
LytR_cpsA_psr Superfamily: cell 
envelope-related 
transcriptional attenuator 
domain cl00581  3.79E-47 1 N N N 
SCO3184 
putative penicillin acylase (EC 
3.5.1.11). 
Ntn_PGA_like: Penicillin G 
acylase belongs to a family of 
beta-lactam acylases that 
includes cephalosporin acylase 
and aculeacin A acylase.  cd03747  2.81E-118 1 N Y - 0.366 N 
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SCO Number Genome annotation 
Top hit in Conserved Domain 
Database Accession E-Value¹ #TMHMM ² SignalP 4.1 ³ TatP 1.0 ⁴ LipoP 1.0 ⁵ 
SCO3848 
putative serine/threonine 
protein kinase 
STKc_PknB_like: catalytic 
domain of bacterial 
Serine/Threonine kinases, 
PknB and similar proteins 
(PASTA Domain containing) cd14014 3.26E-128 1 N N N 
SCO3891 putative membrane protein none - - 1 N N N 
SCO4013 
putative secreted penicillin-
binding protein 
FtsI: cell division protein FtsI; 
penicillin-binding protein 2 
[Cell cycle control; cell 
division; chromosome 
partitioning; Cell wall, 
membrane and envelope 
biogenesis] COG0768  1.74E-89 1 N N N 
SCO4130 
putative integral membrane 
protein none - - 1 N N N 
SCO4141 
phosphate ABC transport 
system permease protein 
Phosphate_pstC: phosphate 
ABC transporter permease 
protein PstC TIGR02138  1.48E-91 5 N N N 
SCO4256 putative hydrolytic protein 
ChW: Clostridial hydrophobic, 
with a conserved W residue, 
domain. smart00728  3.04E-12 1 N N N 
SCO4548 
putative integral membrane 
protein 
BTAD: Bacterial 
transcriptional activator 
domain smart01043  8.46e-14  3 N Y - 0.479 N 
SCO4968 putative membrane protein none - - 1 N N N 
SCO5204 integral membrane protein 
UPF0182: uncharacterized 
protein family  pfam03699  0.00E+00 7 N N N 
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SCO Number Genome annotation 
Top hit in Conserved Domain 
Database Accession E-Value #TMHMM ¹ SignalP 4.1 ² TatP 1.0 ³ LipoP 1.0 ⁴ 
SCO5751 putative membrane protein 
HTH_25: Helix-turn-helix 
domain pfam13413 1.21E-20 1 N N N 
SCO5818 putative ABC transporter 
NatA: ABC-type Na+ transport 
system, ATPase component 
NatA [Energy production and 
conversion, Inorganic ion 
transport and metabolism] COG4555  3.92e-35  5 N N N 
 
¹ E-value of the top hit in the CDD database 
² The number of transmembrane helices predicted by the TMHMM 2.0 server (http://www.cbs.dtu.dk/services/TMHMM/). 
³ SignalP 4.1 software predicts the presence of a signal peptide (http://www.cbs.dtu.dk/services/SignalP/). D-score is a score used to discriminate signal 
peptides from non-signal peptides. Scores > 0.450 indicate a signal peptide. 
⁴ TatP 1.0 predicts the presence of twin arginine (TAT) signal peptides. D-sore > 0.36 predicts the presence of a TAT pathway signal. 
⁵ LipoP 1.0 software produces predictions of lipoproteins (http://www.cbs.dtu.dk/services/LipoP/). SpI denotes SEC signal peptide; SpII denotes lipoprotein 
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Table 4.5 Predicted secreted proteins identified as S. coelicolor glycoproteins in this study  
SCO Number 
Genome 
annotation Top hit in Conserved Domain Database Accession E-Value #TMHMM ¹ SignalP 4.1 ² TatP 1.0 ³ LipoP 1.0 ⁴ 
SCO3540 
proteinase 
(putative secreted 
protein) 
Abhydrolase_4: family of putative 
bacterial peptidases and hydrolases that 
bear similarity to a tripeptidyl 
aminopeptidase isolated from 
Streptomyces lividans.  pfam08386  5.21E-40 1 Y - 0.627 Y - 0.700 SpI - 18.2099 
SCO4847 
putative D-alanyl-
D-alanine 
carboxypeptidase 
DacC: D-alanyl-D-alanine 
carboxypeptidase COG1686  3.80E-49 1 Y - 0.711 Y - 0.427 SpI - 27.3476 
SCO5776 
glutamate binding 
protein 
PBP2_GluB: substrate binding domain of 
ABC glutamate transporter; the type 2 
periplasmic binding protein fold cd13690  1.79E-93 - Y - 0.618 N SpI - 21.8509 
 
¹ E-value of the top hit in the CDD database 
² The number of transmembrane helices predicted by the TMHMM 2.0 server (http://www.cbs.dtu.dk/services/TMHMM/). 
³ SignalP 4.1 software predicts the presence of a signal peptide (http://www.cbs.dtu.dk/services/SignalP/). D-score is a score used to discriminate signal 
peptides from non-signal peptides. Scores > 0.450 indicate a signal peptide. 
⁴ TatP 1.0 predicts the presence of twin arginine (TAT) signal peptides. D-sore > 0.36 predicts the presence of a TAT pathway signal. 
⁵ LipoP 1.0 software produces predictions of lipoproteins (http://www.cbs.dtu.dk/services/LipoP/). SpI denotes SEC signal peptide; SpII denotes lipoprotein 
 
 
 
Chapter 4 - Glycoproteomics 
130 
Table 4.6 S. coelicolor glycoproteins identified in this study with no predicted transmembrane domains or secretory signals. 
SCO Number 
Genome 
annotation Top hit in Conserved Domain Database Accession E-Value #TMHMM ¹ SignalP 4.1 ² TatP 1.0 ³ LipoP 1.0 ⁴ 
SCO3353 
hypothetical 
protein none - - - N N N 
SCO4307 
conserved 
hypothetical 
protein SCD95A.40c 
murQ: N-acetylmuramic acid-6-phosphate 
etherase (cell wall recycling) PRK05441  4.41E-159 - N N N 
SCO5115 
BldKD, putative 
ABC transporter 
intracellular ATPase 
subunit 
ABC_NikE_OppD_transporters: ATP-
binding cassette domain of 
nickel/oligopeptides specific transporters cd03257  4.48E-122 - N N N 
SCO5736 
30S ribosomal 
protein S15 rpsO: 30S ribosomal protein S15 PRK05626  1.36E-53 - N N N 
SCO6558 
putative protein 
associated with 
oxidoreductase 
activity 
PRK00724: formate dehydrogenase 
accessory protein PRK00724  9.29E-128 - N N N 
  
¹ E-value of the top hit in the CDD database 
² The number of transmembrane helices predicted by the TMHMM 2.0 server (http://www.cbs.dtu.dk/services/TMHMM/). 
³ SignalP 4.1 software predicts the presence of a signal peptide (http://www.cbs.dtu.dk/services/SignalP/). D-score is a score used to discriminate signal 
peptides from non-signal peptides. Scores > 0.450 indicate a signal peptide. 
⁴ TatP 1.0 predicts the presence of twin arginine (TAT) signal peptides. D-sore > 0.36 predicts the presence of a TAT pathway signal. 
⁵ LipoP 1.0 software produces predictions of lipoproteins (http://www.cbs.dtu.dk/services/LipoP/). SpI denotes SEC signal peptide; SpII denotes lipoprotein
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Figure 4.9 The positions of glycosylated peptides relative to transmembrane domains predicted using the TMHMM server v 2.0 in S. coelicolor membrane 
glycoproteins. Transmembrane domains indicated in red. The positions of the glycosylated peptides are indicated with yellow arrowheads. The y-axis indicates 
the probability localisation of the transmembrane domain. Pink indicates outside and blue indicates inside. 
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Figure 4.9 continued. The positions of glycosylated peptides relative to transmembrane domains predicted using the TMHMM server v 2.0 in S. coelicolor 
membrane glycoproteins. Transmembrane domains indicated in red. The positions of the glycosylated peptides are indicated with yellow arrowheads. The 
y-axis indicates the probability localisation of the transmembrane domain. Pink indicates outside and blue indicates inside. 
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Figure 4.9 continued. The positions of glycosylated peptides relative to transmembrane domains predicted using the TMHMM server v 2.0 in S. coelicolor 
membrane glycoproteins. Transmembrane domains indicated in red. The positions of the glycosylated peptides are indicated with yellow arrowheads. The 
y-axis indicates the probability localisation of the transmembrane domain. Pink indicates outside and blue indicates inside. 
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Figure 4.10 O-glycosylation site positional analysis in S. coelicolor glycoproteins. The O-
glycosylation site localisation ratio = glycosylated amino acid position/total number of amino 
acids in the protein. A localisation ratio closer to 0 indicates a position closer the N-terminus, 
while a ratio closer to 1 indicates a position closer the C-terminus. 
 
 
 
 
 
 
Figure 4.11 O-glycosylation site motif generated from the confident S. coelicolor O-
glycosylation sites confirmed in this study. Shown are fifteen amino acids both before and 
after the glycosylated serine or threonine residue.
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4.4 Discussion 
 
Using a glycoproteomics strategy, the in-depth characterisation of the S. coelicolor 
membrane glycoproteome in this study resulted in the identification of 37 new S. coelicolor 
glycoproteins. In addition, this study enabled the further characterisation of the previously 
identified S. coelicolor glycoprotein PstS (SCO4142) by the observation of glycopeptides, 
which were not seen previously in the work carried out by Wehmeier et al. (2009). 
The time-course glycoprotein enrichment and analysis using mass spectrometry with CID 
fragmentation on the maXis HD resulted in the identification of glycopeptides belonging to 
15 S. coelicolor glycoproteins. However, the localisation of glycosylation sites in these 
glycopeptides was not possible in many cases. Glycosylation sites could be assigned in 
glycopeptides where only a single glycosylated residue was possible. However, in some cases 
the assignments were supported by product ions with the glycan attached. In many cases, 
there was ambiguity over the localisation of the glycan in the glycopeptide, especially in 
multiply glycosylated glycopeptides. As expected, spectra generated by CID fragmentation 
were often dominated by product ions formed as a result of the preferential cleavage of 
glycosidic bonds associated with a glycopeptide (Huddleston et al. 1993). When the hexose 
modifications fragment more easily than the peptide backbone, glycosylation site positional 
information is often lost.  
The glycopeptide analysis by mass spectrometry on the Orbitrap Fusion with ETD and HCD 
fragmentation, using the Ion trap and Orbitrap mass analysers, demonstrated the merit of 
performing complementary peptide fragmentation techniques in glycoproteomics 
strategies. The glycopeptide analyses carried out using ETD fragmentation greatly increased 
the number of glycosylation sites localised, over the acquisitions carried out using HCD 
fragmentation. The confidence in the glycosylation site assignments made in this study are 
supported by the MD-scores and assignments of the respective product ion series. The 
increased number of glycopeptide identifications made after HCD fragmentation compared 
to ETD fragmentation could be explained by the fact that ETD fragmentation is more efficient 
for precursor ions with higher charged states (Brodbelt 2015).  
The localisation of glycosylation sites in the glycoproteins identified in this study enabled the 
analysis of a glycosylation sequence motif in S. coelicolor. While no distinct consensus 
sequence was identified, a high propensity for hydrophobic amino acid (e.g. Ala, Pro, Gly) 
signatures was observed. This feature is reminiscent of sequences surrounding O-
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glycosylation sites in other Actinobacteria (Dobos et al. 1995; Herrmann et al. 1996; Michell 
et al. 2003; Smith et al. 2014). 
In some cases, there was heterogeneity in the number of glycans attached to the 
glycopeptide. For example, the SCO3353 glycopeptide N- KPSAPECGTPPAGSAK-C was 
observed with both Hex₂ and Hex₃ modifications on the same threonine residue (Thr9). 
Glycosylation heterogeneity has been described previously in the M. tuberculosis 45 kDa 
glycoprotein characterised by Dobos et al. (1996). Sequential protein O-glycosylation in M. 
tuberculosis has been suggested to occur in a similar fashion to the eukaryotic PMT-mediated 
process, with Pmt catalysing the first step of protein O-mannosylation (VanderVen et al. 
2005). Liu et al. (2013a) demonstrated that a second glycosyltransferase, PimE was required 
for the elongation of oligomannosyl residues on the glycoprotein FasC. It is possible that 
glycoproteins are modified by a similar process in S. coelicolor and that the glycan 
heterogeneity observed in this study is a result thereof. However, this is purely speculative 
and remains to be experimentally validated. 
Protein O-glycosylation by Pmt was shown to be coupled to protein secretion via the SEC 
pathway in M. tuberculosis, suggesting that protein O-mannosylation should only affect 
extracellular proteins (VanderVen et al. 2005). Glycoproteomics studies to date on the M. 
tuberculosis glycoproteome have therefore focussed on characterisation of the culture 
filtrate (Gonzalez-Zamorano et al. 2009; Smith et al. 2014). Many of the glycoproteins 
identified here (Tables 4.3 – 4.6) were predicted to be lipoproteins, membrane proteins and 
secreted proteins, which would agree with the dogma that protein O-glycosylation in 
Actinobacteria is coupled to protein secretion via the SEC pathway. However, a small number 
of the glycoproteins identified had no predicted transmembrane domains or secretory 
signals suggesting that they could be intracellular proteins. Similarly, some glycoproteins 
identified here were predicted to be exported by the TAT system. These “atypical” 
glycoproteins that to do not conform with the existing dogma will be discussed further in the 
general discussion (Chapter 7). 
Upon characterising the membrane glycoproteome in S. coelicolor, we were particularly 
interested in proteins that could help to explain the antibiotic hypersensitivity phenotypes 
observed previously in the pmt and ppm1 S. coelicolor strains (Howlett et al. 2016). It was 
hypothesised that the S. coelicolor glycoproteome could contain proteins that are important 
in cell wall biosynthesis or for maintaining membrane integrity. In this study, at least seven 
glycoproteins have been identified that have predicted functions in the cell wall (SCO4934, 
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SCO4847, SCO3044, SCO3046, SCO3184, SCO4013, SCO4307).  SCO4847, for example is a 
putative D-Ala-D-Ala carboxypeptidase and low molecular weight penicillin binding protein. 
These proteins are thought to catalyse the hydrolysis of the terminal D-alanine from the 
peptidoglycan stem peptide (Pratt 2008). SCO4013 is another predicted penicillin binding 
protein, while SCO4934 is a predicted L, D transpeptidase. L, D transpeptidases catalyse an 
alternative type of peptidoglycan crosslinking between the third position amino acids of 
tetrapeptide stems, termed 3->3 crosslinking. L, D transpeptidases have been identified in 
M. tuberculosis and were shown to be important for maintaining cell shape, virulence and 
resistance to β-lactam antibiotics (Schoonmaker et al. 2014). SCO3044 and SCO3046 both 
belong to the LytR-CpsA-Psr (LCP) family of proteins, that were first shown to catalyse the 
ligation of wall teichoic acids (WTA) to the N-acetylmuramic acid (MurNAc) units of 
peptidoglycan in Bacillus subtilis (Kawai et al. 2011). Other studies have demonstrated that 
LCP proteins are required to attach the capsular polysaccharide to peptidoglycan in both 
Staphylococcus aureus and Streptococcus pneumoniae (Eberhardt et al. 2012; Chan et al. 
2014). Recently however, an LCP protein in M. tuberculosis (Lcp1) was shown to be required 
for cell viability and to attach arabinogalactan to peptidoglycan in a cell free assay (Harrison 
et al. 2016).  
These results demonstrate the presence of a glycoproteome in the S. coelicolor membrane 
that is composed of many proteins that have predicted functions in cell wall biosynthesis.  
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Chapter 5 - Structural characterisation of the glycans modifying S. coelicolor 
glycoproteins. 
 
Wehmeier et al. (2009) previously demonstrated that the S. coelicolor glycoprotein PstS was 
glycosylated with a trihexose by analysing the derivatised glycan using electrospray 
ionisation (ESI) mass spectrometry (MS). Pmt (SCO3154) was shown to be required for the 
glycosylation of PstS, while Ppm1 (SCO1423) was shown to be necessary for the transfer of 
[¹⁴C]mannose  from GDP-[¹⁴C]mannose onto polyprenol phosphate in the S. coelicolor 
membrane. Although the monosaccharide composition of the PstS glycan was not 
determined, the work by Wehmeier et al. (2009) suggests that mannose is a key constituent 
thereof.  
In the closely related M. tuberculosis, the 45/47 kDa secreted antigen MPT 32 was previously 
shown to be modified with mannose, as well as with α(1,2) linked mannobiose and 
mannotriose (Dobos et al. 1996). These linkages are also observed in the mannose branches 
of the lipomannan (LM) and lipoarabinomannan (LAM) core, as well as in the phosphatidyl 
inositol mannoside (PIM) family of phospholipids in mycobacteria (Hunter and Brennan 
1990; Chatterjee et al. 1992). In M. avium the capsular glycoprotein SmT was shown to be 
glycosylated with dihexose (Taylor et al. 2006). Additionally, the secreted antigen MPB83 in 
M. bovis was shown to be modified with mannose, as well as with α(1,3) linked mannobiose 
and mannotriose (Michell et al. 2003). It is currently unclear whether α(1,3) mannose 
linkages exist in M. tuberculosis, although they have been described in the mannan core of 
Mycobacterium chelonae LAM and LM (Guérardel et al. 2002).  
The S. coelicolor membrane glycoproteome has been shown to consist of glycoproteins 
modified with Hex, Hex₂ and Hex₃ glycan moieties (discussed in Chapter 4). However, the 
nature of the monosaccharide and the linkages involved have yet to be fully investigated. 
The aim of the work described in this chapter was to structurally characterise the glycans 
modifying the S. coelicolor glycoproteins that were identified in the work described in 
Chapter 4. The work in this chapter was carried out in collaboration with Dr Jerry Thomas 
and Rachel Bates, from the University of York Bioscience Technology Facility. All spectra 
shown in sections 5.1 and 5.2 were generated by Rachel Bates. 
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5.1 Mass spectrometric analysis of O-linked glycans from S. coelicolor glycoproteins  
 
The samples used in these experiments were obtained after the Con A enrichment of S. 
coelicolor membrane proteins, isolated after 20 h, 35 h, 43 h and 60 h of growth as described 
in Chapter 4, section 4.1. Previous attempts to characterise the glycans from a single 
glycoprotein, by another researcher in the Smith laboratory, were unsuccessful due to 
difficulties encountered because of limited sample amounts. Therefore, analyses were 
carried out on the glycans from the total S. coelicolor glycoproteome. A preliminary analysis 
of the collective glycans from the individual time points was carried out using MALDI-TOF-
MS. The mass spectra from each of the four time points were nearly identical, suggesting 
that there was little difference in the sample compositions. Therefore, the membrane 
preparations from the four time points were pooled to increase the amount of sample 
material. 
The S. coelicolor glycoprotein fractions were run into an SDS-PAGE gel for 10 min. This was 
carried out in order to separate the glycoproteins from the detergent (n-dodecyl-β-D-
maltoside) used to solubilise them. The total O-linked glycans were removed by in-gel, non-
reductive β-elimination (as described in Chapter 2), permethylated and subsequently 
analysed by matrix-assisted laser desorption/ionization Fourier transform ion cyclotron 
resonance mass spectrometry (MALDI-FT-ICR-MS carried out on the solariX XR FTMS 9.4T). 
Two disaccharide standards, cellobiose (β1,4 linked glucose) and maltose (α1,4 linked 
glucose) were permethylated and analysed alongside the glycans from the pooled sample. 
The high resolution and excellent mass accuracy of the solariX XR FTMS 9.4T instrument 
enables accurate mass determination for the identification of small molecules, such as small 
carbohydrates. The mass spectrum of the S. coelicolor β-eliminated and permethylated 
glycans showed signals at m/z 477.23104 and 681.33104. These signals are consistent with 
[M+Na]⁺ species for permethylated Hex₂ (C₂₀H₃₈O₁₁Na – calculated m/z 477.23119) and Hex₃ 
(C₂₉H₅₄O₁₆Na - calculated m/z 681.33096) respectively (Figure 5.1.A). Intense signals 
consistent with the presence of Hex₂ and weaker signals for Hex₃ were also observed in both 
the cellobiose and maltose standards (Figure 5.1.B and 5.1.C respectively). A low intensity 
ion at m/z 631.40361 was observed in the S. coelicolor glycan sample (Figure 5.1.A.I). This 
signal is consistent with the m/z for sodiated permethylated n-dodecyl-β-D-maltoside 
(C₃₁H₆₀O₁₁Na – calculated m/z 631.403335). This finding suggests that despite efforts to 
remove the detergent by running the S. coelicolor glycoprotein fractions into an SDS-PAGE 
gel for 10 min, some of the glycoside detergent was still present in the sample.  
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Figure 5.1 MALDI-FT-ICR-MS analysis of the permethylated S. coelicolor glycans. The S. coelicolor glycans (A) were analysed alongside permethylated 
cellobiose (B) and maltose (C) standards. For clarity of the ion at m/z 631.4036 in the S. coelicolor glycan sample (A), a magnified section of the spectrum is 
shown (I).  
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A high intensity signal at m/z 1247.58772 was also observed in the S. coelicolor glycan sample 
(Figure 5.1.A). In order to investigate the origin of this signal, in-gel β-elimination was carried 
out on a protein-free section of an SDS-PAGE gel and permethylated alongside a fresh 
preparation of S. coelicolor glycans. After the analysis of both samples by matrix-assisted 
laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) it was found 
that the signal at m/z 1247 was also present in the reagent control, submitted to conditions 
for in-gel β-elimination of the protein-free SDS-PAGE gel piece (Figure A.16). Product ion 
analysis of the contaminant ion at m/z 1247 in the S. coelicolor glycan sample was carried 
out using MALDI-TOF-MS/MS. The product ion spectrum was dominated by ions differing by 
204 m/z units, suggesting the presence of an oligosaccharide that was made up of hexoses 
(Figure 5.2).  The m/z value of 1247, and the absence of signals indicating a loss of 221 m/z 
units is consistent with a cyclic glucan (Dell et al. 1984), in this case containing six residues. 
It is well established that the signal intensities of permethylated carbohydrates in MALDI 
mass spectra are directly related to the concentration of those carbohydrates in a sample 
(Wada et al. 2007). The ion at m/z 1247.58772 in the FT-ICR spectrum from the S. coelicolor 
glycan sample (Figure 5.1.A) was more than double the intensity of the next most intense ion 
in the spectrum (m/z 477.23100), suggesting that the contaminant was the most abundant 
carbohydrate in the sample. The ion at m/z 1247.58772 is consistent with the m/z for a 
sodiated permethylated Hex6 cyclic glucan (C₅₄H₉₆O₃₀Na – calculated m/z 1247.588420). α-
Cyclodextrin is an example of a cyclic oligosaccharide consisting of six glucose units linked via 
α-1, 4 linkages. It is likely that the Hex6 cyclic glucan in the S. coelicolor glycan sample is α-
cyclodextrin that originated from the SafeBlue protein stain (NBS Biologicals Ltd) used to 
stain the SDS-PAGE gels, prior to carrying out the in-gel β-elimination. While the 
manufacturer would not confirm this due to “contractual obligations”, the use of α-
cyclodextrin in Coomassie blue based protein assays has been shown to make it compatible 
with detergents (Rabilloud 2016).  
The presence in the sample of a large amount of what is probably α-cyclodextrin raises the 
concern that the Hex₂ and Hex₃ species could have arisen from this by hydrolysis. However, 
there is no evidence, even at very low abundance, of linear Hex₆ (calculated m/z 
1293.63028), Hex₅ (calculated m/z 1089.530501), Hex₄ (calculated m/z 885.43072768) 
(Figure 5.3 A-C) or indeed a hexose monosaccharide (calculated m/z 273.13141) that would 
also be expected products of such hydrolysis, making it very unlikely that the Hex₂ and Hex₃ 
species derive from the contaminant in this way. 
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Figure 5.2 The product ion spectrum of the contaminant ion at m/z 1247 from the S. coelicolor glycan sample, analysed by MALD-TOF-MS/MS.
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Figure 5.3 The MALDI-FT-ICR-MS spectrum of the S. coelicolor glycan sample, confirming 
the absence of signals corresponding to [M+Na]⁺ species for hydrolysed and then 
permethylated cyclic glucan. Magnified sections of the mass spectrum show the m/z regions 
of 882 – 900 (A), 1086 – 1100 (B) and 1287.5 – 1310 (C). 
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In order to further investigate the ions corresponding to Hex₂ (m/z 477.23119) and Hex₃ (m/z 
681.33096) in the S. coelicolor glycans and the standards, CID of the ions was carried out. 
Tandem mass spectrometric analysis of the ion at m/z 477.23119 from the S. coelicolor 
glycan sample yielded product ions m/z 259.11549 and 241.10492 (Figure 5.4.A). These ions 
are consistent with the m/z for the diagnostic sodiated Y₁ (C₁₀H₂₀O₆Na – calculated m/z 
259.115760) fragment ion and Y₁ exhibiting a neutral loss of H₂O (or a sodiated B₁ ion: 
C₁₀H₁₈O₅Na – calculated m/z 241.105195), respectively. Similarly, sodiated Y₁ and Y₁-H₂O 
fragment ions were observed in the product ion spectra of the ions at m/z 477.231 in the 
cellobiose and maltose standards (Figure 5.4.B and 5.4.C respectively). Tandem mass 
spectrometric analysis of the ion at m/z 681.33096 from the S. coelicolor glycan sample 
yielded product ions m/z 463.21408 and 259.11544 (Figure 5.5.A). These ions are consistent 
with the m/z for the diagnostic sodiated Y₂ (C₁₉H₃₆O₁₁Na – calculated m/z 463.215535) and Y₁ 
(C₁₀H₂₀O₆Na – calculated m/z 259.115760) fragment ions, respectively. The sodiated Y₂ and 
Y₁ fragment ions were observed in the product ion spectra of the ions at m/z 681.330 for a 
low level Hex3 contaminant in both of the standards, suggesting the presence of cellotriose 
and maltotriose respectively (Figure 5.5.B and 5.5.C). Additionally, sodiated B₂ (m/z 445.205) 
fragment ions were observed in the product ion spectra of the ions at m/z 681.330 in both 
of the standards. Taken together, these results demonstrate the presence of disaccharides 
and trisaccharides in the S. coelicolor glycans. Additionally, the cellobiose and maltose 
standards were shown to contain disaccharide as expected, as well as some trisaccharide.  
 
5.2 Methylation and linkage analysis of S. coelicolor glycans 
 
After determining the presence of disaccharides and trisaccharides in the S. coelicolor glycan 
sample, methylation analysis was carried out in order to investigate the linkages present in 
the S. coelicolor glycans. Methylation is an important step in the analysis of the structure of 
a carbohydrate and can be used to determine the linkages present, as illustrated in Figure 
5.6 (Carpita and Shea 1989). During this procedure the glycans are methylated, which 
modifies all of the free hydroxyls to become methoxy groups. The hydroxyls participating in 
the linkage and the closure of the monosaccharide rings are protected. The partially 
methylated glycans are then subjected to acid hydrolysis, which breaks the glycosidic 
linkages and reveals the unmodified hydroxyls. The information regarding the anomeric  
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Figure 5.4 MALDI-FT-ICR-MS analysis of the precursor ions at m/z 477.231 demonstrate the presence of Hex₂. The precursor ions at m/z 477.231 in the S. 
coelicolor glycans (A), cellobiose (B) and maltose (C) standards are indicated by . 
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Figure 5.5 MALDI-FT-ICR-MS analysis of the precursor ions at m/z 681.330 demonstrate the presence of trisaccharides. The precursor ions at m/z 681 in the 
S. coelicolor glycans (A) and the standards (cellotriose (B) and maltotriose (C)) are indicated by .
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Figure 5.6 Methylation analysis of maltose. Carbohydrates are methylated, resulting in the modification of all of the free hydroxyl groups. After acid 
hydrolysis, the partially methylated monosaccharides are reduced, acetylated and analysed by GC-MS.
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configuration (α/β) is lost during this step. The partially methylated monosaccharides are 
reduced using NaBD₄ which reduces the aldose to form an alditol and simultaneously tags 
the anomeric carbon atom (C1 in this case) with a deuterium atom. Finally, the partially 
methylated alditols are acetylated to increase their volatility for GC-MS analysis, which 
results in the acetylation of the free hydroxyl groups. The acetylation and methylation direct 
the electron ionisation (EI)-induced fragmentation of the partially methylated alditol acetate 
(PMAA) which allows the structure of the PMAA and thus the substitution pattern of the 
original monosaccharide to be determined. When analysed by GC-MS, the partially 
methylated alditol acetates (PMAAs) fragment in a predictable manner and these 
fragmentation patterns can be used to deduce the original distribution of methoxylated and 
acetoxylated carbons on the carbon backbone (Carpita and Shea 1989). Cleavage is favoured 
between adjacent carbon atoms bearing methoxyl groups, over that between adjacent 
carbons bearing a methoxyl group and an acetoxyl group (Figure 5.7). Due to the little 
electronic influence exhibited by methyl ethers on the alditol carbon, if cleavage occurs 
between two adjacent methoxylated carbons, carbonium ions of either fragment are 
produced at an equal frequency (Figure 5.7.A). However, cleavage between adjacent carbons 
one of which is methoxylated and the other acetoxylated results in a cation formed 
exclusively by the methyoxylated carbon (Figure 5.7.B). This is due to the electron 
withdrawing function exhibited by the keto group of the acetyl substitution. Therefore, only 
the fragment incorporating the methoxylated carbon is observed after EI-MS.  
An example of the predicted fragmentation of a non-reducing terminal (i.e. 1-substituted) 
hexose is illustrated in Figure 5.8. Cleavage of the alditol chain usually results in fragments 
with two, three, four and five carbons (Carpita and Shea 1989). Cleavage is favoured between 
C2-C3 and C3-C4 resulting in fragments of m/z of 118 and 205, and 162 and 161 respectively. 
In the less likely event of a cleavage between a methoxylated and an acetoxylated carbon 
such as between C4-C5, the fragment ion at m/z 206 is observed. In addition to primary 
fragmentation, secondary fragments can result from the loss of acetic acid (CH₃COOH; loss 
of 60 m/z units), methanol (CH₃OH; loss of 32 m/z units), formaldehyde (CH₂O; loss of 30 m/z 
units) and ketene (CH₂CO; loss of 42 m/z units).  
The S. coelicolor glycans were permethylated, hydrolysed, reduced and acetylated, and the 
partially methylated alditol acetates (PMAAs) were subsequently analysed by GC-MS. The S. 
coelicolor glycan derived PMAAs were analysed alongside PMAAs of mannose and glucose as 
standards (provided by the Proteomics Laboratory of the York Bioscience Technology 
Facility).  
Chapter 5 – Characterisation of S. coelicolor glycans 
150 
 
Figure 5.7 Primary fragmentation of PMAAs occurs more favourably between adjacent 
methoxylated carbons. A. Fragmentation between two methoxylated carbons generates 
cations of either fragment at an equal frequency. B. After fragmentation between a 
methoxylated and an acetoxylated carbon, only cations from the fragment bearing the 
methoxylated carbon are produced. 
 
 
 
 
Figure 5.8 The predicted primary fragmentation of a PMAA from a terminal hexose. The 
most likely fragment ions are predicted to result from the cleavage between two 
methoxylated carbons, such as the fragments at m/z 118, 205, 162 and 161. Fragmentation 
is also possible between methoxylated and acetoxylated carbons, such as between C4-C5. 
However, only the fragment bearing the methoxylated carbon is observed in this case, the 
fragment at m/z 206. 
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The mass spectra enabled the assignment of the resulting PMAAs. The identities of the 
monosaccharides were determined by comparison of the retention times of component 
peaks in the sample, with the peaks in the glucose and mannose standard derived PMAAs 
that were separated under the same conditions. The GC-MS analysis of the PMAAs derived 
from the permethylated S. coelicolor glycans gave peaks corresponding to terminal mannose, 
2-substituted mannose, 4-substituted mannose, 4-substituted glucose and terminal glucose, 
as well as spectra consistent with the respective hexitols (Table 5.1; Figure A.17-A.20).  
As an example, the mass spectrum of 2-substituted mannose is shown in Figure 5.9. A peak 
was observed in the S. coelicolor glycan sample with a retention time of 15.585 min, that 
corresponded to the retention time (15.585 min) of the 2-substituted mannose peak in the 
PMAA mannose standard. The mass spectrum of the peak in the mannose standard was 
consistent with a 2-substituted hexitol, since diagnostic product ions at m/z 190 and 161 
resulting from the cleavage between C3-C4 were observed (Figure 5.9.A). Additionally, 
secondary fragment ions were also observed at m/z 130 and 129, resulting from the loss of 
acetic acid and methanol respectively. Similarly, product ions diagnostic of the 2-substituted 
hexitol (m/z 190, 160, 130 ,129) were observed in the mass spectrum of the peak in the S. 
coelicolor glycan sample (Figure 5.9.B). Therefore, the peak in the PMAA data from the 
sample was identified as 2-substituted mannose. 
The observation of 4-substituted glucose can be explained by contamination of the sample 
with α-cyclodextrin, an oligosaccharide composed of α-1,4 linked glucose units. The presence 
of n-dodecyl-β-D-maltoside which is composed of maltose (α-1,4 linked glucose) with an alkyl 
aglycone could also be a source of the 4-substituted glucose, as well as the terminal glucose. 
After acid hydrolysis, the glycosidic bond linking the two glucose units, as well as that 
bonding the alkyl chain to the disaccharide would be cleaved, resulting in terminal and 4-
substituted glucose derivatives. The chromatogram peak intensity of the 4-substituted 
glucose in the S. coelicolor glycan sample was more than three times that of terminal glucose 
and more than forty times that of terminal, 2-substituted and 4-substituted mannose (Figure 
A.21). This is consistent with the observation that the α-cyclodextrin contaminant was the 
most abundant carbohydrate in the S. coelicolor glycan sample (Figure 5.1). 
Taken together, these results suggest that the S. coelicolor glycans are composed of terminal, 
2-substituted and 4-substituted mannose.  
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Table 5.1 GC-MS analysis of the PMAAs derived from the permethylated glycans, released 
by non-reductive β-elimination of S. coelicolor glycoproteins. The GC-MS chromatograms 
for each peak are shown in Figure A.21. 
 
Monosaccharide¹ Retention time (min)² Fragment ions of the PMAA (m/z) 
2-substituted mannose 15.585 190, 161, 130, 129 
4-substituted mannose 15.751 233, 118, 162, 173 
Terminal mannose 13.650 102, 118, 129, 145, 161, 162, 205 
Terminal glucose 13.556 102, 118, 129, 145, 161, 162, 205 
4-substituted glucose 15.839 233, 118, 162, 173 
 
¹ The monosaccharide residue was identified by diagnostic fragment ions observed in the 
mass spectrum of the PMAAs (Figures A.17-A.20) and by co-elution with mannose or glucose 
standards from the column (Figure A.21). 
² Retention time of the PMAAs separated by GC.
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Figure 5.9 GC mass spectrum determining 2-substituted mannose in the partially 
methylated mannose standard (A) and the S. coelicolor glycans (B). Diagnostic fragment 
ions are m/z 190, 161, 130 and 129 are indicated.  
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5.3 Analysis of disaccharides and trisaccharides in the S. coelicolor glycans 
 
After determining that the S. coelicolor glycans were composed of terminal, 2-substituted 
and 4-substituted mannose, an analysis of the di/tri saccharide alditols by GC-MS was carried 
out. This experiment was carried out to investigate the arrangement of the linkages 
identified in the analysis of PMAAs (Table 5.1) in the disaccharide and trisaccharide. The S. 
coelicolor glycans were reduced using NaBD₄, which reduces the aldose to form an alditol 
and simultaneously tags the anomeric carbon atom (C1) with a deuterium atom (Figure 5.10). 
The di/trisaccharides were methylated which modifies all of the free hydroxyls to methoxy 
groups. The permethylated di/trisaccharide alditols were then analysed by GC-MS. 
Disaccharides maltose (α-1,4 linked glucose) and α3 mannobiose (Manα(1->3)Man) were 
prepared and analysed alongside the S. coelicolor glycans as standards. 
In the case of a disaccharide, the molecular mass of the monosaccharide units and the 
position of the glycosidic linkage can be determined based on the GC mass spectra 
(Kärkkäinen 1970). The primary fragmentation patterns that are expected from the (1->2), 
(1->3), (1->4) and (1->6) linked permethylated disaccharide alditols are exemplified in Figure 
5.11. In the case of hexose disaccharides, ions at m/z 219 (B₁) and 236 (Z₁) are expected to 
form through the cleavage of the hexose unit from the molecule and from the cleavage to 
generate an ion containing the alditol unit respectively. Secondary and tertiary fragments of 
these ions at m/z 187 (219 - 32), 155 (187 – 32), 204 (236 – 32) and 172 (204 – 32) resulting 
from a loss of one and two molecules of methanol are also expected. Fragmentation within 
the alditol enables the assignment of the glycosidic linkage.  
In the case of a trisaccharide it is possible to determine the molecular mass of the 
monosaccharide units and the glycosidic linkage to the alditol unit, based on the GC mass 
spectrum (Kärkkäinen 1971). The primary fragmentation patterns expected from 
permethylated trisaccharide alditols with (1->2), (1->3), (1->4) and (1->6) linkages to the 
alditol are exemplified in Figure 5.12. In the case of unbranched trisaccharides composed of 
hexoses, ions formed through the cleavage of the hexose unit and of the alditol unit from 
the molecule (at m/z 219 (B₁), 236 (Z₁), 423 (B₂) and 440 (Z₂)) are expected, as well as 
secondary and tertiary fragments resulting from loss of methanol. As in the case of the 
disaccharide alditols, fragmentation of the alditol backbone enables the assignment of the 
glycosidic linkage to the residue.  
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Figure 5.10 Analysis of methylated di/trisaccharide alditols exemplified using maltose. Carbohydrates are reduced using NaBD₄, methylated and analysed 
by GC-MS. 
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Figure 5.11 The predicted primary fragmentation of permethylated dihexose alditols with (1->2), (1->3), (1->4) and (1->6) linkages.  
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Figure 5.12 The predicted primary fragmentation of permethylated, unbranched trisaccharide alditols with (1->2), (1->3), (1->4) and (1->6) linkages 
respectively.  
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A. Standards 
The relative retention times of the maltose and α3 mannobiose (standards) derived 
methylated disaccharide alditols were 9.900 min and 9.875 min respectively, and the partial 
mass spectra data are summarised in Table 5.2. The fragment ion intensities are shown as a 
percentage of that of the base peak at m/z 88, for each individual spectrum. The ions at m/z 
219 and 236 formed as a result of the cleavage of the hexose unit and the alditol unit from 
the molecule respectively (Figure 5.11), were observed in the spectra of both of the 
standards. These ions can undergo secondary and tertiary fragmentations by the loss of one 
and two molecules of methanol, resulting in ions at m/z 187 (219 - 32), 155 (187 – 32), 204 
(236 – 32) and 172 (204 – 32) respectively. The secondary and tertiary fragmentation ions 
were all observed in spectra of the standards. Taken together, these ions are indicative of 
hexose containing disaccharides. 
The absence of ions at m/z 177 and 178 in the spectra of both standards rules out the 
possibility of (1->2) or (1->6) linked disaccharides respectively. The deuteration was 
necessary to distinguish between the (1->3) (α3 mannobiose) and (1->4) (maltose) linked 
disaccharide. The (1->4) linked disaccharide is identified by the presence of m/z 134 arising 
from the cleavage between the C3 and C4 bonds in the alditol moiety (Figure 5.11; Table 5.2), 
which is absent from the spectrum of the (1->3) disaccharide. Similarly, the presence of the 
ion at m/z 133 in the spectrum of the α3 mannobiose standard along with the absence of 
the ion at m/z 134 identifies the (1->3) linked disaccharide. Due to the mass cut-off of the 
instrument, ions at m/z 45 consistent with the cleavage between C5 and C6 ((1->2), (1->3) 
and (1->4) linked disaccharides) and at m/z 46 consistent with the cleavage between C1 and 
C2 in the alditol moiety ((1->2), (1->3), (1->4) and (1->6) linked disaccharides) could not be 
observed. The low intensity of the higher molecular mass fragment ions at m/z 425, 426, 381 
and 382 meant that these ions were not particularly useful as diagnostic fragment ions in the 
linkage assignment. The ions at m/z 89 and 90 were not useful in distinguishing between (1-
>3) and (1->4) linked disaccharides due to the presence of the isotope peaks of the 
prominent ion at m/z 88. Therefore, the glycosidic linkage assignment is based on the 
product ions at m/z 177, 178, 133 and 134.  
 
B. Sample 
A peak in the S. coelicolor glycan sample with a retention time of 9.890 min was observed. 
The similarity in the retention time of the peak in the sample compared to the peaks in the 
Chapter 5 – Characterisation of S. coelicolor glycans 
159 
maltose and α3 mannobiose standards, suggested that the sample peak was a disaccharide. 
The partial mass spectra data of the unknown methylated disaccharide alditol in the S. 
coelicolor glycan sample is shown in Table 5.2. The fragment ion intensities are shown as a 
percentage of that of the base peak at m/z 101. The ions at m/z 219 and 236, as well as the 
secondary and tertiary fragment ions resulting from a neutral loss of methanol at m/z 187, 
155, 204 and 172 respectively, are consistent with hexose residues. The ion at m/z 134 was 
more than double the intensity of the ion at m/z 133, suggesting that the disaccharide could 
be either (1->4) or (1->6) linked. However, the low abundance of the ion at m/z 178 
compared to the ion at m/z 177 rules out the possibility of a (1->6) linked disaccharide. These 
results suggest the presence of a 4-linked disaccharide alditol made up of hexose 
monosaccharides. A second peak with a retention time of 12.985 min was observed in the S. 
coelicolor glycan sample, where the mass spectrum contained product ions that appeared to 
be consistent with the fragmentation of a permethylated trisaccharide alditol. The partial 
mass spectra data from the peak is shown in Table 5.2. The fragment ion intensities are 
shown as a percentage of the base peak at m/z 88. The later retention time observed (12.985 
min) compared to the disaccharide standards (~ 9.9 min) suggests that the peak is not a 
disaccharide. The ions at m/z 219 and 236, as well as the secondary and tertiary fragment 
ions resulting from neutral loss of methanol at m/z 187, 155, 204 and 172 are consistent with 
the presence of hexose residues. The ion observed at m/z 440 is consistent with a Z₂ fragment 
ion of a permethylated trisaccharide alditol (Figure 5.12). The B₂ fragment ion at m/z 423 
was observed in very low abundance. The higher abundance of the ion at m/z 133 compared 
to the ion at m/z 134 suggests that the linkage is either (1->2) or (1->3). The higher 
abundance of the ion at m/z 177 compared to the ion at m/z 178 suggests that the linkage is 
not (1->6) but could be (1->2). The fragment ion at m/z 89 was more than six times the 
intensity of the ion at m/z 90, which is consistent with a (1->2) linkage. Additionally, higher 
molecular mass ions consistent with a (1->2) linkage at m/z 498, 542 and 586 were observed 
in low abundance. No ions were observed at m/z 629 or 630. These results suggest the 
presence of a (1->2) substitution of the alditol residue in the trisaccharide. 
Taken together, these results provide evidence for a (1->4) linked disaccharide in the S. 
coelicolor glycan sample. Additionally, there is preliminary evidence of a trisaccharide with a 
(1->2) linkage to the alditol moiety. However, without an appropriate trisaccharide standard 
it was not possible to determine the expected intensities of the diagnostic fragment ions of 
a permethylated trisaccharide alditol. In addition, a (1->2) linked di/trisaccharide standard  
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Table 5.2 Partial mass spectra data from the methylated disaccharide and trisaccharide 
alditols analysed by GC-MS. Ions pertinent to the structural interpretations of the glycans 
are shown. Intensities are shown as a percentage of the base peak.  
 
m/z 
Sample 
 (RT: 9.890 min) 
Maltose 
 (RT: 9.900 min) 
3α Mannobiose  
(RT: 9.875 min) 
Sample  
(RT: 12.985 min) 
88 88.1 100.0 100.0 100.0 
89 33.5 53.1 26.2 29.6 
90 13.3 21.1 13.1 4.7 
101 100.0 100.0 94.2 69.0 
133 3.1 3.2 5.6 8.8 
134 6.6 10.4 0.8 5.0 
145 9.0 12.3 5.4 13.9 
146 1.8 2.2 2.0 4.4 
155 18.0 25.7 7.4 12.2 
172 10.3 18.0 15.5 10.1 
177 1.7 0.3 0.2 3.1 
178 1.2 0.6 0.1 1.2 
187 64.3 99.5 33.1 24.2 
204 1.6 1.6 0.6 1.2 
219 9.5 12.6 19.6 6.4 
222 0.8 0.4 0.6 1.3 
236 30.6 50.7 28.2 59.4 
249 1.4 1.3 0.8 1.1 
293 0.7 0.6 0.3 0.4 
294 0.5 0.1 0.1 0.4 
296 2.7 3.4 3.7 0.7 
337 0.1 0.1 - 0.4 
338 0.1 0.1 0.1 0.2 
359 - - - 0.4 
376 - - - 0.3 
381 0.2 0.3 0.0 0.4 
382 0.2 0.3 0.1 0.4 
391 - - - 0.4 
408 - - - 0.3 
423 - - - 0.4 
425 0.2 0.3 0.0 0.3 
426 0.2 0.4 0.0 0.3 
440 - - - 4.4 
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m/z 
Sample 
 (RT: 9.890 min) 
Maltose 
 (RT: 9.900 min) 
3α Mannobiose  
(RT: 9.875 min) 
Sample  
(RT: 12.985 min) 
498 - - - 0.1 
541 - - -   
542 - - - 0.1 
585 - - -   
586 - - - 0.2 
629 - - - - 
630 - - - - 
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could help to determine the lower molecular mass fragmentation pattern of the (1->2) linked 
sugar. 
 
5.4 Discussion 
 
In order to characterise the glycans modifying the S. coelicolor glycoproteins, the glycans 
were analysed by mass spectrometry. Using MALDI-FT-ICR-MS, the S. coelicolor glycans were 
shown to contain Hex₂ and Hex₃. There was significant contamination of the S. coelicolor 
glycan sample with a Hex₆ cyclic glucan, probably α-cyclodextrin most likely to have come 
from the SafeBlue protein stain used to stain the SDS-PAGE gels. There was no evidence of 
partially hydrolysed and permethylated forms of α-cyclodextrin, suggesting that the Hex₂ and 
Hex₃ observed in the S. coelicolor glycan sample were unlikely to be α-cyclodextrin derived. 
Additionally, despite efforts to remove the detergent n-dodecyl-β-D-maltoside, some low 
level contamination was observed in the S. coelicolor glycan sample. 
The presence of Hex₂ and Hex₃ in the S. coelicolor glycans is consistent with observations 
made in the glycoproteomics characterisation of the S. coelicolor membrane proteome, 
where glycopeptides were shown to be modified with Hex, Hex₂ and Hex₃ glycan moieties 
(Chapter 4). Additionally, the previously characterised S. coelicolor glycoprotein PstS 
(SCO4142) was shown to be modified with a trihexose (Wehmeier et al. 2009). The 
carbohydrate methylation and linkage analysis of the S. coelicolor glycans resulted in the 
identification of terminal, 4-substituted and 2-substituted mannose, as well as terminal and 
4-substituted glucose. The main source of the 4-substituted glucose is most likely to be the 
α-cyclodextrin, however the n-dodecyl-β-D-maltoside could also have contributed to this. 
The most likely source of the terminal glucose is the n-dodecyl-β-D-maltoside. The 
identification of 2-substituted mannose in the S. coelicolor glycans was not surprising 
considering the similarity to the pathway in M. tuberculosis, where the glycoprotein MPT32 
was previously shown to be modified with both α (1->2) mannobiose and α (1->2), (1->2) 
mannotriose (Dobos et al. 1996). The identification of 4-substituted mannose in the S. 
coelicolor glycans however, was surprising since there is no record in the literature of (1->4) 
linked mannose in Actinobacterial glycoproteins. The configuration (α/β) of the linked 
mannose monosaccharides identified in this study was not determined, since the non-
reductive β-elimination removes all O-linked glycans non-specifically. Additionally, the 
anomeric configuration of the monosaccharides identified in the linkage analysis is lost after 
hydrolysis. 
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The methylation analysis of the di/trisaccharides in this study provides preliminary evidence 
of a trisaccharide with a (1->2) linkage, which is consistent with observation of 2-substituted 
mannose in the S. coelicolor glycans on linkage analysis. Additionally, the observation of a 
disaccharide with a (1->4) linkage would be consistent with the observation of 4-substituted 
mannose in the S. coelicolor glycans on linkage analysis. Taken together these results could 
suggest that the glycans modifying the S. coelicolor glycoproteins are composed of 
trisaccharides that contain (1->2) linked mannose, and disaccharides that contain (1->4) 
mannose. Since only the linkage to the alditol in the permethylated trisaccharide alditol was 
characterised, it is possible that the trisaccharides are composed of both (1->2) and (1->4) 
linked mannose chains. However, this remains to be experimentally validated. Due to 
contamination of the S. coelicolor glycan sample with α-1, 4 linked glucose containing 
carbohydrates (α-cyclodextrin and n-dodecyl-β-D-maltoside), the origin of the disaccharide 
with a (1->4) linkage in the S. coelicolor glycan sample could not be conclusively determined. 
To gain more conclusive evidence that the (1->4) linked disaccharide is S. coelicolor 
glycoprotein derived, these experiments should be repeated with measures taken to 
eliminate the carbohydrate contaminants. SDS-PAGE gels could be stained with Coomassie 
blue R-250 stain without added cyclodextrins (He 2011). Additionally, the solubilisation of S. 
coelicolor membrane proteins could be carried out with a non-glucoside detergent or its 
removal could be monitored mass spectrometrically before beta-elimination is carried out. 
Due to the experimental approach used in this study, where the glycans eliminated from the 
total S. coelicolor membrane glycoproteome fractions were analysed, it was not possible to 
determine which glycoproteins the respective di/trisaccharides originated from. However, 
the previous characterisation of the S. coelicolor membrane glycoproteome in this work 
(Chapter 4) has resulted the identification of 37 new glycoproteins, which could serve as 
targets for any future validation of the work reported in this chapter, on a single 
glycoprotein. The use of commercially available glycosidases that are specific for certain 
glycosidic linkages (e.g. α1,2 mannosidase) could be used alongside the β-elimination for the 
removal of glycans, whilst enabling the determination of the anomeric configuration of the 
glycosidic linkages. Additionally, the Glyconeer oligosaccharide synthesiser based in the 
University of York Department of Chemistry, could be used to synthesise an appropriate 
disaccharide and trisaccharide standard.
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Chapter 6 – Characterisation of knockout mutants in genes encoding 
glycoproteins required for cell wall biosynthesis. 
 
Among the diverse physiological roles of protein O-glycosylation in nature, the importance 
of glycosylation for maintaining growth and cell wall integrity has been widely reported. In 
fungi, the disruption of PMT family proteins has been shown to result in changes in growth, 
cell morphology, and cell wall rigidity and integrity (Gentzsch and Tanner 1996; Prill et al. 
2005; Mouyna et al. 2010; Guo et al. 2016). In M. smegmatis, pmt mutants displayed a 
reduced tolerance to cell wall stress induced by SDS treatment, suggesting changes in the 
cell wall composition (Liu et al. 2013a). Additionally, Ppm1 in M. tuberculosis has been shown 
to be required for the synthesis of the cell wall glycoconjugates, lipomannan and 
lipoarabinomannan (Gurcha et al. 2002). Recently, Howlett et al. (2016) demonstrated that 
mutants defective in proteins required for the protein O-glycosylation pathway in S. 
coelicolor (discussed in detail in Chapter 1), were hypersusceptible to cell-wall targeting 
antibiotics. They hypothesised that protein O-glycosylation in S. coelicolor is required for the 
optimal function of membrane and periplasmic proteins, including cell wall biosynthetic 
enzymes. 
During my characterisation of the S. coelicolor membrane glycoproteome (Chapter 4) a 
number of glycoproteins with predicted functions in the cell wall were identified. Included in 
these were two putative peptidoglycan biosynthetic enzymes, SCO4847 and SCO4934.  
SCO4847 is a D-Ala-D-Ala carboxypeptidase and predicted low molecular mass penicillin 
binding protein (LMM PBP) (Sauvage et al. 2008). The prediction of a C-terminal 
transmembrane domain in SCO4847 (Chapter 4, Figure 4.9) is consistent with previous 
observations that many LMM PBPs are membrane associated (Pratt 2008). D-Ala-D-Ala 
carboxypeptidases recognise the terminal D-Ala-D-Ala of stem pentapeptides or the already 
crosslinked analogues (Pratt 2008). The reaction of the enzyme with the peptide stem results 
in the formation of an acyl enzyme intermediate, which then undergoes hydrolysis to cleave 
the terminal D-Ala residue and thereby limiting crosslinking (Figure 6.1).  
SCO4934 is a putative L, D transpeptidase. L, D transpeptidases were first reported in 
Enterococcus faecium but have since been discovered in other bacteria, including E. coli, 
Bacillus subtilis and M. tuberculosis (Mainardi et al. 2002; Magnet et al. 2007; Bramkamp 
2010; Sanders et al. 2014). As discussed in Chapter 1, L, D transpeptidases catalyse the 
crosslinking between the third amino acids (commonly meso diaminopimelic acid (meso-
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DAP)) of tetrapeptide stems (known as 3->3 crosslinking). This is in contrast to the more 
widely studied crosslinking between the fourth and third amino acids respectively (normally 
meso-DAP and D-alanine) of peptidoglycan stem pentapeptides (4->3 crosslinking) that is 
carried out by D-Ala-D-Ala transpeptidases (Vollmer et al. 2008). Both 3->3 crosslinking and 
4->3 crosslinking have been observed in S. coelicolor (Hugonnet et al. 2014). 
The aim of the work in this chapter was to understand the roles of the cell wall active 
glycoproteins SCO4934 and SCO4847 in S. coelicolor. By the characterisation of sco4934 and 
sco4847 knockout mutants, I aim to investigate whether loss of these glycoproteins is likely 
to contribute to the antibiotic hypersensitivity phenotype observed previously in the S. 
coelicolor glycosylation deficient pmt mutant, such as DT1025 (discussed in Chapter 1). The 
S. coelicolor parent strain, J1929, will be used for generating the gene knockouts. I expect 
the mutations might result in one of several possible phenotypes: 
1. A phenotype similar to that of the parent strain. This phenotype could be indicative 
of protein functional redundancy and that loss of this glycoprotein does not 
contribute to the antibiotic susceptible phenotype in the pmt- mutant. 
2. A phenotype resembling that of DT1025 (pmt). Loss of this glycoprotein probably 
contributes to the antibiotic hypersensitivity phenotype in the pmt mutant. 
3. A phenotype with increased antibiotic susceptibility to that of DT1025. This 
phenotype could indicate that both the glycosylated and the unglycosylated 
isoforms of the protein have a role in the intrinsic antibiotic resistance we observe 
in the parent strain.  
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Figure 6.1 Schematic summary of the function of D-Ala-D-Ala carboxypeptidases in peptidoglycan crosslinking. D-Ala-D-Ala carboxypeptidases recognise 
the terminal D-Ala-D-Ala of stem pentapeptides (b) or the already crosslinked analogues (a) (1). The reaction of the enzyme with the peptide stem results in 
the formation of an acyl enzyme intermediate (2), which then undergoes hydrolysis to cleave the terminal D-Ala residue (3).  
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6.1 Transposon insertion mutagenesis of genes encoding glycoproteins SCO4847, SCO4934 
and SCO5204. 
 
In order to investigate the functions of the putative cell-wall biosynthetic enzymes SCO4934 
and SCO4847, transposon insertion mutant strains were constructed. A transposon insertion 
mutant in sco5204 was also constructed. sco5204 encodes a putative integral membrane 
protein of unknown function, previously identified as a glycoprotein after the CID mass 
spectrometry analysis of Con A enriched membrane proteins (Chapter 4, Table 4.1).  
The mutants were constructed by taking advantage of the S. coelicolor transposon insertion 
cosmid library available from Dr Paul Dyson (University of Swansea). The positions of the 
transposon insertions in sco5204, sco4934 and sco4847 (indicated in Figure 6.2) were 
identified using the StrepDB (http://strepdb.streptomyces.org.uk). Conserved domains in 
each of the three protein sequences were predicted using the Conserved Domain Database 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) and transposon insertions 
positioned upstream of these were selected for mutant construction. The cosmids with the 
transposon insertions were isolated from the strains sent by Meirwyn Evans (University of 
Swansea). Restriction digestion of the cosmids with EcoRI confirmed that the cosmids 
contained Tn5062 at the correct site (Figure 6.3, Table 6.1). The cosmids were introduced 
into E. coli ET12567(pUZ8002) and then into S. coelicolor J1929 as described in Materials and 
Methods.  
The apramycin resistant, kanamycin sensitive exconjugates from the 2St3B6.1.G02-J1929,  
2St3B6.1.G06-J1929 (transposon insertions in sco5204) and 2SCK31.2.F11-J1929 (transposon 
insertion in sco4934) conjugations were screened by Southern blot analysis to verify the 
genomic integration of the cosmids (Figure 6.4 – 6.5). Genomic DNA isolated from the 
2St3B6.1.G02:J1929 and 2St3B6.1.G06:J1929 exconjugates was digested with XhoI. Similarly, 
the genomic DNA isolated from the 2SCK31.2.F11-J1929 exconjugates was double digested 
with ScaI and SacI. The digested DNA was separated in a 1 % agarose gel and blotted onto a 
Zeta probe membrane (Bio-Rad) as described in the Materials and Methods. The probes were 
prepared by amplifying a region upstream of the sco5204 and sco4934 genes, and 
downstream of the XhoI (-214 bp) (Figure 6.4.A) and SacI (- 147 bp) (Figure 6.5.A) restriction 
sites respectively, using PCR.  
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Figure 6.2 Conserved domains and the positions of the transposon insertions in sco5204, 
sco4934 and sco4847. SCO5204 is predicted to belong to an uncharacterised family of 
integral membrane proteins (UPF1082). SCO4934 has a predicted lgD domain of 
actinobacterial L, D transpeptidases (LDT_lgD_like_2) as well as the catalytic YukD domain of 
L, D transpeptidases. SCO4847 has a predicted penicillin binding protein transpeptidase 
domain (cl21491). The expect (e) scores of each predicted domain generated by the CDD are 
indicated. Positions of the transposon insertions in the cosmids selected for mutagenesis are 
indicated by red arrow heads.  
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Figure 6.3 Restriction digests of the transposon insertion cosmids with EcoRI. The digested 
cosmids were separated in a 1 % agarose gel. Cosmids containing a transposon insertion in 
sco5204 (2St3B6.1.G02, 2St3B6.1.G06) are indicated in panel A. Cosmids containing a 
transposon insertion in sco4934 (2SCK31.2.F11) and sco4847 (5G8.1.A11) respectively are 
indicated in panel B. The genotypes of the cosmids are indicated at the bottom of each panel. 
 
 
 
Table 6.1 Expected fragment sizes for the transposon insertion containing cosmids after 
restriction digestion with EcoRI.  
 
Gene Transposon cosmid 
Expected fragments sizes (bp) after 
EcoRI digest 
sco5204 2St3B6.1.G02 38839, 6792, 6791, 5942, 782, 1 
sco5204 2St3B6.1.G06 39744, 6792, 6791, 5037, 782, 1 
sco4934 2SCK31.2.F11 24662, 13432, 6791, 3172, 782, 1 
sco4847 5G8.1.A11 16696, 12103, 12058, 6791, 782, 1 
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A signal at ~ 2405 bp was observed in all of the 2St3B6.1.G02:J1929 exconjugates screened, 
while the wild type signal at 3035 bp was absent (Figure 6.4.C). These results indicate the 
presence of double cross-overs, thus confirming the successful generation of sco5204 
mutants. None of the 2St3B6.1.G06:J1929 exconjugates were confirmed as double cross-
overs, as it was difficult to distinguish between the wild type signal at 3035 bp and the 
mutant signal at 3310 bp.  
A signal at ~ 1901 bp was observed in all of the 2SCK31.2.F11-J1929 exconjugates screened, 
while the wild type signal at 987 bp was absent (Figure 6.5.C). These results indicate the 
presence of double cross-overs, thus confirming the successful generation of sco4934 
mutants. 
Attempts to confirm the sco4847 mutants using Southern blotting were unsuccessful, 
therefore the genomic DNA from the apramycin resistant, kanamycin sensitive exconjugates 
from the 5G8.1.A11-J1929 conjugation was screened using PCR (Figure 6.6). PCR primers 
were designed upstream and downstream of the transposon insertion (Figure 6.6.A). Two of 
the five exconjugates screened contained a PCR product at 4017 bp while the wild type PCR 
product at 575 bp was absent. These results are consistent with the presence of double 
cross-overs, thus confirming the presence sco4847 mutants (Figure 6.6.B). The new knockout 
strains and genotypes are summarised in Table 6.2. 
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Figure 6.4 Southern blot analysis of the putative transposon mutants in sco5204. A. A schematic showing the genomic positions of the XhoI restriction sites 
relative in sco5204 and the position of the transposon insertions. The expected fragment sizes are indicated. B. Ethidium bromide stained agarose gel showing 
the digested and separated genomic DNA prior to alkaline blotting. C. Southern blot of 2St3B6.1.G02-J1929 (G02) 2St3B6.1.G06-J1929 (G06) exconjugates 
probed with a DIG labelled probe, using the DIG High Prime DNA labelling and detection kit (Roche Life Science). J1929 genomic DNA served as a negative 
control. 2St3B6.1.G02 and 2St3B6.1.G06 cosmid DNA served as the positive controls. 
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Figure 6.5 Southern blot analysis of the putative transposon mutants in sco4934. A. A 
schematic showing the genomic positions of the ScaI and SacI restriction sites relative to 
sco4934 and the position of the transposon insertions. The expected fragment sizes are 
indicated. B. Ethidium bromide stained agarose gel showing the digested and separated 
genomic DNA prior to alkaline blotting. C. Southern blot of 2SCK31.2.F11-J1929 (F11) 
exconjugates probed with a biotin labelled probe, using the Biotin chromogenic detection kit 
(Thermo Fisher Scientific). J1929 genomic DNA served as a negative control. 2SCK31.2.F11 
cosmid DNA served as a positive control. 
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Figure 6.6 PCR analysis of the putative transposon mutants in sco4847. A. A schematic 
showing the positions of the primers used to confirm the presence of double crossovers and 
the expected sizes of the PCR products. B. Ethidium bromide stained agarose gel showing 
the PCR products generated after the amplification of genomic DNA from 5G8.1.A11-J1929 
exconjugates using primers TK87 and TK88. J1929 genomic DNA served as a negative control. 
2SCK31.2.F11 served as a positive control. 
 
 
Table 6.2 New strains generated by transposon insertion mutagenesis of sco5204, sco4847 
and sco4934 respectively. 
Strain Gene knockout Transposon cosmid 
TK005 sco5204 2St3B6.1.G02 
TK006 sco4847 5G8.1.A11 
TK008 sco4934 2SCK31.2.F11 
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In order to investigate whether the glycoprotein deficient mutants displayed changes in 
colony morphology as displayed previously in the DT3017 (ppm1) strain, TK005 (sco5204), 
TK006 (sco4847) and TK008 (sco4934) spores were plated onto DNA and grown for 2 days 
(Figure 6.7). J1929 spores served as a negative control. DT1025 (pmt) and DT3017 (ppm1) 
spores were grown for comparison. No changes in colony morphology compared to J1929 
were observed in any of the glycoprotein deficient mutants. The φC31cΔ25 phage sensitivity 
of the glycoprotein deficient mutants was tested on DNA (Figure 6.8). Large clear plaques 
bearing resemblance to those observed on J1929 were observed on TK005 (sco5204), TK006 
(sco4847) and TK008 (sco4934). These results indicate that the φC31cΔ25 phage receptor is 
present in all of the knockout mutants, suggesting that neither SCO5204, SCO4934 nor 
SCO4847 is the φC31cΔ25 phage receptor in S. coelicolor. 
To investigate whether the glycoprotein deficient mutants displayed changes in sporulation 
they were streaked onto MSA and grown for 7 days (Figure 6.9). All three mutant strains 
sporulated efficiently and displayed no changes in pigment production compared to J1929. 
However, after the mutants were plated onto SMMS medium both TK006 (sco4847) and 
TK008 (sco4934) displayed a slight increase in antibiotic production compared to the parent 
strain J1929 (Figure 6.10). No increase in antibiotic production was observed in the TK005 
(sco5204) strain. These results suggest that the TK006 (sco4847) and TK008 (sco4934) strains 
could be stressed, since the early onset of pigment production is a generic stress response in 
S. coelicolor.  
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Figure 6.7 The colony morphology of the glycoprotein deficient mutants on DNA. Images 
are representative of at least two biological replicates and two technical replicates. 
 
 
 
 
Figure 6.8 The φC31cΔ25 phage sensitivity of the glycoprotein deficient mutants on DNA. 
Images are representative of two biological replicates repeated at least once. φC31cΔ25 (~ 
1 x 10³ pfu) was inoculated with J1929, TK008, TK006 and TK005 whereas ~ 1 x 10 ⁸ pfu of 
φC31cΔ25 was inoculated with DT1025 and DT3017. Images are representative of at least 
two biological replicates and two technical replicates. 
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Figure 6.9 Sporulation of the glycoprotein deficient mutants MSA. A. TK005 (sco5204). B. 
TK008 (sco4934). C. TK006 (sco4847). Images are representative of at least two biological 
replicates and two technical replicates. 
 
 
 
Figure 6.10 Antibiotic production of the glycoprotein deficient mutants SMMS. A. TK005 
(sco5204). B. TK008 (sco4934). C. TK006 (sco4847). Approximately 10⁶ spores were 
inoculated. Images are representative of at least two biological replicates and two technical 
replicates. 
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The antibiotic sensitivity of S. coelicolor TK005 (sco5204), TK006 (sco4847) and TK008 
(sco4934) was measured on DNA using disc diffusion assays (Figure 6.11). S. coelicolor J1929 
served as a negative control. DT1025 (pmt) and DT3017 (ppm1) served as a comparison for 
the severity of the antibiotic hypersensitivity phenotypes. The TK005 (sco5204), TK006 
(sco4847) and TK008 (sco4934) strains displayed increased susceptibilities to imipenem, 
meropenem, ampicillin and penicillin (i.e. β-lactam antibiotics) compared to the parent strain 
J1929 (Figure 6.11.A-C). Additionally, the TK006 (sco4847) strain displayed a slight increase 
in sensitivity to vancomycin (Figure 6.11.B) and the TK005 (sco5204) strain displayed a 
decrease in sensitivity to rifampicin (Figure 6.11.A) compared to the parent strain J1929. The 
β-lactam hypersensitivity phenotype observed in the TK006 (sco4847) and TK008 (sco4934) 
strains was more severe than the hypersensitivity displayed by the DT1025 (pmt) strain. In 
contrast, the hypersensitivity phenotype displayed by the TK005 (sco5204) strain was similar 
to that of the DT1025 (pmt) strain. These results show that not all knockout mutants of 
glycoproteins in S. coelicolor display the same antibiotic hypersensitivity profiles. The 
increased sensitivity of the TK006 (sco4847) and TK008 (sco4934) strains to β-lactams 
compared to the DT1025 (pmt) strain suggests that non-glycosylated SCO4847 and SCO4934 
in the DT1025 (pmt) strain have some activity. Overall, with the exception of rifampicin which 
targets RNA polymerase, the majority of antibiotics with increased efficacy against the 
glycoprotein deficient mutant strains target different stages in peptidoglycan biosynthesis.  
Due to the predicted functions of SCO4847 and SCO4934 in cell wall biosynthesis, the 
sensitivity of the TK006 (sco4847) and TK008 (sco4934) strains to lysozyme was assayed. 
Lysozyme is a glycosyl hydrolase that cleaves the β 1,4 linkage between adjacent N -
acetylmuramic acid and N-acetylglucosamine units in peptidoglycan (Salton and Ghuysen 
1960). S. coelicolor TK006 (sco4847) and TK008 (sco4934) spores were serial diluted, plated 
onto Difco nutrient agar with 0.25 mg/mL of lysozyme and grown for 60 h. (Figure 6.12). 
Spores were plated onto Difco nutrient agar without lysozyme as a negative control for 
lysozyme treatment. J1929 served as a negative control for lysozyme hypersensitivity. The 
TK006 (sco4847) strain was dramatically more sensitive to the lysozyme treatment than both 
the parent J1929 and DT1025 (pmt) (Figure 6.12.A). The lysozyme sensitivity of TK008 
(sco4934) however, appeared to similar to that of the parent strain J1929 (Figure 6.12.B). 
Taken together, these results suggest that SCO4934 and SCO4847 are both required for 
maintaining cell wall integrity. However, the lack of lysozyme hypersensitivity observed in 
the TK008 (sco4934) strain could suggest that there is some functional redundancy in its role 
in cell wall biosynthesis.  
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Figure 6.11 Antibiotic sensitivity of the glycoprotein deficient mutants TK005 (sco5204) (A), TK006 (sco4847) (B) and TK008 (sco4934) (C). Shown are the 
diameters of growth inhibition zones from disc diffusion assays for each mutant against the parent strain J1929, and the glycosylation deficient strains DT1025 
(pmt) and DT3017 (ppm1). Bars represent the mean of three biological replicates except for TK006, where the bars indicate the mean of two biological 
replicates tested three times each. Error bars indicate SEM. * indicates p < 0.05 that the observed difference between the glycoprotein deficient strains 
(TK005, TK006 and TK008 respectively) and J1929 has occurred by chance. The full data set is in Table A.4 – Table A.6. 
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Figure 6.12 Lysozyme sensitivity of TK006 (sco4847) (A) and TK008 (sco4934) (B) compared 
to the parent strain J1929, DT1025 (pmt) and DT3017 (ppm1). Spores were adjusted to 10⁸ 
spores/mL and a ten-fold serial dilution was carried out to get 10⁴ spores/mL. 5 µL of each 
spore stock was plated onto DNA without lysozyme (left-hand panel) and with 0.25 mg/mL 
of lysozyme (right-hand panel). Images are representative of two biological replicates tested 
twice each (A) or three biological replicates tested once (B). 
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Alternatively, it is possible that if the majority of the peptidoglycan in S. coelicolor undergoes 
4->3 crosslinking rather than the 3->3 crosslinking catalysed by L, D transpeptidases, the loss 
of SCO4934 may have less of an impact on peptidoglycan biosynthesis overall. SCO5204 may 
also be required for cell wall integrity, but its role is unclear. 
 
6.2 Complementation of TK005 (sco5204), TK006 (sco4847) and TK008 (sco4934)  
 
To confirm that the changes in the phenotypes observed in the TK005 (sco5204), TK006 
(sco4847) and TK008 (sco4934) strains were directly linked to the disruption of sco5204, 
sco4847 and sco4934 respectively, it was decided to attempt to complement the mutants. 
The wild type copies of sco5204, sco4847 and sco4934 respectively were amplified by PCR 
and cloned into the NdeI restriction site of the shuttle vector pIJ10257 (as described in 
Materials and Methods). The new constructs were confirmed by restriction digests with 
BamHI and EcoRI to confirm the presence of the insert (Figure 6.13). The new constructs and 
expected digest fragments are summarised in Table 6.3. All fragment sizes in the restriction 
digests were as expected. Sequencing of the plasmids confirmed the presence of the correct 
insert. The constructs were introduced into E. coli ET12567(pUZ8002) and then into the S. 
coelicolor glycoprotein deficient mutants as described in the Materials and Methods. The 
empty pIJ10257 vector was introduced into TK005 (sco5204), TK006 (sco4847) and TK008 
(sco4934) to serve as a negative control for the complementation. 
The shuttle vector pIJ10257 enables the constitutive expression of genes under the ermEp* 
promoter (Hong et al. 2005). The plasmid encodes the phiBT1 phage integrase and attP site 
which enables the site specific integration of the vector into the phiBT1 attB site in the S. 
coelicolor genome (Gregory et al. 2003). Genomic DNA was isolated from the exconjugates 
and the presence of the integrated plasmids were confirmed by PCR. To confirm the 
presence of the empty pIJ10257 vector in the TK005 (sco5204), TK006 (sco4847) and TK008 
(sco4934) strains respectively, PCR primers were designed in the S. coelicolor genome 
upstream of sco4848 and in the pIJ10257 vector upstream of the ermE*p site (Figure 6.14.A). 
To confirm the presence of pTAK29 in TK005 (sco5204) PCR primers were designed on the 
vector backbone and in the sco5204 gene (Figure 6.14.B). To confirm the presence of pTAK30 
and pTAK32 in TK006 (sco4847) and TK008 (sco4934) respectively, PCR primers were 
designed on the vector backbone flanking the sco4847 and sco4934 genes respectively 
(Figure 6.14.C-D).  
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Figure 6.13 Restriction digests to confirm the correct construction of pTAK29, pTAK30 and 
pTAK32. A. Digestion of pTAK29 (pIJ10257 with sco5204) constructs with BamHI-HF and 
EcoRI-HF. B. Digestion of pTAK30 (pIJ10257 with sco4847), pTAK32 (pIJ10257 with sco4934) 
and pIJ10257 constructs with BamHI-HF and EcoRI-HF. 
 
Table 6.3 New constructs generated by cloning sco5204 (pTAK29), sco4847 (pTAK30) and 
sco4934 (pTAK32) respectively into pIJ10257. 
Name Construct Function 
BamHI-HF 
fragments (bp) 
EcoRI-HF 
fragments (bp) 
pIJ10257  
 Shuttle vector; 
Integrates into 
phiBT1 
attachment site 
(attB); 
constitutive 
ermEp* promoter 
in front of the 
MCS; 
Hygromycinᴿ .  
Cloning vector in 
E. coli and 
integrating vector 
in S. coelicolor 3280, 3144 2466, 3246, 712 
pTAK29  
sco5204 in 
pIJ10257 
Complementation 
of sco5204 
mutants (TK005) 
4896, 1393, 
3144 2466, 6255, 712 
pTAK30 
sco4847 in 
pIJ10257 
Complementation 
of sco4847 
mutants (TK006) 4604, 3144 2466, 4570, 712 
pTAK32 
sco4934 in 
pIJ10257 
Complementation 
of sco4934  
mutants (TK008) 4531, 3144 2466, 4497, 712 
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Figure 6.14 PCR primer design to confirm the presence of the integrated pIJ10257 (A), pTAK29 (B), pTAK30 (C) and pTAK32 (D) constructs. OriT: origin of 
transfer; TraJ:  oriT recognising protein; Ori: origin of replication; ermEp*: ermE promoter. 
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For each PCR the negative control was J1929 genomic DNA and a positive control was the 
plasmid that was introduced into each respective strain. The PCRs confirmed that all of the 
pTAK29:TK005, pTAK32:TK008, pIJ10257:TK005, pIJ10257:TK006 and pIJ10257:TK008 
exconjugates screened contained the integrated plasmids. However only four of the 
pTAK30:TK006 exconjugates (Figure 6.15.B – lanes 2,3,8 and 9) were positive for the 
integrated vector. The new strains, PCR primers and expected sizes of the PCR products are 
summarised in Table 6.4. 
 
To investigate if the increase in antibiotic production observed previously in the TK006 
(sco4847) and TK008 (sco4934) strains (Figure 6.10) was complemented in TK013 (TK006: 
pTAK30) and TK010 (TK008:pTAK32) respectively, the strains were plated onto SMMS and 
grown for 7 days (Figure 6.16). The slight increase in antibiotic production was still observed 
in TK013 (Figure 6.16.A) and TK010 (Figure 6.16.B).  Complementation of the lysozyme 
sensitivity phenotype observed previously in TK006 (sco4847) (Figure 6.12.A) was observed 
after the reintroduction of wild type sco4847 in the TK013 (TK006: pTAK30) strain (Figure 
6.17.A). No reduction in lysozyme sensitivity was observed in the empty vector control strain 
TK016 (TK006:pIJ10257) as expected.  
Partial complementation of the β-lactam hypersensitivity observed previously in the TK006 
(sco4847) (Figure 6.11.B) and TK008 (sco4934) (Figure 6.11.C) strains was observed upon re-
introduction of the wild type sco4847 and sco4934 in TK013 (TK006: pTAK30) (Figure 6.18.A) 
and TK010 (TK008:pTAK32) (Figure 6.18.B) respectively. Additionally, a slight reduction in 
vancomycin sensitivity was observed in TK013 (TK006: pTAK30). The β-lactam 
hypersensitivity observed previously in TK005 (sco5204) (Figure 6.11.A) was not 
complemented in TK012 (TK005: pTAK29) (Figure 6.18.C). However, the constitutive 
expression of sco5204 in TK012 (TK005: pTAK29) appeared to result in increased sensitivity 
to imipenem, penicillin and ampicillin. Taken together these results suggest that the 
phenotypes observed as a result of knocking out sco4847 and sco4934 in TK006 (sco4847) 
and TK008 (sco4934) respectively, are directly linked to the disruption of the respective 
genes. Additionally, the slightly exacerbated phenotypes observed in TK012 (TK005: pTAK29) 
might suggest that constitutive expression of sco5204 is damaging in S. coelicolor. 
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Figure 6.15 PCRs to confirm the genomic integration of the complementation constructs. 
Panels indicate: A. pTAK29 integration into TK005. B. pTAK30 integration into TK006. C. 
pTAK32 integration into TK008. D. pIJ10257 integration into TK005, TK006 and TK008 
respectively. 
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Table 6.4 New S. coelicolor strains generated by complementation of the glycoprotein 
deficient mutants and the expected sizes of the PCR products. 
 
S. coelicolor 
strain Genotype Description PCR primers 
Expected 
PCR 
products 
(bp) 
J1929 N/A Parent strain 
NR88, TK143  no product 
TK91, TK92 no product 
TK143, TK144 no product 
TK2, TK3 no product 
TK010 TK008: pTAK32 
Complementation of 
sco4934 knockout TK2, TK3 1442 
TK012 TK005: pTAK29  
Complementation of 
sco5204 knockout TK91, TK92 1160 
TK013 TK006: pTAK30 
Complementation of 
sco4847 knockout TK143, TK144 1720 
TK015 TK008: pIJ12057  
Plasmid only controls 
NR88, TK143  1456 
TK016 TK006: pIJ12057  NR88, TK143  1456 
TK017 TK005: pIJ12057  NR88, TK143  1456 
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Figure 6.16 Antibiotic production of the complement strains TK013 (TK006:pTAK30) (A) and 
TK010 (TK008:pTAK32) (B) respectively. A. TK006 (sco4847), TK013 (TK006: pTAK30) and 
TK016 (TK006:pIJ10257). B. TK008 (sco4934), TK012 (TK008:pTAK32) and TK015 
(TK008:pIJ10257). Approximately 10⁶ spores were inoculated. Images are representative of 
at least two biological replicates and two technical replicates. 
 
 
 
 
 
Figure 6.17 Lysozyme sensitivity of the complement strain TK013 (TK006:pTAK30). Spores 
were adjusted to 10⁸ spores/mL and a ten-fold serial dilution was carried out to get 10⁴ 
spores/mL. 5 µL of each spore stock was plated onto DNA without lysozyme (left-hand panel) 
and with 0.25 mg/mL of lysozyme (right-hand panel). Images are representative of two 
biological replicates and two technical replicates. These images are the same plates as in 
Figure 6.12.A. 
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Figure 6.18 Antibiotic sensitivity of the complement strains TK013 (TK006:pTAK30) (A), TK010 (TK008:pTAK32) (B) and TK012 (TK005:pTAK29) (C). Shown 
are the diameters of growth inhibition zones from disc diffusion assays for each complement strain against the mutant, the parent strain J1929, and the 
glycosylation deficient strains DT1025 (pmt) and DT3017 (ppm1). Mutant strains with the integrated empty vector pIJ10257 served as negative controls for 
the complementations. Bars represent the mean of at least three biological replicates except for TK006, where the bars indicate the mean of two biological 
replicates tested three times each. Error bars indicate SEM. * indicates p < 0.05 that the observed difference between the glycoprotein deficient mutant and 
the complement strain has occurred by chance. The full data set is in Table A.5, A.7 and A.8. Data shown for J1929, DT1025, DT3017 and TK006 in panel A is 
the same as for Figure 6.11.B. 
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In a further attempt to rescue the β-lactam hypersensitivity phenotype in TK005 (sco5204) it 
was decided to complement the strains with sco5204 under the control of its native 
promoter. sco5204, along with an extended upstream sequence (251 bp) to include potential 
regulatory elements, was amplified from J1929 genomic DNA by PCR and cloned into the 
HindIII site in the shuttle vector pMS82 (as described in Materials and Methods). pMS82 is 
an integrating vector similar to pIJ10257 without a promoter sequence (Gregory et al. 2003). 
The new construct, pTAK28 was confirmed by restriction digestion with PstI (expected 
fragments: 802 bp and 8793 bp) and BamHI (expected fragments: 1292 bp, 1904 bp and 6399 
bp) (Figure 6.19.A) and sequenced to confirm the presence of the correct insert. The 
construct was introduced into E. coli ET12567(pUZ8002) and then into S. coelicolor TK005 
(sco5204), as described in the Materials and Methods. The empty pMS82 vector was 
introduced into TK005 (sco5204) to serve as a negative control for the complementation. 
Genomic DNA was isolated from the exconjugates and the presence of the integrated 
plasmids were confirmed by PCR (Figure 6.19 B-C). To confirm the presence of the empty 
pMS82 vector in the TK005 (sco5204), PCR primers were designed in the S. coelicolor genome 
upstream of sco4848 and in the pMS82 vector upstream of the origin of replication (Figure 
6.19.D). To confirm the presence of pTAK28 in TK005 (sco5204) PCR primers were designed 
on the vector backbone and in the sco5204 gene (Figure 6.19.E). The PCR products observed 
from both of the TK005:pTAK28 and TK005:pMS82 exconjugates were slightly smaller than 
the expected 3022 bp (Figure 6.19.B) and 3261 bp (Figure 6.19.C) respectively. However, the 
PCR product amplified from the positive control pTAK28 was similarly smaller than expected 
suggesting that the TK005:pTAK28 exconjugates do contain the integrated pTAK28 vector 
(Figure 6.19.B). The new strains were named TK009 (TK005:pTAK28) and TK018 (TK005: 
pMS82) respectively. 
No complementation of the β-lactam hypersensitivity phenotype observed previously in the 
TK005 (sco5204) (Figure 6.11.A) was observed in the TK009 (TK005:pTAK28) strains, however 
ampicillin sensitivity was increased (Figure 6.20). Additionally, no change in rifampicin 
sensitivity was observed in the TK009 (TK005:pTAK28) strains. These results suggest that the 
changes in antibiotic sensitivity in TK005 (sco5204) compared to the parent strain J1929 may 
not be a direct result of a loss of sco5204. 
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Figure 6.19 Restriction digest analysis of pTAK28 and confirmation of vector integration into TK005 (sco5204). A. Restriction digest analysis of pTAK28 with 
PstI and BamHI-HF. B. PCR confirming pTAK28 in TK005:pTAK28 exconjugates. C. PCR confirming pMS82 in TK005:pMS82 exconjugates. D-E. PCR primer design 
to confirm pMS82 (D) and pTAK28 (E) in the exconjugates. OriT: origin of transfer; TraJ:  oriT recognising protein; Ori: origin of replication; ermEp*: ermE 
promoter.  
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Figure 6.20 Antibiotic sensitivity of the complement strain TK009 (TK005:pTAK28). Shown 
are the diameters of growth inhibition zones from disc diffusion assays for the complement 
strain against the mutant, the parent strain J1929, and the glycosylation deficient strains 
DT1025 (pmt) and DT3017 (ppm1). The mutants strain with the integrated empty vector 
pIJ10257 served as negative control for the complementation. Bars represent the mean of 
at least three biological replicates and error bars indicate SEM. * indicates p < 0.05 that the 
observed difference between the glycoprotein deficient mutant and the complement strain 
has occurred by chance. The full data set is in Table A.8. Data for J1929, DT1025, DT3017 and 
TK005 is the same as shown in Figure 6.18.C. 
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6.3 Investigating the importance of the glycosylated amino acid in the SCO4934 
glycopeptide TSQAEVDEAAAK 
 
After confirming the complementation of the β-lactam hypersensitivity phenotype in the 
sco4934 mutant (Figure 6.18) an investigation into whether changes in the glycosylated 
amino acid residue could affect the ability to complement the phenotype, was carried out. 
The SCO4934 glycopeptide, N-40-TSQAEVDEAAAK-51-C identified in the glycoproteomics 
analysis of the S. coelicolor membrane proteome (Chapter 4, Table 4.1) was shown to be 
modified with up to three hexose residues. The glycosylated residue was not identified, 
however two possible glycosylated residues reside within the glycopeptide, T40 and S41. The 
positions of the conserved domains identified in SCO4934 that are associated with L, D 
transpeptidase function (Figure 6.2) (LDT_lgD_like_2: aa 149 – 247; YukD: aa 254 – 384) 
suggest that the glycosylated residue/s in the glycopeptide N-40-TSQAEVDEAAAK-51-C are 
not involved in the enzyme’s catalytic activity. Therefore, we hypothesised that if the 
glycosylated residue/s in SCO4934 were mutated and the mutagenised genes introduced 
into TK008 (sco4934), a loss of the complementation of the β-lactam hypersensitivity could 
suggest that the glycosylation of that residue is required for the function of the protein. 
sco4934 was amplified from pTAK32 and subcloned into the small vector (~ 3 Kb) pGEM7. A 
restriction digest of the new plasmid, pTAK47 with ScaI (expected fragments: 2477 bp, 1816 
bp) and a double digest with BamHI and EcoRI (expected fragments: 1280 bp, 2963 bp) 
confirmed the presence of the insert (Figure 6.21). Using pTAK47 as a template, PCR based 
site directed mutagenesis (described in Materials and methods) was carried out to create 
amino acid substitutions of either T40, S41 or both T40 and S41 in SCO4934 to either alanine 
or valine respectively, as summarised in Figure 6.22. Alanine was selected due to its small 
and chemically inert functional group. Valine was selected since the substitution from 
threonine to valine via an exchange of a methyl group to a hydroxyl group, was the most 
conservative change in mass. The new constructs were sequenced (Figure A.22) to confirm 
the correct mutation and are summarised in Table 6.5.A. Mutated sco4934 was amplified 
from pTAK48 – pTAK53 respectively and cloned into the NdeI site of pIJ10257. The constructs 
were confirmed by restriction enzyme analysis, and are summarised in Table 6.5.B. The 
constructs were introduced into E. coli ET12567(pUZ8002) and then into S. coelicolor TK008 
(sco4934). 
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Figure 6.21 Restriction digest analysis of pTAK47 with BamHI-HF and ScaI-HF. 
 
 
 
 
 
Figure 6.22 Site directed mutagenesis of T40 and S41 amino acid residues of SCO4934 
positioned in the glycopeptide N-40-TSQAEVDEAAAK-51-C. A segment of the nucleotide 
sequence encoding sco4934 (and mutants) is shown, indicating the translation of the 
glycopeptide N-40-TSQAEVDEAAAK-51-C. Amino acid substitutions are indicated in red. 
Nucleotide base changes are indicated in blue. 
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Table 6.5 New constructs generated after site-directed mutagenesis of sco4934 (A) and 
cloning the mutagenised sco4934 in pIJ10257 for conjugation into S. coelicolor. 
 
A. 
Construct Insert Vector  Mutation 
pTAK47  sco4934 pGEM7  none (wild type) 
pTAK48 sco4934 pGEM7  T(40)A 
pTAK49 sco4934 pGEM7 S(41)A 
pTAK50 sco4934 pGEM7 T(40)A, S(41)A 
pTAK51 sco4934 pGEM7 T(40)V 
pTAK52 sco4934 pGEM7 S(41)V 
pTAK53 sco4934 pGEM7 T(40)V, S(41)V 
B. 
Construct Insert Vector  Mutation 
pTAK48.b sco4934 pIJ10257  T(40)A 
pTAK49.b sco4934 pIJ10257  S(41)A 
pTAK50.b sco4934 pIJ10257 T(40)A, S(41)A 
pTAK51.b sco4934 pIJ10257 T(40)V 
pTAK52.b sco4934 pIJ10257 S(41)V 
pTAK53.b sco4934 pIJ10257 T(40)V, S(41)V 
 
 
Table 6.6 New S. coelicolor strains generated by complementation of TK008 (sco4934) with 
constructs with mutated sco4934. 
 
S. coelicolor strain Genotype Description 
TK020 TK008: pTAK48.b sco4934 T(40)A  
TK021 TK008: pTAK49.b sco4934 S(41)A  
TK022 TK008: pTAK50.b sco4934 T(40)A, S(41)A 
TK023 TK008: pTAK51.b sco4934 T(40)V 
TK024 TK008: pTAK52.b sco4934 S(41)V 
TK025 TK008: pTAK53.b sco4934 T(40)V, S(41)V 
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Genomic DNA was isolated from the exconjugates and screened by PCR to confirm the 
presence of the integrated vector. The new S. coelicolor strains are summarised in Table 6.6. 
The sensitivity of the new strains to imipenem was assayed using disc diffusion assays (Figure 
6.23). The complementation of the imipenem hypersensitivity phenotype observed in TK010 
(sco4934:pTAK32) appeared to be lost, at least to some degree, in all of the strains 
complemented with the mutated sco4934 variants, except in TK021 (sco4934:pTAK49). This 
was most obvious in the inhibition zones at 10 µg of imipenem (Figure 6.23.B). These results 
suggest that the mutation S(41)A does not affect the function of SCO4934, possibly indicating 
that S41 is not glycosylated. In contrast, the partial loss of complementation observed after 
the mutations of the T40 to both alanine and valine (TK020 and TK023 respectively), as well 
as after the mutation of both T40 and S41 to either valine or alanine (TK022 and TK025), 
could be consistent with the glycosylation of T40. The mutation S(41)V (TK024) however, 
appeared to result in a partial loss of complementation as well. A possible explanation for 
this could be that the valine in position 41 interferes with the glycosylation of the T40 
residue, due to its slightly bulkier side chain. Taken together, these results could suggest that 
T40 is the most likely glycosylated residue in the glycopeptide N-40-TSQAEVDEAAAK-51-C. 
However, since the differences in the complementation phenotypes were extremely subtle, 
these results would require further validation. 
 
6.4 Discussion 
 
The discovery that mutants defective in protein O-glycosylation in S. coelicolor displayed 
increased sensitivity to cell-wall active antibiotics (discussed in Chapter 1) made by Howlett 
et al. (2016), led to the hypothesis that the S. coelicolor glycoproteome contained proteins 
required for cell wall biosynthesis. After the identification of several predicted cell-wall active 
glycoproteins in this work (Chapter 4), it was decided that the roles of the S. coelicolor 
glycoproteins SCO4847 (a putative D-Ala-D-Ala carboxypeptidase) and SCO4934 (a putative 
L, D transpeptidase) should be investigated. Mutants in both sco4934 and sco4847 were 
successfully generated by transposon insertion mutagenesis and validated. The mutants 
displayed no changes in colony morphology suggesting the loss of SCO4934 and SCO4847, 
had no significant impact on the growth the mutants on DNA. Similarly, no change in 
φC31cΔ25 phage sensitivity was observed in the glycoprotein deficient mutants compared 
to the parent strain, J1929. 
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Figure 6.23 Imipenem sensitivity of the strains generated by the complementation of the sco4934 strain with mutant variants of sco4934. A. Shown are 
the diameters of growth inhibition zones from disc diffusion assays for the complement strains against the sco4934 mutant (TK008) and the parent strain 
J1929. The mutant strain with the integrated empty vector pIJ10257 served as negative control for the complementation. Bars represent the mean of at least 
three biological replicates and error bars indicate SEM. The full data set is in Table A.9. B. Plates showing imipenem sensitivity of the SCO4934 mutants 
complemented with mutant variants of sco4934. All replicates are shown in Figure A.1. 
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This suggests that neither of the glycoproteins SCO4934 and SCO4847 is the φC31cΔ25 phage 
receptor, which has been suggested to be a cell-wall exposed glycoprotein in S. coelicolor 
(Cowlishaw and Smith 2001). Additionally, the glycoprotein deficient mutants displayed no 
changes in sporulation showing that the glycoproteins are not required for sporulation in S. 
coelicolor.   
The increase in susceptibility to β-lactam antibiotics, which target cell-wall biosynthesis, in 
the glycoprotein deficient mutants suggests that both proteins are required for cell wall 
biosynthesis. The antibiotic susceptibility phenotype was rescued partially upon the re-
introduction of the wild type copies of sco4934 and sco4847. The antibiotic susceptibility 
phenotype of both mutants was greater than that observed in the DT1025 (pmt) strain, 
suggesting the non-glycosylated SCO4934 and SCO4847 isoforms in DT1025 (pmt) have some 
activity. The loss of SCO4934 and SCO4847 respectively, in the glycoprotein deficient 
mutants could affect specific aspects of cell wall biosynthesis, such as the ability to form (3-
>3) crosslinks in peptidoglycan (sco4934 mutant), which makes them more susceptible to 
antibiotics. The subsequent treatment of the mutants with antibiotics which non-specifically 
target proteins required for peptidoglycan crosslinking, could further the impact on cell wall 
biosynthesis, leading to an eventual loss of cell wall integrity and cell lysis. 
The sco4847 mutant displayed a significant increase in sensitivity to lysozyme, which is 
further evidence that this protein is required for maintaining the cell-wall in S. coelicolor. The 
phenotype was rescued after the introduction of the wild type copy of sco4847. 
Streptomyces sp. are known to produce large numbers of penicillin binding proteins, most 
likely as a resistance mechanism due their synthesis of β-lactam antibiotics (Ogawara 2015). 
In the StrepDB, the S. coelicolor genome alone has 10 genes that are annotated with D-Ala-
D-Ala carboxypeptidase function (sco0830, sco3408, sco3811, sco4439, sco4847, sco5660, 
sco6131, sco7050, sco7148 and sco7607). The serious phenotypes observed in the sco4847 
deficient mutant in this work might suggest that some D-Ala-D-Ala carboxypeptidases in S. 
coelicolor, such as SCO4847 have specific roles in cell wall biosynthesis or may be required 
during specific growth stages. The SCO4847 glycopeptides identified previously by mass 
spectrometry (Chapter 4) were isolated after 20 h and 35 h of growth. This could suggest 
that SCO4847 is required for actively growing cells. However, this is purely speculative and 
requires further validation. 
The sco4934 mutant displayed no changes in sensitivity to lysozyme, suggesting that a loss 
of this protein alone is unlikely to directly affect cell wall biosynthesis. This could indicate 
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that the majority of the peptidoglycan in S. coelicolor is (4->3) crosslinked. While (3->3) 
crosslinking in S. coelicolor has been identified, the ratio of (3->3) to (4->3) crosslinking has 
not been investigated (Hugonnet et al. 2014). Another explanation could be that other 
proteins compensate for the loss of SCO4934 in the sco4934 mutant. A BLAST search of the 
SCO4934 protein sequence against the StrepDB revealed at least three other putative L, D 
transpeptidases in the S. coelicolor genome (SCO3194, SCO5458 and SCO5457).  
Despite the increase in sensitivity to β-lactam antibiotics observed in the sco5204 
glycoprotein deficient mutant, the inability to complement the mutant phenotype by the 
introduction of the wild type copy of sco5204, suggests that the phenotype is not the direct 
result of a loss of SCO5204. The distance between the stop codon of sco5204 and the start 
codon of the downstream gene sco5205 is 392 bp, suggesting that these genes are not 
translationally coupled. The start codon of the gene immediately upstream of sco5204, 
sco5203 is positioned 36 bp upstream of sco5204 on the -1 strand. However, the position of 
the transposon insertion in the sco5204 mutant was 296 bp into the sco5204 gene and 
therefore unlikely to have disrupted any regulatory elements of sco5203. It is therefore 
unclear whether the knockout of sco5204 resulted in the antibiotic sensitivity observed in 
the TK005 (sco5204-) strain. 
The complete inability to complement the Tn5062 mutation of sco5204 is an odd case. The 
complemented phenotypes of both sco4847 and sco4934 mutants were at best partial. In 
other work, the use of pIJ10257 has been problem free in complementation studies in 
Streptomyces (Hong et al. 2005; Howlett et al. 2016). Therefore, it is possible that there could 
be an unknown effect, such as gene context, that is common amongst the three genes, that 
has yet to be investigated.
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Chapter 7 – General Discussion 
 
7.1 The importance of protein O-glycosylation in S. coelicolor. 
 
The disruption of PMT family proteins in several fungal species has demonstrated that 
protein O-mannosylation is essential and that it is required for maintaining cell wall structure 
and stability, septum formation, hyphal formation and conidiation (Gentzsch and Tanner 
1996; Willer et al. 2005; Mouyna et al. 2010). Additionally, the inactivation of Pmts in S. 
cerevisiae using rhodanine-3-acetic acid derivatives resulted in the transcriptional activation 
of the cell wall integrity (CWI) pathway, a cellular response that includes the activation of 
several genes that have been implicated in cell wall assembly (Levin 2005; Arroyo et al. 2011).  
In Actinobacteria, protein O-glycosylation is thought to be similarly important for 
maintaining cell wall integrity. In M. smegmatis, pmt mutants displayed a reduced tolerance 
to cell wall stress induced by SDS treatment, suggesting changes in the cell wall (Liu et al. 
2013a). In M. tuberculosis, the culture filtrate glycoproteome is thought to consist of more 
than 40 glycoproteins, including a putative glycosyl hydrolase (Rv1096) and a beta-lactamase 
BlaC (Rv2068c) (Gonzalez-Zamorano et al. 2009; Smith et al. 2014). In S. coelicolor, mutations 
in pmt and ppm1 confer pleiotropic phenotypes with increased sensitivity to antibiotics that 
target cell wall biosynthesis (Howlett et al. 2016). The antibiotic sensitivity phenotype in the 
pmt strains was less extreme than in the ppm1 strains. However the pmt strains still 
displayed considerable sensitivity to β-lactam antibiotics and vancomycin. It was 
hypothesised that protein O-glycosylation in S. coelicolor was required for the correct 
functioning of periplasmic or membrane enzymes that are required for cell wall biosynthesis. 
The observation that the S. coelicolor glycoproteome (Chapter 4) contains several 
glycoproteins that are thought to be required for cell wall biosynthesis, supports this 
hypothesis. The phenotype of null mutants that ablate genes encoding two of these 
glycoproteins, a putative D-Ala-D-Ala carboxypeptidase (SCO4847) and an L, D 
transpeptidase (SCO4934) suggests that they are required for cell wall biosynthesis in S. 
coelicolor and that glycosylation could be affecting one or more of the enzymes’ properties. 
Since the sco4934 and sco4847 mutants displayed increased antibiotic susceptibilities 
compared to the glycosylation deficient pmt strain, it is likely that the non-glycosylated 
isoforms of the proteins have some activity in the pmt mutant. As in M. tuberculosis 
(Gonzalez-Zamorano et al. 2009; Smith et al. 2014) S. coelicolor glycosylates a large number 
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of proteins with a wide range of biological functions, including solute binding, polysaccharide 
hydrolases, ABC transporters and cell wall biosynthesis.  
The role of the glycan on each glycoprotein is still unknown but could conceivably affect 
protein activity, stability, folding or localisation. Protein glycosylation has been shown to 
have roles in maintaining protein solubility, as well as in aiding protein folding and protecting 
proteins from protease degradation (Olden et al. 1982; Harty et al. 2001). Protein N-
glycosylation was recently shown to be required to protect Campylobacter jejuni surface 
proteins from protease degradation in the chicken gut (Alemka et al. 2013). Streptomycetes 
require large numbers of extracellular enzymes such as proteases and hydrolases to enable 
survival in the soil on complex, and often insoluble organic polymers. Morphological 
development in Streptomyces is thought to be regulated by trypsin-like proteases that are 
inhibited by protease inhibitors until late in the developmental growth cycle (Kim and Lee 
1995; Kim et al. 2008). These secreted proteases are thought to be required for the digestion 
of the substrate mycelium to be used as a food source when nutrients are limited (Kang et 
al. 1995). It is possible that protein O-glycosylation in S. coelicolor is required for the 
protection of proteins against protease degradation. In the glycosylation deficient pmt strain, 
proteins could be exposed to protease degradation, potentially leading to reduced enzyme 
levels, aberrant stoichiometries and increased rates of protein turnover. This could led to 
depleted levels of some peptidoglycan biosynthetic enzymes or even a limitation in cell wall 
precursors, leading to a greater susceptibility to antibiotics that target the cell wall. This 
hypothesis could be tested by isolating one of the S. coelicolor glycoproteins identified in this 
study and its non-glycosylated isoform (from the pmt mutant) and evaluating the 
susceptibility of the proteins to protease degradation. 
 
7.2 Intracellular glycosylation in S. coelicolor. 
 
Since the early work carried out in protoplasts, it has generally been accepted that protein 
O-mannosylation in yeast is initiated on proteins as they are secreted into the ER (Larriba et 
al. 1976). This idea is supported by the fact that many fungal secreted and cell wall proteins 
have been found to be O-mannosylated (Strahl-Bolsinger et al. 1999; De Groot et al. 2005). 
Additionally, the activity of Pmt1 in S. cerevisiae (ScPmt1p) was shown to require two ER-
lumen exposed loops (loop 1 and 5) (Figure 7.1 A), further suggesting that Pmt-mediated O-
mannosylation occurs on secreted proteins in the ER lumen (Girrbach et al. 2000; Lommel et 
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al. 2011). Analogously in mycobacteria, protein O-mannosylation was shown to be coupled 
to protein translocation via the SEC pathway and secreted glycoproteins have been 
characterised in several actinomycetes, including M. tuberculosis, Corynebacterium 
glutamicum (C. glutamicum) and S. coelicolor (Dobos et al. 1995; Dobos et al. 1996; Michell 
et al. 2003; Mahne et al. 2006; Wehmeier et al. 2009; Smith et al. 2014; VanderVen et al. 
2005) .  
While 33 of the S. coelicolor glycoproteins identified in this study are consistent with the 
dogma that protein O-glycosylation in Actinobacteria is coupled to protein secretion 
(discussed in Chapter 4), five of the glycoproteins identified here had no predicted 
transmembrane domains or secretory signals, suggesting that they could be intracellular 
proteins (Chapter 4, Table 4.6). While it is probable that these intracellular proteins may be 
associated with the inner membrane, these findings could suggest that glycosylation may 
also possible on the cytoplasmic face of the membrane in S. coelicolor. Additionally, some 
glycopeptides belonging to membrane glycoproteins identified in this study (SCO2963, 
SCO4141, SCO4256, SCO4968 and SCO4548), are located in regions predicted to be on the 
cytoplasmic face of the membrane.  
Membrane proteins are generally targeted to the SEC machinery as a ribosome nascent chain 
complex for integration into the membrane (Driessen and Nouwen 2008). They are 
recognised by a signal recognition particle (SRP) that binds directly to hydrophobic 
transmembrane segments of the nascent polypeptide chain and are targeted to the SecYEG 
protein conducting channel, in a cotranslational manner. If protein O-glycosylation in S. 
coelicolor is coupled to protein translocation via the SEC machinery, as has been described 
in mycobacteria (VanderVen et al. 2005), it is possible that during membrane protein 
translocation and insertion, loops destined for the cytoplasm come into contact with the 
glycosylation machinery before they are correctly localised on the cytoplasmic face of the 
membrane. Another possibility to consider is that the membrane protein topology could 
have been incorrectly predicted by the TMHMM algorithm. The authors of the TMHMM 
Server v 2.0 found that inverse topology predictions occurred approximately 7 % of the time 
in a test data set of 160 proteins and that this was one of the most common mistakes made 
by the program, when predicting the topology of a protein with a single transmembrane 
domain (Krogh et al. 2001). Three out of the five membrane proteins identified in this study, 
as having a glycopeptide located in regions predicted in the cytoplasm have only a single 
predicted transmembrane domain (SCO2963, SCO4256, SCO4968). 
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The O-glycosylation of intracellular proteins in S. coelicolor could suggest that protein O-
glycosylation is possible on the cytoplasmic face of the membrane. The enzymatic activity of 
ScPmt1p was previously shown to require two arginine residues located within 
transmembrane domains 1 and 2 (Figure 7.1.A), an aspartic acid and glutamic acid residue 
(DE motif) in the ER facing loop 1, and a large ER facing loop 5 (Girrbach et al. 2000). The DE 
motif forms part of the enzyme’s catalytic site and is crucial for acceptor peptide binding, 
suggesting that substrate binding occurs in the ER lumen (Lommel et al. 2011). Similarly, the 
DE motif was shown to be required for the activity of Pmt in M. tuberculosis (VanderVen et 
al. 2005). The Arg residues and the DE motif are conserved in Pmt from M. tuberculosis and 
S. coelicolor (Figure 7.1.D) and are located in similar topological positions to those in ScPmt1p 
(Figure 7.1.B-C). These findings suggest that similarly to ScPmt1p, loop 1 in Pmt from 
Actinomycetes is required for acceptor peptide binding and that this process occurs in the 
periplasm. It is therefore unclear how cytoplasmic proteins might be glycosylated by Pmt in 
S. coelicolor. One possibility is that another glycosyltransferase has a role in the glycosylation 
of proteins on the cytoplasmic face of the membrane in S. coelicolor. The putative integral 
membrane protein, SCO4023 was identified previously as a pmt homologue in S. coelicolor 
(Varghese 2008). A CDD database search found that the protein has a PMT_2 superfamily 
domain (e = 7.78e-30) that belongs to dolichol phosphate mannose-protein 
mannosyltransferases (CDD database). This protein has thirteen predicted transmembrane 
domains, suggesting that it might be a part of the GT-C glycosyltransferase family like Pmt. 
sco4023 mutants in S. coelicolor were previously shown to display no changes in growth or 
phiC31 phage sensitivity compared to the wild type J1929 strain, suggesting that SCO4023 
was not required for the glycosylation of the extracellular phiC31 phage receptor (Varghese 
2008).  
However, the presence of a pmt homologue in S. coelicolor would not explain the absence 
of Con A-HRP reactivity in the membrane and soluble protein fractions isolated from the S. 
coelicolor pmt (DT1025) mutants (Chapter 3, Figure 3.9). Another possibility is that a 
cytoplasmic facing domain in the S. coelicolor Pmt can also catalyse glycosyltransferase 
activity. The cytoplasmic N-terminal domain of S. coelicolor Pmt contains a DE motif and is 
extended by 55 amino acids in comparison to its M. tuberculosis homologue (Figure 7.1.D). 
This might suggest that it has a function that is unique to S. coelicolor.  
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Figure 7.1 Models of Pmts from S. cerevisiae (A), M. tuberculosis (B) and S. coelicolor (C). A. ScPmt1p based on the work of Girrbach et al. (2000). B. A model 
of Mt-Pmt as described by VanderVen et al. (2005). C. A model of S. coelicolor Pmt (SCO3154). The membrane topology was predicted using the TMPred 
algorithm. Amino acid residues predicted in the transmembrane domains are indicated. The conserved Arg residues (R) and DE motif are indicated. D. Amino 
acid sequence alignment of Pmt1p, Pmt2p and Pmt4p from S. cerevisiae, as well as Pmts from M. tuberculosis (Rv1002c) and S. coelicolor (SCO3154). 
Conserved Arg residues and the DE motif are highlighted in red.   
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An in depth characterisation of the various domains of the S. coelicolor Pmt, similar to the 
work carried out by Girrbach et al. (2000) on ScPmt1p in yeast, could help to test this 
hypothesis. 
 
7.3 Glycosylation of folded proteins in S. coelicolor 
 
In addition to the O-mannosylation of unfolded eukaryotic proteins as they are translocated 
into the ER lumen, Pmt mediated glycosylation of misfolded proteins after they have been 
translocated into the ER has been demonstrated (Harty et al. 2001). These findings led to the 
proposal that surface exposed O-mannosylation acceptor sites within misfolded proteins are 
modified after prolonged ER residence, as a protein quality control mechanism. In 
mycobacteria, protein O-glycosylation was shown to be coupled to protein translocation via 
the SEC pathway, suggesting that protein O-glycosylation occurs on unfolded proteins 
(VanderVen et al. 2005). In contrast, a number of the S. coelicolor glycoproteins identified in 
this study (Chapter 4, Table 4.3) are predicted to contain TAT pathway signal peptides. The 
TAT protein transport system functions to secrete folded proteins across the cytoplasmic 
membrane and to insert some integral membrane proteins into the membrane (Berks et al. 
2003). The pathway is well characterised in S. coelicolor and it is known to translocate large 
numbers of lipoproteins (Widdick et al. 2006; Thompson et al. 2010). SCO4934, a 
glycoprotein and predicted TAT substrate identified in this study, was experimentally verified 
as a TAT substrate by Thompson et al. (2010) after it was shown to be absent from S. 
coelicolor ΔtatC strains. The translocation of glycoproteins via the TAT pathway in S. 
coelicolor suggests that glycosylation is also possible on folded glycoproteins. Considering 
that Pmt mediated protein O-mannosylation of misfolded proteins occurs in yeast (Harty et 
al. 2001), it is plausible that the glycosylation of folded proteins in S. coelicolor is Pmt 
mediated. One could hypothesise that the glycosylation occurs on surface exposed regions 
of the protein or in flexible loops that link secondary structure elements.  
 
7.4 NetOGlyc for the prediction of O-glycosylation sites in Actinobacteria. 
 
While a consensus sequence for protein N-glycosylation has been defined in eukaryotes (N-
X-S/T) and prokaryotes (D/E-X-N-X-S/T), little is known about the consensus sequence 
required for protein O-glycosylation. The NetOGlyc algorithm was developed for the 
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prediction of eukaryotic, mucin type O-glycosylation sites and is based on the amino acid 
sequence context (Hansen et al. 1998). The glycosylation of mucin-like proteins occurs on 
serine and threonine residues, in serine, threonine and proline rich sequences (Varki et al. 
2009). Herrmann et al. (2000) found that the NetOGlyc algorithm correctly predicted 8 out 
of 11 O-glycosylation sites in mycobacterial glycoproteins. Additionally, they found that the 
amino acids flanking the glycosylation sites were important, and that they often contained 
alanine and proline.  
While no definitive O-glycosylation consensus sequence in S. coelicolor was identified in this 
study, a higher propensity for alanine, proline and glycine was observed in sequences 
surrounding the O-glycosylation sites (Chapter 4, Figure 4.11). However, out of the eighteen 
O-glycosylation sites identified in thirteen of the S. coelicolor glycoproteins, only 27 % were 
correctly identified by the NetOGlc algorithm. A recent characterisation of the culture filtrate 
glycoproteome in M. tuberculosis led to the identification of thirteen glycoproteins, in which 
eight had validated glycosylation sites (Smith et al. 2014). Interestingly, around 76 % of the 
glycosylation sites were correctly predicted by the NetOGlyc algorithm. These findings 
suggest that while the NetOGlyc algorithm might perform well when predicting O-
glycosylation in mycobacterial glycoproteins, it is not particularly accurate for the prediction 
of S. coelicolor O-glycosylation sites. This observation is supported by the fact that NetOGlyc 
predicted O-glycosylation sites in the putative S. coelicolor glycoprotein SCO4471 could not 
be experimentally verified by mass spectrometry (Chapter 3, Table 3.1). However, it is worth 
noting that many of these mycobacterial O-glycosylation sites (10 out of 17) were clustered 
along the sequence. Mucin type O-glycosylation sites were often found to be clustered in the 
NetOGlyc algorithm training dataset (Hansen et al. 1998). Therefore, it could be possible that 
if O-glycosylation sites in Actinobacterial glycoproteins are clustered in serine/threonine rich 
sequences, they are more likely to be identified by the NetOGlyc algorithm. Based on these 
findings, I propose that there is a real requirement for an algorithm that can predict protein 
O-glycosylation sites in Actinobacterial glycoproteins. This would require the further 
identification of novel Actinobacterial glycoproteins and the definitive characterisation of 
more O-glycosylation sites. The characterisation of the S. coelicolor glycoproteome 
presented in this study would undoubtedly make a significant contribution to this. 
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7.5 Glycan chain elongation in S. coelicolor. 
 
In yeast, while protein O-mannosylation is initiated by Pmt in the ER, the glycans can undergo 
further extension in the Golgi apparatus (Loibl and Strahl 2013). In S. cerevisiae, the glycan is 
extended by α-1,2 mannosyltransferases of the KTR family to form α-1,2-linked mannobiose 
and mannotriose (Lussier et al. 1999). Then, an MNN1-family α-1,3 mannosyltransferase can 
further extend the glycan by the addition of α-1,3-linked mannose to form an oligosaccharide 
that generally contains five mannose residues. Similarly, in M. tuberculosis Pmt is thought to 
catalyse the first step of protein O-mannosylation, while extension is thought to be carried 
out by an additional glycosyltransferase, PimE (VanderVen et al. 2005; Liu et al. 2013a). In 
M. tuberculosis, the 45/47 kDa secreted antigen (Apa) was shown to be modified with α1,2 
linked mannobiose and mannotriose glycans (Dobos et al. 1996). PimE, a putative PPM-
dependent α1,2-mannosyltransferase was shown to be required for the elongation of the 
glycan moiety on the glycoprotein FasC in M. smegmatis (Liu et al. 2013a). pimE mutants in 
M. smegmatis could be complemented with pimE (Rv1159) from M. tuberculosis, suggesting 
that glycan chain elongation by PimE also occurs in M. tuberculosis. 
I have shown that 2-linked, 4-linked and terminal mannose are components of the glycans 
that modify S. coelicolor glycoproteins (Chapter 5). Additionally, there was preliminary 
evidence of an O-linked trisaccharide, where the reducing residue was substituted via a 1,2 
linkage, and a disaccharide with a 1,4 linkage. These findings suggest that the glycans on S. 
coelicolor glycoproteins could be different to those present in M. tuberculosis, based on the 
linkages present. In M. bovis, glycans modifying the glycoprotein MBP83 are composed of 
α1,3-linked mannobiose and mannose, suggesting that there is even variability in the glycan 
linkages between mycobacteria spp. It is possible that the glycans on S. coelicolor 
glycoproteins are extended sequentially, in a fashion that is similar to M. tuberculosis. A pimE 
homologue in S. coelicolor (SCO2335) has been identified. S. coelicolor sco2335 mutants 
displayed a slight increase in sensitivity to vancomycin, ampicillin, rifampicin and imipenem 
when compared to the wildtype strain J1929. However no change in phiC31 phage sensitivity 
was observed (R. Howlett. Unpublished). These findings could suggest that a lack of extended 
glycans on S. coelicolor glycoproteins might not drastically affect glycoprotein function. 
Alternately, there may be other glycosyltransferases involved. According to the CAZy 
database, there are more than 50 proteins identified as glycosyltransferases in the S. 
coelicolor genome, many of which are genes that have not yet been characterised. It would 
be interesting to identify the glycosyltransferases responsible for the formation of 1,2 and 
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1,4 linkages in S. coelicolor glycoproteins, as well as to understand the factors that influence 
the formation of certain glycosidic linkages over others and essentially whether these 
contribute to the overall role of the glycan. 
 
7.6 A revised model for protein O-glycosylation for in S. coelicolor 
 
Based on the work reported in this thesis, I present a revised model for protein O-
glycosylation in S. coelicolor (Figure 7.2). I have demonstrated that S. coelicolor has a 
glycoproteome consisting of glycoproteins with a variety of functions, including cell wall 
biosynthesis, transport and solute binding. Some of the glycoproteins identified here are 
predicted to be translocated via the TAT pathway, suggesting that protein O-glycosylation in 
S. coelicolor is possible on folded proteins. I have hypothesised that this process is Pmt 
mediated, although this remains to be experimentally validated. I have presented 
preliminary evidence that S. coelicolor glycoproteins are modified glycans that are composed 
of 2-linked, 4-linked and terminal mannose and I therefore propose that there may be other 
glycosyltransferases required for glycan extension. The S. coelicolor homologue (SCO2335) 
of pimE in M. tuberculosis could be involved in glycan chain extension. However, this remains 
to be experimentally validated. Additionally, I have shown that some putative intracellular 
proteins are glycosylated and I have hypothesised that this could be Pmt mediated. However, 
a full characterisation of S. coelicolor Pmt is required to understand the roles of the different 
functional domains of the protein and to further investigate its role, if any in the glycosylation 
of proteins on the cytoplasmic face of the membrane. 
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Figure 7.2 A revised model of protein O-glycosylation in S. coelicolor.
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A.1 List of primers 
Table A.1 Primers used for PCR and sequencing 
Primer Sequence Description 
TK2 GTGCGGGGAGGATCTGAC  forward primer pIJ10257  
TK3 CCAACGTCATCTCGTTCTCC reverse primer pIJ10257  
F_pGEM7-test: TGCAAGGCGATTAAGTTGGG pGEM7 sequencing primer 
R_pGEM7-seq GCGTTGGATGCATAGCTTGA pGEM7 sequencing primer 
NR88 CGTGCGGCGATACTGAAA C 
binds upstream of the phiBT1 attB 
site in S. coelicolor 
TK33 GGGAACCGAGTAAACGATGA 
Forward primer - for the generation 
of probe for southern blotting to 
confirm sco5204 mutant  
TK34 ACGAGTAGTGGACCGACCTG 
Reverse primer - for the generation of 
probe for southern blotting to 
confirm sco5204 mutant  
TK82 CGGTCGTAGCGTTGAAAGTT 
Forward primer - for the generation 
of probe for southern blotting to 
confirm sco4934 mutant  
TK83 GAGTTGTTGATGGAGGCGTT 
Reverse primer - for the generation of 
probe for southern blotting to 
confirm sco4934 mutant  
TK85 
CCTAGGATCCAAGCTTCC 
GGAGACGTACTCGTCGAT 
Forward primer - cloning sco5204 
into pMS82 
TK86 
GCATAGATCTAAGCT 
TTCAGCCGGTGTCCGCTCC 
Reverse primer - cloning sco5204 into 
pMS82 
TK87 CCGTCCCCAATACGAAGGAG 
Forward primer - confirming sco4847 
mutants by PCR 
TK88 CTCCCAGTGCGCGTTGT 
Reverse primer - confirming sco4847 
mutants by PCR 
TK91 CAAGGTCCTGGTGAGCTACG 
Forward primer - confirm S. coelicolor 
genome integration of pTAK29 
TK92 GCTACAAAATCACGGGCGTC 
Reverse primer - confirm S. coelicolor 
genome integration of pTAK29 
TK93 
ACAGGAGGCCCCATC 
TGATGCCGGACCGCGGCGGA 
Forward primer - cloning sco5204 
into pIJ10257 
TK94 
ACTCGAGATCTCATA 
TGTCAGCCGGTGTCCGCTCC 
Reverse primer - cloning sco5204 into 
pIJ10257 
TK97 
ACAGGAGGCCCCATAT 
GGTGCCCGCTCCCAAGAAG 
Forward primer - cloning sco4847 
into pIJ10257 
TK98 
ACTCGAGATCTCATA 
TGGGCAGCAAGGCGCAGGAA 
Reverse primer - cloning sco4847 into 
pIJ10257 
TK101 
ACAGGAGGCCCCATATGA 
TGACGGACGGTAAGCGG 
Forward primer - cloning sco4934 
into pIJ10257 
TK102 
ACTCGAGATCTCATATGT 
CAGACCGCCGAACCCGC 
Reverse primer - cloning sco4934 into 
pIJ10257 
TK109 GCCGTTGATCGTGCTATGA Forward primer pMS82 
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Primer Sequence Description 
TK110 CGCCAGTGGTATTTATGTC Reverse primer pMS82 
TK116 
GGGGGTGGGGACAAG 
GCCTCGCAGGCCGAGG 
Forward primer - SDM of sco4934  
T(40)A 
TK117 GGAGGTGCCGGCGTCGCT 
Reverse primer - SDM of sco4934  
T(40)A 
TK143 ACGTCCATGCGAGTGTCC 
forward primer - to confirm 
integration of pTAK30 into the S. 
coelicolor genome 
TK144 CCAAACGGCATTGAGCGTC 
Reverse primer - to confirm 
integration of pTAK30 into the S. 
coelicolor genome 
TK160 
GGAATTCGGTACCCCAT 
GACGGACGGTAAGCGG 
Forward primer - cloning sco4934 
into pGEM7 
TK161 
ATCGATTTCGAACCCTC 
AGACCGCCGAACCCGC 
Reverse primer - cloning sco4934 into 
pGEM7 
TK203 
CTCCGGGGGTGGGGAC 
AAGGCCGCGCAGGCCGAGGTC
GAC 
Forward primer - SDM of sco4934  
T(40)A, S(41)A 
TK204 GTGCCGGCGTCGCTACTG 
Reverse primer - SDM of sco4934  
T(40)A, S(41)A 
TK205 
CCTCCGGGGGTGGGGA 
CAAGGTCTCGCAGGCCGAGGTC
G 
Forward primer - SDM of sco4934  
T(40)V 
TK206 TGCCGGCGTCGCTACTGGA 
Reverse primer - SDM of sco4934  
T(40)V 
TK207 
CCGGGGGTGGGGA 
CAAGACCGTGCAGGCCGAGGTC
G 
Forward primer - SDM of sco4934  
S(41)V 
TK208 AGGTGCCGGCGTCGCTACT 
Reverse primer - SDM of sco4934  
S(41)V and S(41)A 
TK209 
CCTCCGGGGGTGGGGA 
CAAGGTCGTGCAGGCCGAGGTC
GAC 
Forward primer - SDM of sco4934  
T(40)V, S(41)V 
TK210 TGCCGGCGTCGCTACTGG 
Reverse primer - SDM of sco4934  
T(40)V, S(41)V 
TK211 
CCGGGGGTGGGGACAA 
GACCGCGCAGGCCGAGGTCG 
Forward primer - SDM of sco4934  
S(41)A 
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A.2 Antibiotic susceptibility disc diffusion assays 
Table A.2 Antibiotic susceptibility of S. coelicolor J1929, DT1025 (pmt) and DT3017 (ppm1) on DNA assayed by disc diffusion. Raw data for three biological 
replicates including the zone of growth inhibition (mm), mean (AVERAGE), standard error of the mean (SEM) and p-value of a two-sample t-test assuming 
unequal variances between samples. 
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Table A.3 Antibiotic susceptibility of S. coelicolor J1929, DT1025 (pmt) and DT3017 (ppm1) on F134 agar assayed by disc diffusion. Raw data for three 
biological replicates including the zone of growth inhibition (mm), mean (AVERAGE), standard error of the mean (SEM) and p-value of a two-sample t-test 
assuming unequal variances between samples. 
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Table A.4 Antibiotic susceptibility of S. coelicolor TK005 (sco5204) compared to the parent strain J1929, DT1025 (pmt) and DT3017 (ppm1) on DNA assayed 
by disc diffusion. Raw data is for three biological replicates including the zone of growth inhibition (mm), mean (AVERAGE), standard error of the mean (SEM) 
and p-value of a two-sample t-test assuming unequal variances between samples. 
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Table A.5 Antibiotic susceptibility of S. coelicolor TK006 (sco4847), TK013 (sco4847: pTAK30) and TK016 (sco4847: pIJ10257), compared to the parent strain 
J1929, DT1025 (pmt) and DT3017 (ppm1) on DNA assayed by disc diffusion. Raw data is for at least three biological replicates, except for TK006 where the 
mean of 2 biological replicates tested three times is shown. Includes the zone of growth inhibition (mm), mean (AVERAGE), standard error of the mean (SEM) 
and p-value of a two-sample t-test assuming unequal variances between samples. 
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Table A.6 Antibiotic susceptibility of S. coelicolor TK008 (sco4934) compared to the parent strain J1929, DT1025 (pmt) and DT3017 (ppm1) on DNA assayed 
by disc diffusion. Raw data is for at least three biological replicates including the zone of growth inhibition (mm), mean (AVERAGE), standard error of the 
mean (SEM) and p-value of a two-sample t-test assuming unequal variances between samples. 
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Table A.7 β-lactam antibiotic susceptibility of S. coelicolor TK008 (sco4934), TK010 (sco4934: pTAK32) and TK015 (sco4934: pIJ10257), compared to the 
parent strain J1929, DT1025 (pmt) and DT3017 (ppm1) on DNA assayed by disc diffusion. Raw data is for at least three biological replicates, including the 
zone of growth inhibition (mm), mean (AVERAGE), standard error of the mean (SEM) and p-value of a two-sample t-test assuming unequal variances between 
samples. 
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Table A.8 Antibiotic susceptibility of S. coelicolor TK005 (sco5205), TK009 (sco5204: pTAK28), TK018 (sco5204: pMS82), TK012 (sco5204: pTAK29) and TK017 
(sco5204: pIJ10257) compared to the parent strain J1929, DT1025 (pmt) and DT3017 (ppm1) on DNA assayed by disc diffusion. Raw data is for three 
biological replicates, including the zone of growth inhibition (mm), mean (AVERAGE), standard error of the mean (SEM) and p-value of a two-sample t-test 
assuming unequal variances between samples. 
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Table A.9 Imipenem sensitivity of the strains generated by the complementation of the sco4934 knockout strain with mutant variants of sco4934 assayed 
by disc diffusion assays. Raw data is for at least three biological replicates, including the zone of growth inhibition (mm), mean (MEAN), standard error of the 
mean (SEM) and p-value of a two-sample t-test assuming unequal variances between samples. 
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Figure A.1 Imipenem sensitivity of the strains generated by the complementation of the 
sco4934 mutant with mutant variants of sco4934. 
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A.3 Identification of putative glycoproteins and deglycosylation analysis 
Table A.10 Protein identification summary of the ~ 45 kDa band enriched from the J1929 culture filtrate (a) and membrane (b). 
a) gi|21222858    Mass: 46976    Score: 441    Matches: 8(8)  Sequences: 8(8) 
 hypothetical protein SCO4471 [Streptomyces coelicolor A3(2)] 
 Peptide Observed m/z Expected MW  
Calculated 
MW    ppm   Miss  Score  Expect  
 R.YDASSPGGR.Q 909.3867 908.3794 908.3988 -21.3 0 43 5.70E-03 
 R.TPCLLGQDR.L 1073.533 1072.5257 1072.5335 -7.31 0 52 1.80E-03 
 R.LYDPPNNPR.G 1085.5369 1084.5296 1084.5301 -0.5 0 49 2.90E-03 
 K.APAYNYPGWR.E 1194.5698 1193.5625 1193.5618 0.65 0 67 3.80E-05 
 R.GASDIGYLTDEHIK.A 1518.73 1517.7227 1517.7362 -8.88 0 105 7.50E-09 
 F.SWDGAGEVGNGLFPR.F 1561.7313 1560.724 1560.7321 -5.17 0 111 1.80E-09 
 R.FLDLAQEHGAHMTFF.L 1763.7933 1762.7861 1762.8137 -15.7 0 104 7.10E-09 
 R.QFTDWLDVQKPEVLAK.L 1916.9784 1915.9711 1916.0044 -17.4 0 140 1.80E-12 
 
 b) gi|21222858    Mass: 47147    Score: 477    Matches: 6(6)  Sequences: 4(4) 
 hypothetical protein SCO4471 [Streptomyces coelicolor A3(2)] 
 Peptide Observed m/z Expected MW  Calculated MW    ppm   Miss  Score  Expect  
 K.APAYNYPGWR.E 1194.5898 1193.5826 1193.5618 17.4 0 67 3.90E-06 
 K.APAYNYPGWR.E 1210.5829 1209.5756 1209.5567 15.6 0 -37 3.70E-03 
 R.TVEVGQRPAGGWNAFLK.E 1829.9786 1828.9714 1828.9584 7.08 0 95 6.80E-09 
 R.TVEVGQRPAGGWNAFLK.E 1845.9647 1844.9574 1844.9533 2.23 0 -46 5.80E-04 
 R.QFTDWLDVQKPEVLAK.L 1917.0106 1916.0033 1916.0044 -0.53 0 127 3.80E-12 
 R.TNSGWTDLPSLPFDYDKELVGGR.T 2567.2017 2566.1944 2566.234 -15.4 1 188 3.60E-18 
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Table A.11 MASCOT search results summary of trypsin and Asp-N digested SCO4471 analysed by LC-MS. Fixed modifications indicated in the MASCOT 
search: Carbamidomethyl (C). Variable modifications indicated in the MASCOT search: Oxidation (M), Ser->Diamino-propanoate (S), Thr->Diamino-butyrate 
(T).  
 
Observed 
m/z 
Expected 
MW  
Calculated 
MW   ppm Peptide e-value Peptide sequence 
632.3151 1262.6156 1262.6143 1.03 4.20E-02 K.APAKPIGDGSTSY.T 
517.2666 1548.778 1548.7784 -0.26 2.30E-06 K.APAKPIGDGSTSYTGK.Q 
775.3974 1548.7802 1548.7784 1.21 1.60E-06 K.APAKPIGDGSTSYTGK.Q 
517.2704 1548.7893 1548.7784 7.07 2.00E-02 K.APAKPIGDGSTSYTGK.Q 
775.4043 1548.794 1548.7784 10.1 4.60E-03 K.APAKPIGDGSTSYTGK.Q 
517.2721 1548.7945 1548.7784 10.4 1.80E-06 K.APAKPIGDGSTSYTGK.Q 
691.353 1380.6915 1380.6885 2.17 1.30E-05 P.AKPIGDGSTSYTGK.Q 
691.3542 1380.6939 1380.6885 3.94 4.90E-03 P.AKPIGDGSTSYTGK.Q 
461.2388 1380.6946 1380.6885 4.39 2.10E-03 P.AKPIGDGSTSYTGK.Q 
461.2404 1380.6992 1380.6885 7.77 6.80E-03 P.AKPIGDGSTSYTGK.Q 
591.7857 1181.5569 1181.5564 0.35 1.20E-02 K.PIGDGSTSYTGK.Q 
969.4952 1936.9759 1936.9935 -9.07 5.90E-03 P.DAPVPLEPGQTPPQFVVF.S 
969.5079 1937.0013 1936.9935 4.04 7.90E-05 P.DAPVPLEPGQTPPQFVVF.S 
969.5109 1937.0072 1936.9935 7.06 1.10E-02 P.DAPVPLEPGQTPPQFVVF.S 
686.8054 1371.5963 1371.5878 6.22 3.60E-02 L.DLAQEHGAHMTF.F + Oxidation (M) 
752.3353 1502.6561 1502.6613 -3.43 5.40E-05 L.DLAQEHGAHMTFF.L 
760.335 1518.6554 1518.6562 -0.53 3.90E-03 L.DLAQEHGAHMTFF.L + Oxidation (M) 
760.3384 1518.6623 1518.6562 4.05 1.10E-02 L.DLAQEHGAHMTFF.L + Oxidation (M) 
683.8837 1365.7528 1365.7544 -1.17 3.20E-03 F.FLSGLYLLPESK.K 
Appendix 
225 
Observed 
m/z 
Expected 
MW  
Calculated 
MW   ppm Peptide e-value Peptide sequence 
683.8856 1365.7566 1365.7544 1.6 1.90E-02 F.FLSGLYLLPESK.K 
610.3508 1218.6871 1218.686 0.94 1.80E-04 F.LSGLYLLPESK.K 
610.3522 1218.6898 1218.686 3.15 7.40E-05 F.LSGLYLLPESK.K 
610.3532 1218.6919 1218.686 4.85 1.20E-03 F.LSGLYLLPESK.K 
553.8087 1105.6029 1105.6019 0.89 4.90E-04 L.SGLYLLPESK.K 
553.8099 1105.6052 1105.6019 2.98 4.10E-05 L.SGLYLLPESK.K 
510.2933 1018.572 1018.5699 2.09 3.90E-04 S.GLYLLPESK.K 
510.2935 1018.5724 1018.5699 2.51 7.80E-03 S.GLYLLPESK.K 
759.876 1517.7374 1517.7362 0.81 3.00E-04 R.GASDIGYLTDEHIK.A 
759.8782 1517.7418 1517.7362 3.7 1.00E-03 R.GASDIGYLTDEHIK.A 
506.9219 1517.7438 1517.7362 5.02 1.10E-02 R.GASDIGYLTDEHIK.A 
695.8464 1389.6783 1389.6776 0.52 9.30E-03 A.SDIGYLTDEHIK.A 
652.3275 1302.6405 1302.6456 -3.91 7.60E-03 S.DIGYLTDEHIK.A 
652.3293 1302.6441 1302.6456 -1.1 1.70E-04 S.DIGYLTDEHIK.A 
387.7295 773.4444 773.4395 6.24 2.10E-02 K.ATLTNVR.R 
506.7271 1011.4396 1011.441 -1.4 7.90E-04 L.DGHEIGTHF.N 
576.2925 1150.5704 1150.5618 7.44 2.30E-03 F.DYDKELVGGR.T 
576.2928 1150.571 1150.5618 7.98 3.30E-02 F.DYDKELVGGR.T 
455.2057 908.3969 908.3988 -2.11 7.60E-04 R.YDASSPGGR.Q 
455.2071 908.3996 908.3988 0.85 8.80E-04 R.YDASSPGGR.Q 
455.208 908.4015 908.3988 2.93 1.20E-03 R.YDASSPGGR.Q 
455.2082 908.4018 908.3988 3.26 1.40E-03 R.YDASSPGGR.Q 
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Observed 
m/z 
Expected 
MW  
Calculated 
MW   ppm Peptide e-value Peptide sequence 
455.2085 908.4024 908.3988 3.94 1.10E-02 R.YDASSPGGR.Q 
455.2085 908.4024 908.3988 3.94 9.20E-05 R.YDASSPGGR.Q 
455.2095 908.4044 908.3988 6.15 4.80E-05 R.YDASSPGGR.Q 
455.2096 908.4047 908.3988 6.49 2.20E-03 R.YDASSPGGR.Q 
455.2117 908.4088 908.3988 11 3.30E-03 R.YDASSPGGR.Q 
455.2117 908.4089 908.3988 11.1 1.60E-02 R.YDASSPGGR.Q 
681.3679 1360.7213 1360.7139 5.4 8.70E-04 W.DLPLQQIPFPGH.S 
681.3709 1360.7271 1360.7139 9.7 1.30E-04 W.DLPLQQIPFPGH.S 
798.4073 1594.8001 1594.8144 -8.93 1.50E-02 W.DLPLQQIPFPGHSF.E 
798.4163 1594.818 1594.8144 2.24 3.10E-06 W.DLPLQQIPFPGHSF.E 
798.4169 1594.8193 1594.8144 3.08 1.00E-03 W.DLPLQQIPFPGHSF.E 
1086.0393 2170.0641 2170.0769 -5.91 5.20E-04 W.DLPLQQIPFPGHSFEVLSM.D + Oxidation (M) 
1086.0513 2170.088 2170.0769 5.11 1.50E-03 W.DLPLQQIPFPGHSFEVLSM.D + Oxidation (M) 
597.7886 1193.5627 1193.5618 0.8 2.70E-02 K.APAYNYPGWR.E 
597.791 1193.5675 1193.5618 4.79 9.60E-04 K.APAYNYPGWR.E 
513.7422 1025.4698 1025.4719 -2.02 7.90E-03 P.AYNYPGWR.E 
393.2128 784.411 784.4119 -1.2 8.20E-03 K.AYISGFK.R 
393.2131 784.4117 784.4119 -0.27 2.80E-03 K.AYISGFK.R 
393.2155 784.4164 784.4119 5.73 2.40E-04 K.AYISGFK.R 
393.2182 784.4218 784.4119 12.6 1.00E-04 K.AYISGFK.R 
563.8278 1125.641 1125.6394 1.43 1.40E-02 L.DVQKPEVLAK.L 
563.829 1125.6435 1125.6394 3.71 1.70E-04 L.DVQKPEVLAK.L 
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Observed 
m/z 
Expected 
MW  
Calculated 
MW   ppm Peptide e-value Peptide sequence 
376.2223 1125.645 1125.6394 5.05 3.10E-02 L.DVQKPEVLAK.L 
563.83 1125.6455 1125.6394 5.44 1.10E-03 L.DVQKPEVLAK.L 
376.223 1125.6471 1125.6394 6.84 1.20E-02 L.DVQKPEVLAK.L 
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Table A.12 Bioinformatic predictions of candidate glycoproteins enriched by Con A affinity chromatography. Candidate glycoproteins were searched 
through the bioinformatics tools indicated in order to classify the proteins. Searches were carried out on the 12/07/2016. 
 
SCO 
number 
LipoP 1.0 
¹ 
LipoP 
1.0 
score 
SignalP 
4.1 
SignalP 
4.0  
D-score ² TMHMM 2.0 ³ 
Number of 
predicted 
transmembrane 
helices PRED_LIPO ⁴ TatP 1.0 ⁵ 
TATP.1.0 
D-score Overall verdict 
SCO5204 - - N 0.177 Y 7 membrane N 0.282 membrane protein 
SCO4856 - - N 0.175 N - cytoplasmic N 0.206 cytoplasmic protein 
SCO4471 SpII 21.718 Y 0.612 Y 1 lipoprotein Y 0.610 lipoprotein 
SCO4142 SpII 26.798 Y 0.661 N - lipoprotein N 0.322 lipoprotein 
SCO6009 SpII 18.197 Y 0.671 N - lipoprotein N 0.217 lipoprotein 
SCO1796 - - N 0.161 Y 1 membrane N 0.053 membrane protein 
SCO5776 SpI 21.851 Y 0.820 N - lipoprotein N 0.173 lipoprotein 
 
¹ LipoP 1.0 software produces predictions of lipoproteins (http://www.cbs.dtu.dk/services/LipoP/). SpI denotes SEC signal peptide; SpII denotes lipoprotein 
² SignalP 4.1 software predicts the presence of a signal peptide (http://www.cbs.dtu.dk/services/SignalP/). D-score is a score used to discriminate signal 
peptides from non-signal peptides. Scores > 0.450 indicate a signal peptide. 
³ TMHMM 2.0 software predicts the presence of transmembrane helices in a protein sequence (http://www.cbs.dtu.dk/services/TMHMM/).  
⁴ PRED_LIPO enables the prediction of lipoproteins in Gram positive bacteria (http://www.compgen.org/tools/PRED-LIPO).  
⁵ TatP 1.0 predicts the presence of twin arginine (TAT) signal peptides. D-sore > 0.36 predicts the presence of a TAT pathway signal 
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A.4 Glycoproteomics 
 
Table A.13 A full list of the high confidence glycopeptides identified by mass spectrometry using CID fragmentation.  
SCO 
Number Accession Expect score¹ Peptide sequence # Hex² 
Site 
allocation 
Time 
point 
Precursor 
ion m/z 
Retention 
time 
(min) Charge 
SCO0996 gi|499337797 3.00E-05 ATAPSAEGFPVTIDNCGVK 3 - 20 1210.56 75.7 2 
SCO4739 gi|499340123 1.10E-08 TEQSASAGGAEESAPAGK 3 - 20 1067.46 25.7 2 
SCO4739 gi|499340123 4.10E-06 TEQSASAGGAEESAPAGK 4 - 20 1148.48 25.1 2 
SCO4739 gi|499340123 2.50E-04 TEQSASAGGAEESAPAGK 6 - 20 874.023 24.3 3 
SCO4739 gi|499340123 3.40E-04 TEQSASAGGAEESAPAGK 9 - 20 1036.08 23.6 3 
SCO4739 gi|499340123 1.10E-03 TEQSASAGGAEESAPAGK 8 - 20 982.061 23.7 3 
SCO4739 gi|499340123 1.80E-03 TEQSASAGGAEESAPAGK 8 - 20 982.06 23.8 3 
SCO4739 gi|499340123 2.20E-03 TEQSASAGGAEESAPAGK 8 - 20 982.061 23.9 3 
SCO4739 gi|499340123 2.50E-03 TEQSASAGGAEESAPAGK 5 - 20 1229.5 24.8 2 
SCO4739 gi|499340123 1.20E-02 TEQSASAGGAEESAPAGK 7 - 20 928.04 24.1 3 
SCO4739 gi|499340123 2.90E-02 TEQSASAGGAEESAPAGK 7 - 20 928.045 24.3 3 
SCO4739 gi|499340123 3.40E-02 TEQSASAGGAEESAPAGK 8 - 20 982.063 23.8 3 
SCO4905 gi|490071893 1.60E-08 ATPGLPAQVFLLCGSSLVAVDR 3 - 20 919.788 121.6 3 
SCO4905 gi|490071893 1.90E-04 ATPGLPAQVFLLCGSSLVAVDR 2 - 20 865.783 122.5 3 
SCO4934 gi|499340251 2.30E-02 TSQAEVDEAAAK 3 - 20 853.378 27.9 2 
SCO5736 gi|490071116 5.00E-04 EGDTGSPEVQVALLSR 1 - 20 910.45 79.3 2 
SCO0472 gi|21219012 2.10E-04 GGGSTPSATPAASVQDPLVATFDGGLYILDGK 9 - 35 1507.67 136.5 3 
SCO0472 gi|21219012 1.00E-02 GGGSTPSATPAASVQDPLVATFDGGLYILDGK 9 - 35 1507.67 136.5 3 
SCO1714 gi|499338228 1.90E-02 TVTEPAADR 3 - 35 723.318 25.9 2 
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SCO 
Number Accession Expect score¹ Peptide sequence # Hex² 
Site 
allocation 
Time 
point 
Precursor 
ion m/z 
Retention 
time 
(min) Charge 
SCO3540 gi|21221959 5.50E-05 ATPAELSPYYEQK 2 - 35 910.927 53.2 2 
SCO4739 gi|499340123 4.50E-03 TEQSASAGGAEESAPAGK 8 - 35 982.063 23.3 3 
SCO4739 gi|499340123 8.70E-03 TEQSASAGGAEESAPAGK 9 - 35 1036.08 23.1 3 
SCO4739 gi|499340123 3.10E-02 TEQSASAGGAEESAPAGK 8 - 35 982.063 23.4 3 
SCO4847 gi|21223223 8.30E-04 SATAASPSAEASGEAGGTGK 9 - 20 1055.76 59.5 3 
SCO4847 gi|21223223 3.00E-04 SATAASPSAEASGEAGGTGK 9 - 35 1055.76 59.5 3 
SCO4934 gi|499340251 1.90E-04 TSQAEVDEAAAK 2 - 35 772.341 27.4 2 
SCO4934 gi|499340251 2.40E-04 TSQAEVDEAAAK 3 - 35 853.368 27 2 
SCO3357 gi|21221786 1.30E-02 DEGPAHADAVGGAGSASPAPAAK 6 - 43 992.761 35.9 3 
SCO3540 gi|21221959 1.90E-02 ATPAELSPYYEQK 2 T2 43 910.921 56.4 2 
SCO4934 gi|499340251 3.60E-03 TSQAEVDEAAAK 3 - 43 853.373 30.1 2 
SCO5204 gi|490071596 1.20E-02 QVQSQFNSEQDIAESIR 1 - 43 1071 73.2 2 
SCO6558 gi|499341298 1.20E-02 IPDITLER 1 T5 43 559.797 87.9 2 
SCO6558 gi|499341298 4.60E-02 IPDITLER 1 T5 43 559.798 85.6 2 
SCO4141 gi|499339752 4.00E-02 TPQPPATEDTRPGR 1 - 60 562.28 31.2 3 
SCO4739 gi|499340123 4.10E-03 TEQSASAGGAEESAPAGK 8 - 60 982.063 23.8 3 
SCO4905 gi|490071893 9.10E-03 ATEVPTDYGPAPSR 3 - 60 973.935 46.7 2 
SCO4934 gi|499340251 1.90E-04 TSQAEVDEAAAK 2 - 60 772.35 27.7 2 
SCO4934 gi|499340251 2.40E-02 TSQAEVDEAAAK 3 - 60 853.375 27.4 2 
SCO5115 gi|1532204 8.90E-03 AVDGLSFDLER 1 S6 60 692.336 103.6 2 
SCO5818 gi|499340768 4.10E-02 SPHAARLAALVTK 3 S1, T12 60 910.982 128.8 2 
¹ Expect value assigned to the glycopeptide match in the MASCOT search 
² Number of hexose residues on the glycopeptide. 
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Figure A.2 CID spectrum of the SCO5815 tryptic peptide SPHAARLAALVTK (aa 228 – 240) indicates Hex₂ on Ser228 and Hex on Thr239. Precursor m/z 910.981 
charge = 2+; retention time = 128.8 min; e-value = 4.10E-02. Product ions that contain the hexose are indicated by + Hex(n), where n = number of hexose 
residues. The precursor ion is indicated by a . (++) Indicates 2+ ion series. (0) Indicates ions that have lost H₂O. (*) Indicates ions that have lost NH₃ 
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Figure A.3 CID spectrum of the SCO6558 tryptic peptide IPDITLER (aa 100 – 107) indicates monohexosylation on Thr104. Precursor m/z 559.797; charge = 
2+; retention time = 87.9 min; e-value = 1.20E-02. Product ions that contain the hexose are indicated by + Hex(n), where n = number of hexose residues. The 
precursor ion is indicated by a (++) Indicates 2+ ion series. (0) Indicates ions that have lost H₂O. (*) Indicates ions that have lost NH₃. 
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Table A.14 A full list of the high confidence glycopeptides identified by mass spectrometry in the HCD_IT, ETD_IT and ETD_OT acquisitions. 
 
SCO 
Number Accession¹ 
Expect 
score² Peptide sequence 
# 
Hex³ 
Site 
allocation 
MD-
score⁴ Method 
Precursor 
ion m/z Charge Scan 
SCO0996 gi|21219513 8.20E-04 ATAPSAEGFPVTIDNCGVK 2 - - HCD_IT 753.3517 3 46383 
SCO0996 gi|21219513 2.10E-02 ATAPSAEGFPVTIDNCGVK 3 - - HCD_IT 1210.55 2 45042 
SCO2035 gi|21220516 6.60E-03 DDGSESAGPVVAPSGAQGK 2 - - HCD_IT 1026.959 2 14239 
SCO2096 gi|21220576 5.90E-03 KLDACPNESAVAVPVTGDDGPK 3 - - HCD_IT 909.4205 3 26945 
SCO2156 gi|21220633 1.50E-03 EGTFLGKCAELCGVDHSR 1 - - HCD_IT 733.3296 3 25242 
SCO2838 gi|21221288 2.00E-03 AAGAGITQQPK 2 T7 
Only 
possible 
site ETD_IT 683.3412 2 2576 
SCO2963 gi|21221408 6.50E-03 GRGSSDADR 1 - - ETD_IT 541.7381 2 8834 
SCO3044 gi|21221487 3.20E-05 GDAGQPSDEPAADSEIGVLVQNATR 3 - - HCD_IT 995.119 3 63502 
SCO3044 gi|21221487 6.40E-03 GDAGQPSDEPAADSEIGVLVQNATR 3 - - HCD_IT 995.1174 3 63661 
SCO3046 gi|32141189 3.10E-06 VAKPTPNAAGQTPLNILVIGSDAR 2 T5 32 ETD_OT 909.8197 3 
Sum of 2 
scans in 
range 
22872 to 
22874  
SCO3046 gi|32141189 8.60E-05 VAKPTPNAAGQTPLNILVIGSDAR 2 - - HCD_IT 909.8185 3 56534 
SCO3184 gi|32141194 1.10E-05 ATVETAAPDRGDGYGVALR 1 - 4.1 ETD_OT 694.3423 3 9131 
SCO3184 gi|32141194 2.60E-04 ATVETAAPDRGDGYGVALR 1 - 8.4 ETD_IT 694.3432 3 10892 
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SCO 
Number Accession¹ 
Expect 
score² Peptide sequence 
# 
Hex³ 
Site 
allocation 
MD-
score⁴ Method 
Precursor 
ion m/z Charge Scan 
SCO3184 gi|32141194 1.60E-03 ATVETAAPDRGDGYGVALR 1 - 2.1 ETD_OT 694.3431 3 
Sum of 2 
scans in 
range 
10601 to 
10603 
SCO3184 gi|32141194 1.40E-03 KATVETAAPDRGDGYGVALR 1 - - HCD_IT 737.0407 3 
Sum of  
scans in 
range 
16301 to 
16323 
SCO3184 gi|32141194 4.50E-02 KATVETAAPDRGDGYGVALR 1 - - HCD_IT 737.0419 3 16390 
SCO3353 gi|21221782 1.60E-05 KPSAPECGTPPAGSAK 2 T9 35.2 ETD_OT 626.9599 3 2027 
SCO3353 gi|21221782 5.50E-04 KPSAPECGTPPAGSAK 2 - - HCD_IT 939.9368 2 4189 
SCO3353 gi|21221782 7.10E-04 KPSAPECGTPPAGSAK 3 - - HCD_IT 680.9775 3 4050 
SCO3353 gi|21221782 7.80E-04 KPSAPECGTPPAGSAK 2 T9 28.2 ETD_IT 626.9593 3 2303 
SCO3353 gi|21221782 1.50E-03 KPSAPECGTPPAGSAK 3 T9 15.5 ETD_OT 680.9777 3 1965 
SCO3353 gi|21221782 1.60E-03 KPSAPECGTPPAGSAK 3 T9 23.5 ETD_IT 680.9773 3 2241 
SCO3357 gi|21221786 2.90E-02 ASPSKAPDRVDAVR 6 - - ETD_IT 814.373 3 2155 
SCO3357 gi|21221786 7.60E-04 DEGPAHADAVGGAGSASPAPAAK 6 S15 S17 
Only 
possible 
sites ETD_OT 992.7591 3 
Sum of 2 
scans in 
range 
2970 to 
2972 
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SCO 
Number Accesion¹ 
Expect 
score² Peptide sequence 
# 
Hex³ 
Site 
allocation 
MD-
score⁴ Method 
Precursor 
ion m/z Charge Scan 
SCO4130 gi|21222529 6.50E-05 
TSATAPSGTRPVQSGFAHDAQ 
GAQSAAANYAVALGSDGMFDK 2 - - HCD_IT 1109.511 4 58511 
SCO4130 gi|21222529 3.60E-04 
TSATAPSGTRPVQSGFAHDAQ 
GAQSAAANYAVALGSDGMFDK 2 - 4.7 HCD_IT 1109.514 4 
Sum of 2 
scans in 
range 
23637to 
23639  
SCO4130 gi|21222529 9.80E-03 
TSATAPSGTRPVQSGFAHDAQ 
GAQSAAANYAVALGSDGMFDK 2 - - HCD_IT 1113.511 4 
Sum of 2 
scans in 
range 
21239 to 
21241 
SCO4141 gi|21222539 2.10E-04 TPQPPATEDTRPGR 1 T1 27.8 ETD_OT 562.2769 3 
Sum of 2 
scans in 
range 
2571 to 
2584  
SCO4141 gi|21222539 4.10E-03 TPQPPATEDTRPGR 1 T1 13 ETD_OT 562.2767 3 2323 
SCO4141 gi|21222539 6.10E-03 TPQPPATEDTRPGR 1 T1 21.7 ETD_IT 562.2783 3 
Sum of 2 
scans in 
range 
2611  to 
2665 
SCO4141 gi|21222539 3.70E-02 TPQPPATEDTRPGR 1 - - HCD_IT 842.9104 2 5650 
SCO4142 gi|21222540 7.80E-04 
ADTLPATKSFLNYMASED 
GQGLLADAGYAPMPTEIITK 1 - - HCD_IT 1388.343 3 91188 
SCO4142 gi|21222540 4.80E-02 CDDAKGQLQASGSSAQK 1 - - HCD_IT 956.9326 2 4208 
Appendix 
236 
 
SCO 
Number Accesion¹ 
Expect 
score² Peptide sequence 
# 
Hex³ 
Site 
allocation 
MD-
score⁴ Method 
Precursor 
ion m/z Charge Scan 
SCO4142 gi|21222540 8.10E-03 DGIKTVDVK 1 T5 
Only 
possible 
site ETD_OT 379.5407 3 3598 
SCO4142 gi|21222540 3.60E-05 
GGQSAQGSSGLAGQV 
KQTPGAISYFELSYAK 1 - - HCD_IT 1083.868 3 58627 
SCO4142 gi|21222540 2.80E-03 QTPGAISYFELSYAKDGIK 1 S12 24.8 ETD_IT 750.7115 3 24203 
SCO4142 gi|21222540 1.90E-03 TAAAEPVKATVENATAAIGAAK 1 - - HCD_IT 739.7253 3 42536 
SCO4142 gi|21222540 1.70E-02 TAAAEPVKATVENATAAIGAAK 1 - 0.8 ETD_IT 739.7249 3 
Sum of 2 
scans in 
range 
18332 to 
18361 
SCO4142 gi|21222540 1.40E-02 
VCKDGQAIDLPMVGGPIAV 
GFNVTGVDSLVLDAPTMAK 1 - - HCD_IT 1345.343 3 92043 
SCO4256 gi|21222651 1.80E-02 GGGGGGGGESKKPKPPVR 3 S10 
Only 
possible 
site ETD_OT 527.7643 4 
Sum of 2 
scans in 
range 
1711 to 
1712  
SCO4307 gi|21222700 6.00E-03 LIYAGAGTAGR 1 T8 
Only 
possible 
site ETD_IT 404.5446 3 6751 
SCO4548 gi|32141241 4.20E-04 TTSSSSSTAPSAPSAPR 1 - - HCD_IT 877.4079 2 6204 
SCO4885 gi|21223231 8.10E-07 SDQAPEPGFADSPYITVTFR 1 - - HCD_IT 1180.552 2 71923 
SCO4905 gi|21223279 7.20E-05 ATPGLPAQVFLLCGSSLVAVDR 2 - - HCD_IT 865.7785 3 88724 
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SCO 
Number Accesion¹ 
Expect 
score² Peptide sequence 
# 
Hex³ 
Site 
allocation 
MD-
score⁴ Method 
Precursor 
ion m/z Charge Scan 
SCO4905 gi|21223279 2.40E-02 ATPGLPAQVFLLCGSSLVAVDR 3 - - HCD_IT 919.7954 3 88232 
SCO4968 gi|21223341 9.10E-06 VDFKEPAEQDASAGPEAKPQR 1 S12 
Only 
possible 
site ETD_OT 811.3916 3 
Sum of 2 
scans in 
range 
6230 to 
6232  
SCO4968 gi|21223341 3.20E-02 VDFKEPAEQDASAGPEAKPQR 1 S12 
Only 
possible 
site HCD_IT 811.3906 3 13570 
SCO5646 gi|21223997 5.90E-03 AILTKDNPQGDVFFGVDNTLLSR 1 - - HCD_IT 894.7915 3 72287 
SCO5751 gi|21224097 4.40E-04 KPADPKPEPSDSAIAAAPADKVTVK 6 S10 S12 31.8 ETD_OT 869.6701 4 
Sum of 4 
scans in 
range 
4856 to 
4896 
SCO5751 gi|21224097 2.90E-03 KPADPKPEPSDSAIAAAPADKVTVK 6 S10 S12 28 ETD_OT 695.9383 5 4335 
SCO5776 gi|21224122 1.30E-03 SEKVDFAGPYLLAHQDVLIR 1 S1 
Only 
possible 
site HCD_IT 609.072 4 60208 
SCO7218 gi|21225495 6.60E-04 ASSGGHYPVTVENCGEK 3 - 7.8 ETD_OT 759.9905 3 
Sum of 2 
scans in 
range 
3702 to 
3705 
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SCO 
Number Accesion¹ 
Expect 
score² Peptide sequence 
# 
Hex³ 
Site 
allocation 
MD-
score⁴ Method 
Precursor 
ion m/z Charge Scan 
SCO7218 gi|21225495 2.70E-02 ASSGGHYPVTVENCGEK 3 - - ETD_OT 759.9905 3 3332 
SCO7218 gi|21225495 4.70E-03 ASSGGHYPVTVENCGEKLTFEK 3 - 6.1 ETD_IT 724.83 4 11845 
 
¹ GenBank accession number 
² Expect value assigned to the glycopeptide match in the MASCOT search 
³ Number of hexose residues on the glycopeptide. 
⁴ The difference between the MASCOT ion scores for the two best alternative modification sites in the same peptide, assigned by the database search. The 
MD-score for HCD was not considered to be reliable and therefore is not reported. Sites within glycopeptides containing only one possible glycosylated residue 
were automatically assigned. 
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Figure A.4 ETD spectrum of the SCO3046 tryptic peptide VAKPTPNAAGQTPLNILVIGSDAR (aa 43 – 66) indicates Hex₂ on Thr47. Precursor m/z 909.819; 
charge = 3+; retention time = 89.4 min; scan = 22874; e-value = 3.10E-06; method = HCD_IT, ETD_OT. Product ions that contain the hexose are indicated by 
+ Hex(n), where n = number of hexose residues. (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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Figure A.5 ETD spectrum of the SCO4938 tryptic peptide VDFKEPAEQDASAGPEAKPQR (aa 54 – 74) indicates Hex on Ser65. Precursor m/z 811.391; charge 
= 3+; retention time = 31.4 min; scan = 6232; e-value = 9.10E-06; method = ETD_OT. Product ions that contain the hexose are indicated by + Hex(n), where n 
= number of hexose residues. (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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Figure A.6 ETD spectrum of the SCO3353 tryptic peptide KPSAPECGTPPAGSAK (aa 86 – 101) indicates Hex₂ on Thr94. Precursor m/z 626.959; charge = 3+; 
retention time = 17.5 min; scan = 2027; e-value = 1.60E-05; method = HCT_IT, ETD_IT, ETD_OT. Product ions that contain the hexose are indicated by + Hex(n), 
where n = number of hexose residues.  
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Figure A.7 ETD spectrum of the SCO3353 tryptic peptide KPSAPECGTPPAGSAK (aa 86 – 101) indicates Hex₃ on Thr94. Precursor m/z 680.977; charge = 3+; 
4retention time = 17.3 min; scan = 4050; e-value = 7.10E-04; method = HCT_IT, ETD_IT, ETD_OT. Product ions that contain the hexose are indicated by + 
Hex(n), where n = number of hexose residues.  
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Figure A.8 ETD spectrum of the SCO4141 tryptic peptide TPQPPATEDTRPGR (aa 15 – 28) indicates Hex on Thr15. Precursor m/z 562.276 charge = 3+; 
retention time = 18.7 min; scan = 2571; e-value = 2.10E-04; method = HCD_IT, ETD_OT, ETD_IT. Product ions that contain the hexose are indicated by + Hex(n), 
where n = number of hexose residues. (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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Figure A.9 ETD spectrum of the SCO5751 tryptic peptide KPADPKPEPSDSAIAAAPADKVTVK (aa 184 – 207) indicates a trihexose on both Ser193 and Ser195. 
Precursor m/z 695.938 charge = 5+; retention time = 26.8 min; scan = 4858; e-value = 4.40E-04; method = ETD_OT. Product ions that contain the hexose are 
indicated by + Hex(n), where n = number of hexose residues. (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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Figure A.10 ETD spectrum of the SCO3357 tryptic peptide DEGPAHADAVGGAGSASPAPAAK (aa 23 – 45) indicates a trihexose on both Ser37 and Ser39. 
Precursor m/z 938.741 charge = 3+; retention time = 20.4 min; scan = 2972; e-value = 7.60E-04; method = ETD_OT. Product ions that contain the hexose are 
indicated by + Hex(n), where n = number of hexose residues. (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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Figure A.11 HCD spectrum of the SCO5776 tryptic peptide SEKVDFAGPYLLAHQDVLIR (aa 114 – 133) indicates a hexose on Ser114. Precursor m/z 609.072 
charge = 4+; retention time = 94.1 min; scan = 60208; e-value = 1.30E-03; method = HCD_IT. Product ions that contain the hexose are indicated by + Hex(n), 
where n = number of hexose residues. The precursor ion is indicated by a (++) Indicates 2+ ion series. (0) Indicates ions that have lost H₂O. (*) Indicates 
ions that have lost NH₃ 
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Figure A.12 ETD spectrum of the SCO2838 tryptic peptide AAGAGITQQPK (aa 32 – 42) indicates Hex₂ on Thr38. Precursor m/z 683.3412 charge = 2+; retention 
time = 18.5 min; scan = 2576; e-value = 2.00E-03; method = ETD_IT. Product ions that contain the hexose are indicated by + Hex(n), where n = number of 
hexose residues. The precursor ion is indicated by a (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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Figure A.13 ETD spectrum of the SCO4307 tryptic peptide LIYAGAGTAGR (aa 76 – 86) indicates a hexose on Thr83. Precursor m/z 404.5446 charge = 3+; 
retention time = 32.5 min; scan = 6751; e-value = 6.00E-04; method = ETD_IT. Product ions that contain the hexose are indicated by + Hex(n), where n = 
number of hexose residues. The precursor ion is indicated by a (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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Figure A.14 ETD spectrum of the SCO4142 tryptic peptide DGIKTVDVK (aa 255 – 263) indicates a hexose on Thr259. Precursor m/z 379.5407 charge = 3+; 
retention time = 23.9 min; scan = 3598; e-value = 8.10E-03; method = ETD_OT. Product ions that contain the hexose are indicated by + Hex(n), where n = 
number of hexose residues. (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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Figure A.15 ETD spectrum of the SCO4356 tryptic peptide GGGGGGGGESKKPKPPVR (aa 308 – 325) indicates a trihexose on Ser317. Precursor m/z 527.7643 
charge = 4+; retention time = 15.5 min; scan = 1712; e-value = 8.10E-02; method = ETD_OT. Product ions that contain the hexose are indicated by + Hex(n), 
where n = number of hexose residues. (++) Indicates 2+ ion series. (+2) Indicates z+2 ions. 
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A.5 Glycomics 
 
Figure A.16 MALDI-TOF-MS spectrum of permethylated S. coelicolor glycans alongside a mock glycan preparation from a blank SDS-PAGE gel. S. coelicolor 
glycans (A) were prepared alongside an in-gel β-elimination of a protein free section of SDS-PAGE gel (B). Panel C indicates a matrix blank. This analysis was 
carried out by Rachel Bates at the University of York Bioscience Technology Facility. 
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Figure A.17 GC mass spectrum confirming terminal mannose in the mannose standard (A) 
and the S. coelicolor glycans (B). Diagnostic fragment ions of m/z 118, 162, 205, 161, 129, 
145 and 102 are indicated. 
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Figure A.18 GC mass spectrum confirming 4-substituted mannose in the mannose standard 
(A) and the S. coelicolor glycans (B). Diagnostic fragment ions of m/z 118, 162, 233 and 173 
are indicated. 
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Figure A.19 GC mass spectrum confirming 4-substituted glucose in the glucose standard (A) 
and the S. coelicolor glycans (B). Diagnostic fragment ions of m/z 118, 162, 233 and 173 are 
indicated. 
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Figure A.20 GC mass spectrum confirming terminal glucose in the glucose standard (A) and 
the S. coelicolor glycans (B). Diagnostic fragment ions of m/z 118, 162, 205, 161, 129, 145 
and 102 are indicated.
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Figure A.21 GC chromatograms showing the co-elution of peaks in the S. coelicolor glycan 
sample with peaks in the PMAAs mannose and glucose standards. Panels show peaks 
corresponding to: A. 2-substituted mannose. B. terminal mannose. C. 4-substituted 
mannose. D. 4-substituted glucose. E. Terminal glucose. 
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A.6 Sequencing data 
Figure A. 22 Sequencing of the mutated sco4934 genes in pTAK48 – pTAK53 to confirm the 
mutations introduced by site directed mutagenesis. Red arrows indicate the positions of 
the mutations. 
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Abbreviations 
 
Abbreviation Description 
~ approximately 
°C degree Celsius 
µg microgram 
µL microliter 
Asn asparagine   
CID collision induced dissociation 
Con A Concanavalin A 
Con A-HRP 
Concanavalin A from Canavalia ensiformis (Jack bean) peroxidase 
conjugate 
CV column volume 
ddH₂O double distilled water 
DNA Deoxyribonucleic acid  
DNB Difco nutrient broth 
Dol Dolichol 
ER endoplasmic reticulum  
ETD electron transfer dissociation 
eV  electron volt 
x g times gravity 
g gram 
GalNAc N-acetylgalactosamine  
GDP Guanosine diphosphate 
GlcNAc N-acetylglucosamine 
h hour 
Hex hexose 
kPsi  kilopound per square inch, Pressure 
LB Luria-Burtani mediuma 
LC-ESI-
MS/MS 
Liquid chromatography coupled to electrospray ionisation tandem mass 
spectrometry 
LC-MS Liquid chromatography coupled to mass spectrometry 
MALDI-FT-
ICR-MS  
Matrix-assisted laser desorption/ionization Fourier transform ion 
cyclotron resonance tandem mass spectrometry 
MALDI-TOF-
MS 
Matrix-assisted laser desorption/ionization time of flight mass 
spectrometry 
Man mannose 
MeOH methanol 
mg milligram 
min minute 
mL millilitre 
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Abbreviation Description 
MSA mannitol soya flour agar 
MurNAc N-acetylmuramic acid 
MW molecular weight 
NEB New England Biolabs 
N-linked asparagine linked 
nm nanometre 
O-linked serine/threonine linked 
OST oligosaccharyl transferase  
PCR polymerase chain reaction 
pmt protein O-mannosyl transferase (gene) 
Pmt protein O-mannosyl transferase (protein) 
PP  polyprenol phosphate 
ppm1 polyprenol phosphate mannose synthase (gene) 
Ppm1 polyprenol phosphate mannose synthase (protein) 
rpm revolutions per minute 
RT room temperature 
s second 
SDS-PAGE 
Sodium dodecyl sulfate Polyacrylamide gel 
electrophoresis  
Ser serine  
TFA trifluoroacetic acid 
Thr threonine 
UV Ultraviolet 
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